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Abstract 
The purpose of these studies was to investigate the impact of high-fat diet (HFD) 
exposure during pregnancy and the early post-natal period on fetal and post-natal 
development of the endocrine pancreas of the Japanese macaque.  Specifically I 
hypothesized that the HFD would alter islet morphology and lead to disturbances in 
glucose homeostasis in these animals.  
Adult female Japanese macaques were placed on either a control (CTR) or HFD 
diet for 4 years.  Fetuses were collected at gestational day 130 (G130), while other 
offspring  from the CTR and HFD mothers were carried to term. After birth, infant 
animals were maintained with their mothers on the same diet then weaned onto either the 
CTR or HFD diet for five months. Animals were studied up to 13 months of age, yielding 
4 postnatal groups: CTR/CTR, CTR/HFD, HFD/CTR and HFD/HFD. Pancreata were 
collected from these offspring for gene expression and immunohistochemical analysis. 
Physiological measurements, including body weight, body fat percentage, fasting 
glucose, insulin, glucagon and response to intravenous glucose tolerance tests (IVGTTs) 
and an intravenous insulin tolerance test (IVITT) were collected from the post-natal 
offspring. 
Total fetal islet mass and β cell mass were not changed, but α cell mass was 
significantly decreased in HFD fetuses, leading to a significant increase in the β cell to α 
cell ratio in HFD fetal offspring. The HFD offspring displayed a significant change from 
CTR offspring in expression of genes involved in glucose homeostasis and islet 
neogenesis, including PDX1, NeuroD, Glucokinase and Glut2. Postnatal HFD animals 
were significantly heavier than CTR offspring and had increased adiposity by 6-7 months 
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of age.  There was no significant effect on fasting or stimulated insulin secretion at this 
time point, but HFD offspring were significantly insulin resistant just prior to weaning.  
At 13 months of age, basal and glucose-stimulated insulin secretion were elevated 
in HFD/HFD animals and the CTR/HFD group displayed moderate insulin resistance. 
There was also a significant sex effect, with males from the HFD/CTR and HFD/HFD 
group having increased body weight and elevated fasting glucose. Although pancreata 
from both the HFD/HFD and CTR/HFD animals displayed significant changes in 
expression of genes involved in glucose homeostasis, the pattern was distinct for the two 
groups. Islet mass was also elevated in both of these groups; yet, HFD/HFD only 
displayed an increase in β cell area, while CTR/HFD had a concomitant increase in α cell 
area, which served to normalize the β cell to α cell ratio to control levels. In contrast, the 
HFD/HFD group exhibited a 40% increase in the β cell to α cell ratio. 
These studies demonstrate that in-utero exposure to a HFD leads to decreased α 
cell plasticity in response to chronic post-natal HFD consumption. Animals exposed to 
the HFD during pregnancy and the early post-natal period become insulin resistant, but 
remain normoglycemic. HFD consumption during the post-weaning period causes similar 
complications in glucose homeostasis and islet mass in both the CTR/HFD and 
HFD/HFD animals. However, there are distinct differences in the molecular and cellular 
adaptive response between these two groups. 
 
 
 
 
Comstock, iii 
Dedication 
 
 
To my husband, Ben Comstock 
You are my rock and encouragement.   
Thank you for your love and support.   
 
 
To my son, Droiy Comstock 
 You are my inspiration and my joy.   
Thank you for your love and enthusiasm. 
  
Comstock, iv 
Acknowledgments 
I would like to acknowledge and thank all those who have helped make this 
research possible.  First I am grateful to the members of my committee. Thank you, Dr. 
Kevin Grove for mentoring me and allowing me to complete my research in your lab.  
Thank you, Dr.  Keith Garlid for your willingness to support me in the accomplishment 
of this research.  Thank you to the other members of my committee, Dr. Bradley 
Buckley, Dr. Jason Podrabsky, Dr. David Peyton and Dr. Charles Roberts, for being 
supportive and flexible.   
I am grateful to the members of my lab.  Thank you, Anne Evans for introducing 
me to laboratory research and for being a supportive friend through both the fortunate and 
difficult chapters of the past 10 years. Thank you, Diana Takahashi for taking over the 
NHP projects and being a gracious manager and friend. I am grateful to the members of 
the Gestational Diabetes Mellitus Team and the Obese Resource Team from the 
Grove Laboratory who are dedicated to the care of our animals. 
I also want to acknowledge and thank the technical assistance of many at the 
Oregon National Primate Research Center, including the Division of Animal Resources, 
the Veterinary Staff, the RIA Core, and the Imaging Core. 
I am also grateful to the members of my family for their support and 
encouragement throughout the completion of my PhD research.  Thank you, Gary and 
Julie Williams, Tim and Sandra Joachim, Alex Williams and Jeff, Maureen and 
Jenny Comstock for your love and support. 
 
  
Comstock, v 
Table of Contents 
Abstract ................................................................................................................................ i 
Dedication .......................................................................................................................... iii 
Acknowledgments.............................................................................................................. iv 
List of Tables ................................................................................................................... viii 
List of Figures .................................................................................................................... ix 
List of Abbreviations ......................................................................................................... xi 
Chapter 1:  Background and Introduction ..................................................................... 1 
Introduction ................................................................................................................. 2 
Obesity ......................................................................................................................... 5 
Homeostasis ................................................................................................................. 7 
Pancreas Morphology, Function and Development .................................................... 9 
Type 2 Diabetes Mellitus and the Glucolipotoxicity Hypothesis .............................. 14 
Animal Models of Maternal Overnutrition ................................................................ 17 
Animal Models of Intrauterine Growth Restriction .................................................. 20 
Chapter 1 Figures....................................................................................................... 23 
Chapter 1 Table ......................................................................................................... 28 
Chapter 2: Model and Study Design ............................................................................. 30 
A Nonhuman Primate Model of Maternal HFD Consumption ................................. 31 
Metabolic Syndrome and Type 2 Diabetes Mellitus in the Macaque ........................ 35 
Comstock, vi 
Effect of Maternal HFD Consumption on NHP Offspring........................................ 36 
Specific Aims ............................................................................................................ 39 
Chapter 2 Figures....................................................................................................... 41 
Chapter 2 Table ......................................................................................................... 44 
Chapter 3: Maternal High-fat Diet Consumption During Pregnancy Leads to 
Reduced α Cell Mass in Fetal Offspring ....................................................................... 46 
Introduction ............................................................................................................... 47 
Materials and Methods .............................................................................................. 49 
Results ....................................................................................................................... 53 
Discussion .................................................................................................................. 57 
Chapter 3 Figures....................................................................................................... 62 
Chapter 3 Tables ........................................................................................................ 69 
Chapter 4: High-Fat Diet During Perinatal Development Leads to Early Insulin 
Resistance in the Nonhuman Primate Infant ............................................................... 73 
Introduction ............................................................................................................... 74 
Materials and Methods .............................................................................................. 75 
Results ....................................................................................................................... 77 
Discussion .................................................................................................................. 79 
Chapter 4 Figures....................................................................................................... 81 
Chapter 4 Tables ........................................................................................................ 85 
Comstock, vii 
Chapter 5: Chronic High-Fat Diet Consumption During Pregnancy and the Early 
Postnatal Period Leads to Decreased α Cell Plasticity in the Juvenile Nonhuman 
Primate ............................................................................................................................. 89 
Introduction ............................................................................................................... 90 
Materials and Methods .............................................................................................. 92 
Results ....................................................................................................................... 96 
Discussion ................................................................................................................ 100 
Chapter 5 Figures..................................................................................................... 106 
Chapter 5 Tables ...................................................................................................... 116 
Chapter 6: Limitations and Future Studies................................................................ 122 
Limitations of the HFD Fed Macaque Model ......................................................... 123 
Future Study Recommendations .............................................................................. 125 
Chapter 7: Summary and Discussion .......................................................................... 130 
Fetal Effects of the Maternal HFD .......................................................................... 132 
Post-natal Effects of the HFD .................................................................................. 135 
Chapter 7 Figures..................................................................................................... 138 
Works Cited ................................................................................................................... 143 
 
  
Comstock, viii 
List of Tables 
Table 1.1: Embryonic/Fetal Development of the Pancreas in Macaques and Humans .... 29 
Table 2.1: Post-natal offspring groups .............................................................................. 45 
Table 3.1: Comparison of CTR and HFD Fetuses ............................................................ 70 
Table 3.2: Real-time RT-PCR Gene Expression in Fetal Pancreas .................................. 71 
Table 3.3: Comparison of CTR and HFD Dams............................................................... 72 
Table 4.1: Physiology of P30 and P90 Offspring ............................................................. 86 
Table 4.2: Physiology of P180 and P210 Offspring ......................................................... 87 
Table 4.3: Physiology of Dams of Infant Offspring ......................................................... 88 
Table 5.1: Juvenile Physiology ....................................................................................... 117 
Table 5.2: Juvenile Female Physiology .......................................................................... 118 
Table 5.3: Juvenile Male Physiology .............................................................................. 119 
Table 5.4: Real-time PCR Values of Juvenile Pancreas ................................................. 120 
Table 5.5: α cell and β cell Measurements...................................................................... 121 
 
  
Comstock, ix 
List of Figures 
Figure 1.1: Metabolic Syndrome ...................................................................................... 24 
Figure 1.2: Diagram of Glucose Homeostasis .................................................................. 25 
Figure 1.3: Diagram of Fully Formed Pancreas................................................................ 26 
Figure 1.4: Glucose-stimulated Insulin Secretion in the β cell ......................................... 27 
Figure 2.1: Characterization of CTR and HFD Dams ...................................................... 42 
Figure 2.2: Characterization of Metabolic Syndrome and Diabetes in Females .............. 43 
Figure 3.1: Diagram of Pancreas Sections ........................................................................ 63 
Figure 3.2: Immunohistochemical Analysis of Fetal Islet Mass....................................... 64 
Figure 3.3: Islet Characterization in Fetal Offspring ........................................................ 65 
Figure 3.4: β cell Correlation Analysis ............................................................................. 66 
Figure 3.5: Transcription Factor Expression in Fetal Pancreas ........................................ 67 
Figure 3.6: Expression of Genes Involved in Glucose-stimulated Insulin Secretion in 
Fetal Pancreas ................................................................................................................... 68 
Figure 4.1: P30 Physiology ............................................................................................... 82 
Figure 4.2: P90 Physiology and Maternal IVGTT IAUC ................................................. 83 
Figure 4.3: P180 and P210 Physiology ............................................................................. 84 
Figure 5.1: Juvenile Physiology ...................................................................................... 107 
Figure 5.2: Sex Differences in Body Weight and Fasting Glucose ................................ 108 
Figure 5.3: Juvenile Islet Mass and Contributing Factors .............................................. 109 
Figure 5.4: Relative Mass, Diameter and Density of Islets ............................................ 110 
Figure 5.5: α cell and β cell Mass ................................................................................... 111 
Figure 5.6:  β cell and α cell Quantification ................................................................... 112 
Comstock, x 
Figure 5.7: Gene Expression in Juvenile Pancreas ......................................................... 113 
Figure 5.8: Normalized Gene expression in Juvenile Pancreas ...................................... 114 
Figure 5.9: Glut2 versus Glut1 Expression ..................................................................... 115 
Figure 7.1: Islet Development in the CTR versus HFD Offspring ................................. 139 
Figure 7.2: Islet Paracrine Function – Glucagon Regulation of Insulin Secretion ......... 140 
Figure 7.3: Islet Paracrine Function – Insulin Regulation of Glucagon Secretion ......... 141 
Figure 7.4: Pathological Progression to T2DM .............................................................. 142 
 
 
  
Comstock, xi 
List of Abbreviations 
Cldu – 5-chlorodeoxyuridine 
CNS – central nervous system 
CTR – control  
CTR/CTR – postnatal offspring born to a mother on a CTR diet and maintained on this 
diet until necropsy at 13 months of age. 
CTR/HFD – postnatal offspring born to a mother on a CTR diet and switched to the HFD 
after weaning at approximately 8 months of age. 
CVD – cardiovascular disease 
DHA - docosahexaenoic acid 
FFA – free fatty acid 
G130 –fetus collected by c-section at 130 days gestation 
GIP – gastric inhibitory peptide 
GK - glucokinase 
GLP-1 – glucagon like peptide-1 
GLUT1 – facilitated glucose transporter 1 
Comstock, xii 
GLUT2 – faciltiated glucose transporter 2 
GLUT5 – facilitated glucose transporter 5 
GR – glucagon receptor 
GSIS – glucose-stimulated insulin secretion 
HFD – high-fat diet 
HFD/CTR – postnatal offspring born to a mother on a HFD and switched to the CTR diet 
after weaning at approximately 8 months of age 
HFD/HFD – postnatal offspring born to a mother on a HFD and maintained on this diet 
until necropsy at 13 months of age. 
HGP – hepatic glucose production 
HNF4α – hepatocyte nuclear factor 4 alpha is a transcription factor that facilitates 
KCNJ11 transcription 
IAPP – islet amyloid polypeptide 
Idu – 5-iododeoxyuridine 
INGAP – islet neogenesis-associated protein 
IR – insulin receptor 
Comstock, xiii 
IUGR – intra-uterine growth restriction 
IVGTT – intravenous glucose tolerance test 
IVITT – intravenous insulin tolerance test 
KATP – potassium sensitive ATP channel 
KCNJ11 – gene encoding for Kir6.2 
Kir6.2 - inward rectifier K+ channel subunit of the KATP channel in islet cells 
MafA – musculoaponeurotic fibrosarcoma oncogene homolog A 
MetS – metabolic syndrome 
NAFLD – non-alcoholic fatty liver disease 
NHP – nonhuman primate 
NKX6.1 – NK6 homeobox 1 is a transcription factor expressed in β cells 
NeuroD – also called BETA2 is a transcription factor expressed in islet cells 
P30 – postnatal day 30 in NHP offspring 
P90 – postnatal day 90 in NHP offspring 
P180 – postnatal day 180 in NHP offspring 
Comstock, xiv 
P210 – postnatal day 210 in NHP offspring 
PCR – polymerase chain reaction 
PCK1 - phosphoenolpyruvate carboxykinase 1 is a transcription factor involved in 
hepatic gluconeogenesis 
PDX1 – pancreatic duodenal homeobox 1 is a transcription factor expressed in the 
pancreas 
PGC1A - peroxisome proliferator-activated receptor gamma coactivator-1 alpha is a 
transcription factor involved in hepatic gluconeogenesis 
PUFA – polyunsaturated fatty acid 
qRT-PCR – quantitative reverse-transcription PCR 
SUR1 – sulfonylurea receptor 1subcomponent of the KATP channel in islet cells 
T2DM – Type 2 Diabetes Mellitus 
TG – triglyceride 
TUNEL - terminal deoxynucleotidyl transferase dUTP nick end labeling 
 
 
 
Comstock, 1 
 
 
 
 
 
 
 
Chapter 1:  Background and Introduction 
 
  
Comstock, 2 
Introduction 
The framework of my research is based on the theory that environmental stimuli 
during fetal development lead to adaptations in the fetus to prepare it for post-natal life 
conditions.  This concept was first presented by Dr. David Barker, a physician and 
professor of clinical epidemiology at the University of Southampton and a professor in 
the Department of Cardiovascular Medicine at Oregon Health and Science University.  
Based on his research in epidemiology, Dr. Barker presented the now widely accepted 
theory that disturbed intrauterine growth has a negative influence on fetal development 
which leads to an increased risk for multiple diseases later in life, such as Type 2 
Diabetes Mellitus (T2DM) and cardiovascular disease (CVD) (Barker, Winter, Osmond, 
Margetts, & Simmonds, 1989; Hales & Barker, 1992). During fetal development, the in-
utero environment is significantly affected by maternal health and nutrition.  The 
conditions at this stage provide a signal to the fetus of what to expect after birth.  The 
fetus often adapts to early life stress, such as malnourishment, by trading off the 
development of less critical organs, such as the pancreas, in favor of maintaining the 
development of essential organs such as the brain. These adaptations allow the fetus to 
survive until birth while maintaining critical organs that are essential for post-natal 
survival.  However, poor development of less essential organs usually leads to significant 
health complications during later life. 
Many studies on humans and animals support this hypothesis.  However, a unique 
human population, composed of adult children born to mothers who were pregnant 
during the Dutch famine,  provides distinctive insight into the link between fetal 
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undernutrition and adverse post-natal health effects (Smith, 1947a). This famine lasted 
from November 1944 to May 1945 due to an exhaustion of food supplies during World 
War II in the western portion of the Netherlands. At the height of the famine, official 
rations fell to between 400 and 800 calories per day.  While pregnant and lactating 
women were entitled to additional food, supplies were insufficient to accommodate this 
need.  However, when the Netherlands was liberated in May 1945, food rations rose 
nearly immediately to over 2000 calories per day (T. Roseboom, de Rooij, & Painter, 
2006).  Studies performed on survivors of this famine demonstrated that babies born 
during the famine were growth restricted, weighing about 200 grams lighter at birth than 
those born to the same mothers not during the famine (Smith, 1947b). Offspring during 
their adult life were also found to have an increased risk for developing T2DM and CVD 
(Ravelli et al., 1998; T. J. Roseboom et al., 2000).  The health complications observed in 
the Dutch famine adult offspring demonstrate a significant effect of fetal malnourishment 
on adult health outcomes.  Based on this and many other studies of fetal intra-uterine 
growth restriction (IUGR), Dr. Barker hypothesized that fetuses that undergo IUGR 
develop a “thrifty phenotype,” which makes them more likely to conserve energy and 
become obese later in life. The early life undernutrition permanently changes glucose-
insulin metabolism which leads to insulin resistance and reduced insulin secretion 
(Phillips, 1996).  This ultimately leads to an increased incidence of obesity and T2DM 
within this population (Hales & Barker, 1992).   
Although fetal malnoushiment may be an expected concern in developing 
countries, where many young women of child-bearing years are chronically under-
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nourished, it is also a concern in Western countries, such as those in North America and 
the Europen Union. It is important to understand that both maternal undernutrition and 
overnutrition can result in fetal malnourishment, when inappropriate nutrients are 
delivered to the fetus.  For example, in the case of overnutrition, maternal consumption of 
high calorie diets has been demonstrated to lead to fetal malnoushishment because these 
diets are unbalanced in macronutrients and deficient in micronutrients necessary for 
normal fetal development (Shafrir & Khassis, 1982). These diets are usually rich in 
carbohydrates and saturated fat, but deficient in protein and essential vitamins, which 
directly affect fetal nutrient availability (Rao et al., 2001; Villar et al., 2003).  Also, the 
diets have a direct impact on the health of the mother, because consumption of a high 
calorie diet usually leads to the development of obesity. Maternal obesity can greatly 
affect the nutrient supply to the fetus because placental function is significantly affected 
if a mother is excessively overweight (Farley et al., 2009; Radaelli et al., 2009; 
Varastehpour et al., 2006). The affect on the placenta often translates to fetal IUGR 
because the complications of obesity result in fetal malnourishment. Maternal obesity 
greatly increases the risk of obesity in their offspring.  It is necessary to understand how 
the unbalanced or restricted nutrient supply from these mothers affects the developing 
fetus.  My research focuses on how maternal obesity and the consumption of a high-
calorie/high-fat diet may affect the developing offspring. 
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Obesity 
Obesity is a global epidemic. In fact, approximately 20% of the world’s 
population is classified as either obese or overweight  (Finucane et al.).  However, in the 
United States, the world leader in this health crisis, more than one third of adults are 
obese, while an additional one third are classified as overweight (Ogden et al., 2006).  
While obesity is a serious health concern, the added burden of the co-morbidities 
associated with obesity, including T2DM and CVD,  make this disease a significant 
health burden (Burton, Foster, Hirsch, & Van Itallie, 1985).  In fact, a classification 
termed Metabolic Syndrome (MetS) has been designated to a cluster of metabolic risk 
factors that usually appear together and directly promote the development of both CVD 
and T2DM (Grundy et al., 2005).  These factors include central obesity, elevated 
triglycerides, reduced HDL cholesterol, elevated blood pressure and elevated fasting 
glucose (Alberti et al., 2009) (Fig. 1.2).  While some health organizations encourage 
treating the symptoms individually and discourage this classification (R. Kahn, Buse, 
Ferrannini, & Stern, 2005), the coexistence of these disorders appears to be more frequent 
than would be expected by chance (Grundy, 2006).  In addition, the clustering of these 
symptoms increase the risk for CVD and T2DM above the effect of individual risk 
factors.  Moreover, increasing evidence indicates that insulin resistance may be the 
common etiological factor that is leading to these symptoms (Haffner et al., 1992; 
Zimmet, 1992).  
An additional confounding factor that adds to the obesity crisis is children born to 
obese mothers (Boney, Verma, Tucker, & Vohr, 2005; Forsen et al., 1997; Koupil & 
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Toivanen, 2008; Whitaker, 2004) or those who consume a high-fat diet (HFD) during 
pregnancy (Bayol, Simbi, & Stickland, 2005; Buckley et al., 2005) are at increased risk 
for childhood obesity and MetS.  This is evidenced by the steep rise in childhood obesity 
that has followed the increase in adult obesity within the last few decades.  In fact, today 
approximately 17% of children in the United States are classified as obese, while an 
additional 14% are overweight (Ogden, Carroll, Curtin, Lamb, & Flegal, 2010).  
Childhood obesity is becoming an epidemic that has far reaching effects in most modern 
societies.  Likewise, the International Obesity Task Force categorizes over 20% of 
children in the European Union as being overweight or obese (Cattaneo et al., 2010). 
Since early childhood and adolescent obesity is a strong predictor of being obese or 
overweight as an adult (Guo, Wu, Chumlea, & Roche, 2002; Magarey, Daniels, Boulton, 
& Cockington, 2003), this rise in childhood obesity indicates that we have not reached 
the peak in the obesity health crisis that is plaguing our world today.  If the incidence of 
obesity continues to rise, especially among women, we will likely see an increased 
incidence of childhood MetS in future generations.  It is necessary to understand the 
mechanisms that lead to the increased risk for childhood obesity and MetS in order to 
treat or prevent this disease. 
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Homeostasis 
In order to understand the disease progression of obesity and MetS, it is essential 
to keep in mind the normal homeostatic mechanisms that are disregulated by these health 
issues. As I indicated earlier, many factors are pushing the scale toward increased energy 
input while minimizing energy output.  However, the healthy individual maintains a 
normal, steady weight due to a balance between signals from both the central nervous 
system (CNS) and peripheral organs.  There is complex interplay between peripheral 
hormone signaling and CNS processing of these signals.   
A important homeostatic mechanism is the regulation of whole-body glucose 
homeostasis.  Glucose is an essential fuel source for the body, that, when broken down 
within individual cells, provides sufficient energy to support most cellular processes 
(Dzeja & Terzic, 2003; Dzeja, Zeleznikar, & Goldberg, 1998).   The circulating levels of 
glucose within a healthy individual are tightly controlled by counterregulatory hormones.  
In fact, after a meal, when circulating glucose levels rise, insulin is released by the 
pancreas and leads to glucose uptake and utilization by various organs, which, in turn, 
reduces the level of glucose in the circulation (Cushman & Wardzala, 1980; Lang, 
Goldstein, & Levine, 1954).  However, this uptake is counterbalanced by glucagon that is 
released from the pancreas, when glucose levels fall, which results in the generation and 
release of glucose back into circulation (Drury, Wick, Bancroft, & Mac, 1951; Staub, 
Sinn, & Behrens, 1955) (Fig. 1.3).  In a healthy individual, these hormones tightly control 
glucose levels to meet the body’s requirements.  However, disregulation of these 
hormones can lead to obesity and T2DM.  It is essential to understand the normal 
Comstock, 8 
function of the pancreas in order to determine how disregulation of insulin and glucagon 
can lead to these diseases.  In the next section, I will explain pancreas development and 
morphology and the role of this organ in maintaining glucose homeostasis. 
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Pancreas Morphology, Function and Development 
The pancreas is both an exocrine and an endocrine organ.  The exocrine tissue is 
composed of ductal cells that secrete bicarbonate (HCO3
-
), which acts to neutralize 
stomach chyme that is delivered to the duodenum (Hegyi, Maleth, Venglovecz, & 
Rakonczay, 2011), and also acinar cells that secrete digestive enzymes, which aid in the 
digestion of protein, fat and carbohydrates within the intestine (Carriere, Barrowman, 
Verger, & Laugier, 1993; Williams & Lee, 1976).  The endocrine pancreas is made up of 
islets of Langerhans, which are composed of four main cell types that secrete hormones 
directly into the circulatory system. In humans and the the nonhuman primate (NHP), β 
cells, which are the most common islet cell type (about 50-70%), secrete insulin and 
amylin (Cabrera et al., 2006).  The α cells make up 30-45% of the total islets and secrete 
glucagon, glucagon like peptide (GLP1), gastric inhibitory peptide (GIP) and (Cabrera, et 
al., 2006).  Less common are the δ cells and the PP cells, which secrete somatostatin and 
pancreatic polypeptide respectively (Ganong, 2007; Hall, 2000). In the rodent, a 
commonly used model for studying islet morphology, the β cells form a core at the center 
of the islet and are surrounded by α, δ and PP cells. However, the NHP islet, the model I 
use for research, is more similar to the human islet, with a more random organization but 
with clear associations with other endocrine cells, suggesting unique paracrine 
interactions in islets of both humans and NHPs (Brissova et al., 2005; Cabrera, et al., 
2006; Kim et al., 2009). This makes the NHP an excellent model for the study of islet 
development and function that is relevant to the human condition.  
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It should be noted that pancreas development follows a similar pattern in 
mammals. The key developmental occurrences are indicated in Table 1.1 which is 
derived from studies in humans and macaques (Fowden & Hill, 2001; Gerich, 1976; Hill, 
2005; Kerr, Allen, Scheffler, & Couture, 1974; Myers et al., 1971; Piper et al., 2004; 
Remacle et al., 2007). In summary, within the embryo, the pancreas develops from two 
buds that form as an outgrowth from the primitive gut – termed the dorsal and ventral 
buds. In the human and the macaque, the dorsal bud first appears less than a month after 
conception; then the ventral bud appears in the embryo about 24 hours later. Ultimately 
the ventral bud rotates around the stomach and fuses with the dorsal bud, forming one 
organ. By the middle of the first trimester, the pancreas resembles the adult organ with a 
head, body, tail and an uncinate process (Fig. 1.4). Endocrine cells and acinar cells 
develop from ductal cell precursors. These cells bud off to form clumps of acinar cells or 
endocrine cells, which differentiate into individual islet cells (Fowden & Hill, 2001; 
Piper, et al., 2004; Remacle, et al., 2007).  By the beginning of the second trimester, 
mature islets are noticable, based on the accumulation of islet amyloid polypeptide 
(IAPP) in α cells and β cells (Lukinius, Korsgren, Grimelius, & Wilander, 1996). Toward 
the end of the second trimester, most islets are fully functional and they begin to 
proliferate during the third trimester (Mourmeaux, Remacle, & Henquin, 1985). This 
makes the third trimester a critical window of islet expansion.  By birth, islets have been 
demonstrated to compose approximately 4% of the human pancreas (Fowden & Hill, 
2001).  After birth, there is a significant period of islet remodeling that is marked by islet 
replication and neogenesis which is counter-balanced by apoptosis (Bonner-Weir, 2001; 
Georgia & Bhushan, 2004; Scaglia, Cahill, Finegood, & Bonner-Weir, 1997).  However, 
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the potential for replication appears to significantly decline with age, so that by 
adulthood, while the pancreas is significantly larger than it is at birth, islets now only 
compose 1 to 2% of its total mass.  Within the healthy adult, islet mass is usually 
homeostatically maintained due to a balance between neogenesis and apoptosis (Butler et 
al., 2010; Hanley et al., 2010; Reers et al., 2009); however, some factors can induce islet 
loss or expansion.  One such factor is obesity, which leads to islet expansion, principally 
due to the expansion of β cells.  A second phenomenon that results in islet size 
disturbance is insulin resistance, which initially leads to islet expansion but ultimately 
may result in β cell loss if the disease progresses to T2DM (Butler et al., 2003).  In order 
to determine the causes of islet cell destabilization, it is necessary to understand the 
function of these cells. 
The role of the pancreas is critical in maintaining glucose homeostasis due, 
primarily to the function of β cells and α cells. In healthy subjects, β cells secrete insulin 
in response to elevated circulating glucose levels. Glucose uptake and insulin secretion 
by β cells is a complex pathway (Fig. 1.5). The first step in this pathway is mediated by 
the facilitated glucose transporter 2 (GLUT2) which permits diffusion of glucose into the 
β cell.  Once glucose enters the cell, it is phosphorylated by hexokinase or glucokinase 
(GCK) into glucose-6-phosphate (G6P).  GCK is considered a “glucose sensor,” 
determining the threshold level of glucose necessary for insulin secretion (Postic, Shiota, 
& Magnuson, 2001). G6P is then metabolized by the additional steps of glycolysis to 
produce pyruvate, NADH and ATP.  NADH and pyruvate both enter the mitochondria 
where they are metabolized to produce an estimated 98% of the total β cell ATP content 
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(MacDonald, Joseph, & Rorsman, 2005), resulting in the increase of cytosolic ATP/ADP 
ratio. ATP-sensitive potassium (KATP) channels on the cell membrane are closed as a 
result of the increased ATP/ADP ratio, leading to depolarization of the β cells. These 
channels are composed of 2 subunits – the sulfonyurea receptor 1 (SUR1) and the 
inwardly rectifying potassium channel 6.2 (Kir6.2, encoded by the KCNJ11 mRNA).  
The depolarization of β cells leads to the opening of voltage-dependent calcium channels 
that allow the influx of calcium.  The rise in β cell calcium concentration triggers insulin 
granule exocytosis (Miki, Nagashima, & Seino, 1999).  After it is released into 
circulation, insulin is bound by insulin receptors in various target tissues which leads to 
the uptake of glucose to be used as a fuel source or stored for later use. 
However, when glucose levels start to fall, α cells secrete glucagon.  It should be 
noted, however, that α cells also take up glucose via the glucose transporter Glut1, store it 
as glycogen and then later metabolize glycogen as a fuel source ATP production 
(Quesada, Tuduri, Ripoll, & Nadal, 2008).  Thus, while glucose inhibits glucagon 
secretion,  glucose is also required for maintenance of α cell energetics.  Little is known 
about the mechanism that leads to the stimulation or inhibition of glucagon secretion 
(Walker et al., 2011). However, recent studies indicate that glucagon secretion may be 
mediated by the effects of insulin or other β cell secretory products on α cells.  Elevated 
insulin levels have been shown to lead to sensitization of KATP channels within the α 
cell, which causes α cell hyperpolarization and inhibits glucagon release (Franklin, 
Gromada, Gjinovci, Theander, & Wollheim, 2005; Leung et al., 2006). In contrast, when 
glucose levels decline the inhibitory signal produced by β cell (i.e. insulin, zinc or 
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GABA) is diminished.  This results in decreased efflux of potassium through KATP 
channels, which when exposed to and alevated ATP/ADP ratio produced by glycogen 
metabolism, will lead to depolarization of α cells and glucagon secretion.  When 
glucagon is elevated, it is taken up by hepatic cells which undergo glycogenolysis – 
conversion of glycogen to glucose by the enzyme glucose-6-phosphatase – thereby 
releasing glucose into the bloodstream. When glycogen stores are depleted, hepatic cells 
produce glucose through a process called gluconeogenesis – anabolic converstion of non-
carbohydrate sources, such as lactate and pyruvate, into glucose (Chakravarty, Cassuto, 
Reshef, & Hanson, 2005; Consoli, Nurjhan, Capani, & Gerich, 1989; Yoon et al., 2001). 
Glucagon also promotes lipolysis of adipose tissue, which is the breakdown of 
triglycerides from fat depots into FFAs and glycerol, by increasing the mobilization of 
glycerol after lipolysis occurs (Slavin, Ong, & Kern, 1994). FFAs and glycerol can then 
be used as sources of energy for the body.  
It is evident that healthy, functional islet cells work in concert to maintain glucose 
homeostasis.  However, glucose homeostasis can be disrupted in obese individuals.  This 
often leads to the development of MetS, which puts the individual at increased risk for 
developing T2DM. The mechanisms that lead to this disruption are intensely studied.  In 
the next section I will explain the etiology of T2DM and the progression of MetS to the 
development of this disorder.  I will also present the most widely accepted theory of the 
mechanism of T2DM disease progression. 
  
Comstock, 14 
Type 2 Diabetes Mellitus and the Glucolipotoxicity Hypothesis 
T2DM is a metabolic disorder that is characterized by elevated fasting glucose 
(hyperglycemia) that results in metabolic abnormalities due to defects in insulin action 
and insulin secretion. Diagnostic criteria for diabetes in adult humans is a fasting blood 
glucose greater than 126 mg/dL and a glucose level of 200 mg/dL or greater two hours 
after an oral glucose tolerance test ("Diagnosis and classification of diabetes mellitus," 
2011).  The etiology of T2DM is not completely understood, but the disease progression 
usually follows a similar pattern in animal models and humans. The risk for T2DM is 
associated with an increase in insulin levels and insulin resistance of peripheral tissues.  
This insulin resistance usually occurs concurrently with other maladies including central 
obesity and increased circulating triglycerides (TGs) which are hallmark symptoms of 
MetS.  Ultimately T2DM will develop in 20% of MetS sufferers while the remaining 
80% are able to compensate through β cell expansion (E. S. Ford, Giles, & Dietz, 2002; 
Guiot, Sempoux, Moulin, & Rahier, 2001; L. C. Jones & Clark, 2001).  Many theories 
have been presented as what leads to T2DM progression. The most commonly accepted 
theory of the pathogenesis of this disease is that concurrent glucotoxicity and lipotoxicity 
of  peripheral tissues, including pancreatic β cells,  leads to insulin resistance and 
ultimately progression to T2DM (Unger, 1995).   
Glucotoxicity occurs when chronic hyperglycemia impairs glucose-stimulated 
insulin release of β cells and reduces insulin gene transcription. β cells become 
desensitized to glucose after a short exposure to elevated levels (above 100 mg/dL), 
meaning they steadily release lower doses of insulin in response to the same glucose 
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stimulus.  This is a normal physiological adaptation that is readily reversible if glucose 
levels return to normal levels. However, if glucose is chronically elevated, β cells are 
exhausted, meaning their releasable insulin pool is depleted (Kilpatrick & Robertson, 
1998).  Initially this exhaustion is reversible. However, after long term, chronic 
hyperglycemia, exhaustion is no longer reversible and thus glucotoxicity ensues (Moran 
et al., 1997). Recent studies have shown that this chronic hyperglycemia leads to 
oxidative damage in β cells that diminishes the activity of two insulin gene promoters - 
PDX1 (pancreatic-duodenal homeobox 1) and MafA (musculoaponeurotic fibrosarcoma 
oncogene homolog A) - thereby reducing insulin gene transcription and insulin secretion 
(Olson et al., 1995; Robertson, 2004; Sharma, Olson, Robertson, & Stein, 1995). 
Lipotoxicity is a condition in which free fatty acids (FFAs) accumulate in excess 
of the required need of oxidative pathways within an organism and spill over into non-
oxidative, toxic pathways (Unger & Zhou, 2001).  FFAs provide an alternative fuel 
source for the body during prolonged periods of fasting and protect against the use of 
proteins that would otherwise be used for gluconeogenesis – production of glucose by the 
liver.  During the fed state, insulin is raised in order to use glucose as a fuel source and 
thereby suppresses circulating FFA levels. However, it has been shown that, in obese 
individuals and those who have MetS, FFA levels remain elevated in the presence of high 
insulin, likely because of an increase in adipose tissue and adipocyte insensitivity to 
insulin (Y. D. Chen, Golay, Swislocki, & Reaven, 1987; Groop et al., 1992). The feed-
back between adipocytes and β cells is thereby inhibited and thus leads to a paradoxical 
elevation of both basal insulin and FFAs. 
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The glucolipotoxicity hypotheses postulates that chronically elevated glucose and 
FFAs impair β cell function by inhibiting insulin transcription and secretion (Poitout, 
2008). In patients that are susceptible to T2DM, there is a blunted response to nutrient 
overload caused by excess glucose and FFA (Cusi, Kashyap, Gastaldelli, Bajaj, & 
Cersosimo, 2007; Kashyap et al., 2003). As indicated, this occurs prior to the 
development of the disease and may be a complicating factor that ultimately leads to 
disease progression.  However, in patients with MetS, glucolipotoxocity leads to similar 
impairment of β cell function, yet 80% of these patients do not develop overt diabetes.  
This disparity highlights the importance of investigating the causes that may lead to the 
differential development of T2DM within susceptible individuals.   
While many factors may influence whether an individual ultimately develops 
T2DM, the early life environment likely plays a role in disease progression.  While, both 
maternal HFD consumption and obesity increase the risk of developing MetS and T2DM 
in the offspring, it is unclear what mechanisms lead to this increased risk.  Many others 
have investigated the effects of maternal HFD consumption or obesity on offspring and 
have provided insight into these mechanisms.  These studies are reviewed  in the 
following pages. 
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Animal Models of Maternal Overnutrition 
The most common animal models used to investigate HFD consumption and the 
effects of obesity are rodents – principally rats and mice. In fact, our lab has used both 
rats and mice as models of early post-natal overnutrition to study the effects of obesity on 
metabolic systems (Enriori et al., 2007; Glavas et al., 2010; Xiao et al., 2007).  By 
reducing litter size, our group is able to increase nutrient availability to young rodents. 
This results in increased susceptibility to obesity, insulin resistance and alterations in 
energy homeostasis, indicating that early overnutrition may increase the risk of MetS. 
 In order to study the effects of HFD on offspring, many studies in rodents 
provide the HFD to mothers during a portion of, or all of, gestation and/or lactation (Cerf, 
Muller, Du Toit, Louw, & Wolfe-Coote, 2006; Cerf et al., 2005). However, the range of 
maternal HFD exposure in many rodent studies varies greatly – 21 days (for gestation 
only) up to 142 days (100 days prior to and including gestation and lactation).  When 
dams consume a chronic HFD more than 30 days prior to conception, this usually results 
in maternal obesity – allowing some studies to focus on not only maternal HFD but also 
maternal obesity effects in the offspring (H. Chen, Simar, Lambert, Mercier, & Morris, 
2008; Ferezou-Viala et al., 2007; Howie, Sloboda, Kamal, & Vickers, 2009; Srinivasan, 
Katewa, Palaniyappan, Pandya, & Patel, 2006). The results of these studies vary based on 
the length of time the mother is exposed to the HFD.  In most rodent models, the 
consumption of the HFD leads to MetS-like effects in the offspring: they become obese, 
hyperinsulemic, have a propensity to develop T2DM, and are at increased risk for 
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developing CVD (Koukkou, Ghosh, Lowy, & Poston, 1998; Srinivasan, et al., 2006; 
Taylor et al., 2005).  
Specific effects on the pancreas of offspring exposed to maternal HFD have been 
described in a few of these models. In one study by Cerf et al., β cell mass was reduced in 
1-day-old rats only if the mother consumed a HFD all throughout pregnancy. Short-term 
exposure, for one week of the three week pregnancy, did not have a significant effect on 
β cell mass, regardless of which week the mother consumed the HFD (Cerf, et al., 2005). 
When this study was followed through until the animals were of weaning age, offspring 
of mothers that were exposed to the diet through gestation and lactation were 
normoglycemic. However, when they were fed the HFD during lactation only, the 
offspring became hyperglycemic and hypoinsulinemic, indicating that switching from a 
healthy diet to a HFD may be more harmful than continued exposure to HFD alone (Cerf, 
et al., 2006).  
While experimental models with sheep do not provide these animals a HFD, they 
are often used as a model of overnutrition by increasing their food supply above the 
recommended portion for their size (George et al., 2010; Zhu et al., 2008). These animals 
achieve obesity if allowed to consume an obesogenic diet (150% of recommended 
calories) 60 days prior to conception.  Differential results have been reported on 
developing islets from the fetuses of obese ewes based on the length of exposure to the 
diet.  One study indicates that obese ewes produce fetuses at mid-gestation that are 
hyperglycemic, hyperinsulinemic, have over-growth of pancreatic islets and β cell 
hyperplasia (S. P. Ford et al., 2009).  However, if the fetuses were analyzed at the end of 
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pregnancy, there was a significant reduction in pancreatic growth and markedly 
decreased numbers of β cells due to increased apoptosis, which resulted in reduced 
circulating insulin concentrations in the fetuses from obese ewes (L. Zhang et al., 2011). 
One confounding factor of this research is that only ewes carrying singleton fetuses were 
analyzed in the mid-gestation study, whereas the fetuses that were carried to full term 
were twins. This makes the results difficult to interpret, because there is possibly 
increased growth restriction in the full term, twin sheep.  Other studies in the sheep 
model of overnutrition have examined the effects maternal obesity on various organs, but 
do not describe how this affects the pancreatic islets (George, et al., 2010; Long et al., 
2010; Zhu, et al., 2008). 
The effects of maternal overnutrition on fetal development indicate that this is 
likely to cause MetS-like effects due to the increased adiposity, decreased insulin 
sensitivity and hyperinsulinemia demonstrated in these animals.  However, it is unclear 
from these studies how pancreatic islets may be affected, since the reported results appear 
to conflict between the sheep and rodent models.   It will be necessary to perform similar 
studies on a higher species, such as the NHP, that is more closely related to the human, in 
order to determine if factors within the endocrine pancreas may be leading to the 
association between maternal overnutrition and MetS in offspring. 
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Animal Models of Intrauterine Growth Restriction 
A second model which leads to obesity is intrauterine growth restriction (IUGR).  
Evidence from human studies has demonstrated that IUGR leads to an increased risk of 
developing MetS in adults (Barker, 1995; Barker et al., 1993). In fact, Dr. Barker’s 
hypothesis of the developmental origins of adult disease theorizes that associations 
between poor fetal and infant growth and later development of T2DM and the MetS are a 
result of poor nutrition in early life (Hales & Barker, 1992).  IUGR is accomplished in 
rodent models through a variety of methods, including restricing maternal caloric or 
protein intake that both reduce the nutrient supply to the fetus. In addition, exposure to 
high levels of glucocorticoids or restriction of placental blood supply by bilateral uterine 
artery ligation both also lead to IUGR. These experimental models lead to decreased beta 
cell mass and lower pancreatic insulin content in neonatal offspring, yet ultimately these 
offspring become obese and diabetic (Dahri, Snoeck, Reusens-Billen, Remacle, & Hoet, 
1991; Dumortier et al., 2007; Garofano, Czernichow, & Breant, 1997, 1998, 1999; Park, 
Stoffers, Nicholls, & Simmons, 2008).  
The ovine model of IUGR is accomplished by restricting maternal caloric intake, 
exposing pregnant dams to elevated temperatures (40⁰ C versus 25⁰ C), induction of 
maternal hypoglycemia by continuous insulin infusion, uterine horn ligation, induction of 
uterine artery embolism or by surgical ablation of major uterine caruncles in the ewe 
prior to conception (Darp et al., 2010; Limesand, Jensen, Hutton, & Hay, 2005; Meyer, 
Koch, Ramadoss, Kling, & Magness, 2010; Morrison, 2008; Rozance, Limesand, & Hay, 
2006; Sebert et al., 2011). While all these models produce IUGR by different 
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mechanisms, these protocols can result in smaller lambs that have deficient insulin 
secretion and usually smaller β cells (Gatford et al., 2008; Limesand, Rozance, Zerbe, 
Hutton, & Hay, 2006). 
While studies in IUGR animals indicate that diabetes occurs due to the 
deficiencies in β cell mass and insulin secretion, studies in human IUGR fetuses are not 
consistent with these findings.  The human studies indicate that IUGR does not change 
fetal β cell mass (Beringue et al., 2002), although adults with born with IUGR do have an 
increased risk for of developing T2DM, indicating that insulin resistance occurs first due 
to the insult of IUGR, followed by hyperinsulinemia. While the results from the IUGR 
animals may provide insight into islet development in animal models, they do not explain 
the association between human IUGR and deficiencies in insulin secretion.  An animal 
model that may be more predictive of the effects of human IUGR would be the NHP.  In 
fact, one recently described model of inter-placental vessel ligation that is being 
developed in rhesus macaques has the potential to lead to IUGR in its offspring (Roberts 
et al., 2012).  However, no significant pancreatic fetal effects have been reported to date.  
Follow-up studies on these animals may provide insight into the mechanistic link 
between IUGR and insulin resistance. 
Based on the experimental models described in the last two sections, it is evident 
that fetal malnutrition or early post-natal overnutrition may lead to the development of 
MetS-like effects and ultimately may increase the risk for T2DM, just as has been 
demonstrated in the human population.  However, while the development of insulin 
resistance and hyperinsulinemia are common to all models, the effects on islets vary 
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significantly.  While some studies indicate that β cell mass may be affected, no consistent 
effects on α cells have been studied or reported (Cerf, et al., 2005; S. P. Ford, et al., 2009; 
L. Zhang, et al., 2011).  In addition, the inconsistencies between the described animal 
models and human studies make it evident that studies in higher species are necessary to 
determine the process that leads to the increased risk of MetS and T2DM in these 
offspring.  For this reason, our lab has developed a NHP model of maternal HFD 
consumption and obesity.  The purpose of this model is to determine how the altered 
maternal physiology may lead to an increased risk of metabolic complications in the 
offspring.  While many organ systems have been demonstrated to be affected by maternal 
HFD and obesity in our NHP model, my research specifically focuses on the 
development of β cells and α cells in these animals.  Due to the counter-regulatory nature 
of these cells, it is necessary to examine effects in both, rather than specifically focusing 
on the β cell, as many other studies have done.  In the next chapter, I will characterize the 
model, explain the specific effects that have been demonstrated in other organ systems 
thus far and describe the specific aims of my studies in these offspring. 
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Figure 1.1: Metabolic Syndrome 
 
Metabolic syndrome is a clustering of health effects that increase an individual’s risk for 
developing cardiovascular disease and T2DM.  The International Diabetes Federation 
defines this disorder as abdominal obesity with two other associated symptoms listed 
above, while the American Heart Association identifies this syndrome as a clustering of 
any three symptoms listed above.  Most organizations recognize insulin resistance as a 
common etiology that leads to this disease. 
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Figure 1.2: Diagram of Glucose Homeostasis 
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Whole-body glucose homeostasis is maintained by the hormones insulin and glucagon. 
When glucose levels rise, β cells secrete insulin. Insulin binds to its receptor on various 
tissues and allows for glucose uptake, utilization and storage. When glucose levels fall, 
glucagon is released from α cells. This leads to lipolysis of fat stores and causes the liver 
to undergo glycogenolysis and gluconeogenosis which releases glucose into circulation. 
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Figure 1.3: Diagram of Fully Formed Pancreas 
 
During embryonic development, the duodenal c-shape is formed due to the rotation of the 
ventral pancreatic bud into the dorsal bud. After the buds fuse, the dorsal pancreatic bud 
becomes the body and tail of the pancreas and the ventral pancreatic bud forms the head 
and uncinate process. 
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Figure 1.4: Glucose-stimulated Insulin Secretion in the β cell 
 
Glucose is transported into the β cell by the facilitated glucose transporter, Glut2.  It is 
broken down by the enzyme glucokinase (GK) into glucose-6-phosphate, which 
undergoes glycolysis to produce pyruvate.  Pyruvate is transported into the mitochondria 
and metabolized to produce ATP. The rise in intracellular ATP/ADP ratio leads to a 
closure of ATP sensitive potassium (KATP) channels on the cell membrane, which 
causes depolarization of the cell and Ca2+ influx via voltage gated calcium channels.  
The influx of calcium leads to insulin granule exocytosis. 
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Chapter 1 Table 
  
Comstock, 29 
Table 1.1: Embryonic/Fetal Development of the Pancreas in Macaques and Humans 
Macaque 
(day) 
Human 
(day) 
Development 
15.5 26 Dorsal pancreatic bud first appears 
16 26.5 Ventral pancreatic bud appears less than a day after the dorsal bud 
21 35 
The stomach rotates to the left and the ventral bud rotates around 
the forgut and comes in contact with the dorsal bud; the gland 
grows as a single unit 
32 52 
Pancreas resembles the adult pancreas with a tail, body, head & 
uncinate process. 
33 54 
First epithelial cells stain for insulin, first beta cells begin to develop 
and a fine capillary network is formed 
36 59.5 
Glucagon and somatostatin expressed separately in isolated 
epithelial cells 
38 63 Endocrine cell precursors begin to form 
38 63 
Acini begin to develop and islet cell precursors begin to form and 
clump off 
38 63 Ducts grow and branch until this point. 
43 70 The first alpha cells begin to differentiate. PP cells are now detected 
47 77 Delta cells first appear 
51 84 Rare endocrine and exocrine cells are continue to differentiate 
51-57 84-98 
Islets begin to co-express IAPP  - indicating mature is β cell and α 
cells; Diffuse staining PDX1 co-localized in insulin stained islets in 
both nucleus and cytoplasm 
60 98 
Capillary beds surround and penetrate the islets by this stage; 
Interlobular ducts are formed and acini begin to differentiate 
67 112 
Clusters of immature islet cells become vascularized and then 
encapuslated by connective tissue and isolated from ducts 
71 119 Insulin secretion begins 
73-85 120 – 140 
Transient glucagon secretion begins; Well formed islets are 
identifiable although isolated endocrine cells persist between the 
acinar cells. 
85 140 
Fetal pancreas begins to demonstrate mature glucose transporter 
transporter levels 
114-170 187-280 Beta cells double each day 
114-170 187-280 Islet remodeling occurs 
Birth Birth Islets account for 4% of the total pancreas 
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A Nonhuman Primate Model of Maternal HFD Consumption 
 The Grove laboratory at the Oregon National Primate Research Center (ONPRC) 
uses a Japanese macaque model to investigate the relationship between maternal HFD 
consumption, maternal obesity and health risks in the offspring.  Macaques are an 
essential animal model to study the progression of obesity because they are 
phylogenentically close to humans (Isa, Yamane, Hamai, & Inagaki, 2009).  Their body 
structure, physiology, gestation and development have been well characterized and are 
more similar to humans than other commonly used laboratory animal models (i.e. rodents 
and sheep) (Hamada, 1999).  This model has been developed and used for the past 10 
years to characterize effects of HFD consumption in adult females as well as their 
offspring.  
Adult female NHPs, ages 5 to 7, were randomly assigned to this project from a 
larger breeding colony that has been at ONPRC since the 1960s.  Females were age- and 
weight-matched at the beginning of this study and placed into two separate groups. One 
group was fed a normal, monkey chow control (CTR) diet supplying 13% of calories 
from fat. The fat in the CTR diet is principally made of vegetable fat.  The experimental 
group was fed a high-calorie, high-fat diet (HFD) supplying 35% of calories from fat plus 
calorically dense treats.  This HFD is made from animal fats, principally lard, and is rich 
in total fatty acids, saturated, and monounsaturated fat.  Furthermore, this diet is balanced 
in essential fatty acids but has an increased n-6 to n-3 polyunsaturated fatty acid ratio that 
is similar to the current Western diet (Grant et al., 2011). The animals were maintained 
on their respective diets until they reach early middle age (12 to 14 years of age).   
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All females were socially housed in indoor/outdoor housing with two males and 
approximately 8 to 10 females per group.  They were allowed to breed naturally and 
become pregnant. The adult females have been extensively characterized during each 
year of the study throughout the pre-gravid, pregnant, and lactation periods. Specifically, 
animals were weighed monthly and checked for pregnancy throughout the breading 
season (November through May).  Dual-energy X-ray absorptiometry (DEXA) scans 
were performed annually on each animal during the Fall (August – October).  IVGTTs 
were performed twice each year; once prior to breeding season and a second time at 
approximately 123 days gestation (during the early third trimester). Like humans, the 
HFD dams vary in their sensitivity to the diet. They are classified as either sensitive or 
resistant to the diet based on their insulin clearance rates in response to an IVGTT at the 
end of the second year on the diet, according to methods previously described (McCurdy 
et al., 2009). To be classified as resistant to the diet, the HFD animal’s insulin area under 
the curve (IAUC) must fall within 2 standard deviations of the mean of the control 
animals for that same year (Fig. 2.1a).  
A correlation analysis between the IAUC at the end of year 2 and body weight of 
these animals at the end of year 4 demonstrated a significant correlation (Pearson 
correlation = 0.46, p = 0.0092), indicating that insulin sensitivity at 2 years is a predictor 
of long-term weight gain in these animals (Fig. 2.1b). Concurrent with this finding, all 
HFD animals during year 4 displayed an increase in body weight and body fat (Fig. 
1.1c&d). However, this increase was significantly more severe in the animals that were 
classified as diet sensitive (HFD-S) versus the resistant (HFD-R) animals.  A similar 
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response has been established in various rodent models in which a subset of animals 
exposed to a HFD are more resistant to obesity (Enriori, et al., 2007; Speakman, Hambly, 
Mitchell, & Krol, 2007).    
Some offspring from the CTR and HFD mothers were collected by C-section at 
gestational day 130 (G130).  Since the normal pregnancy term in a Japanese macaque is 
approximately 173 days (Hayama, Nakiri, & Konno, 2011), G130 corresponds to the 
early third trimester of development, a critical period of islet development within the 
fetus (Fowden & Hill, 2001) .  Likewise, in order to investigate the effects of post-natal 
HFD consumption, a subset of the CTR and HFD offspring were born by natural means 
and maintained with their mothers in the same housing and on the same diet until 
weaning at approximately 7 to 9 months of age. At this time, the offspring were weaned 
and placed into a social housing facility with peers, where they were maintained on their 
same diet or switched to the opposing diet for approximately 5 months. This produced 
four post-weaning groups: CTR/CTR, CTR/HFD, HFD/CTR and HFD/HFD (Table 2.1). 
As indicated above, the purpose of this model is to investigate the effects of HFD 
consumption on fetal and early post-natal pancreatic development.  We have chosen the 
HFD as a model of overfeeding that is similar to the Western diet. By providing a highly 
saturated fatty diet that is also calorically dense to our animals, we believe that we can 
mimic the detrimental effects of the Western diet and begin to understand some of the 
mechanisms that are leading to the health complications in children today.  Also, by 
allowing animals to be maintained with their mothers until weaning, we are endeavoring 
to mimic the early lifestyle in humans.  If a mother eats a healthy diet throughout her 
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pregnancy, she is likely to continue to do so during the breast-feeding period. The 
opposite is true as well – a mother who eats fatty foods throughout her pregnancy will not 
be likely to change her lifestyle during breastfeeding. While the CTR/CTR and the 
HFD/HFD juvenile groups are best representative of the human population, the two 
opposing groups, CTR/HFD and HFD/CTR are essential to test which might be the 
factors (maternal diet versus post-weaning diet) that lead to the complications that we 
demonstrate in these offspring. 
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Metabolic Syndrome and Type 2 Diabetes Mellitus in the Macaque 
T2DM has been demonstrated to develop spontaneously in macaques as they 
reach middle age (approximately 15 years of age), which is preceded by typical 
symptoms of MetS in these animals.  Macaques that develop MetS are obese, have 
increased waist circumference, are insulin resistant and have elevated triglycerides, lower 
HDL and increased fasting plasma glucose levels, when compared to healthy macaques 
(Hansen & Bodkin, 1990; Wagner et al., 2001; X. Zhang et al., 2011).  MetS occurs 
spontaneously in approximately 5-15% of both young and middle aged macaques that eat 
a healthy diet (Kaufman et al., 2005; X. Zhang, et al., 2011), while T2DM occurs in 
nearly one third of macaques with MetS-like effects (Hansen & Bodkin, 1986). 
While not all of the above mentioned markers of MetS were measured, in our 
macaque model, MetS-like effects occur in approximately 13% (4/31) of CTR females 
and are characterized by elevations in fasting plasma insulin, fasting blood glucose, body 
weight and body fat (Fig. 2.2).  In contrast, MetS occurs in approximately 72% (26/36) of 
age matched HFD females that have consumed the diet for 4 years or more, while 28% of 
remain resistant to MetS-like effects.  All females that have consumed the HFD for 4 
years or more are at least 9 years old; however, those that develop MetS tend to be about 
2 years older than the average HFD female.  Of the females who developed MetS, 12% 
(3/26) went on to develop T2DM, which is characterized by an average fasting blood 
glucose level of 117 mg/dL in these animals (Fig. 2.2).   T2DM has not occurred 
spontaneously in the CTR animals; however, females are removed from the study before 
the onset of middle age.   
Comstock, 36 
Effect of Maternal HFD Consumption on NHP Offspring 
We have previously demonstrated significant effects on fetal and early post-natal 
development due to exposure to the HFD or maternal obesity. Maternal HFD 
consumption translated to an increased n-6 to n-3 polyunsaturated fatty acid ratio in the 
fetal offspring, with a reduction in the essential fatty acid docosahexaenoic acid (DHA). 
This diet also decreased the supply of DHA to the nursing offspring through breast milk, 
while increasing total insulin content of the breast milk (Grant, et al., 2011). This could 
result in serious defects in the offspring, as DHA is essential for neuronal formation and 
cognitive function (Uauy et al., 1996). 
Placental studies established a significant reduction in uterine volume blood flow 
from HFD animals and a significant increase in inflammatory cytokines regardless of 
maternal sensitivity to the HFD. HFD consumption by obese mothers with 
hyperinsulinemia also reduced volume blood flow on the fetal side of the placenta and 
resulted in increased number of placental infarctions and stillbirths. These studies 
indicate that a HFD, independent of obesity, may lead to placental insufficiency, and that 
maternal obesity and insulin resistance results in decreased blood volume to the fetus 
(Frias et al., 2011).  The reduction in blood flow and the increase in cytokines are likely 
to have a significant effect on various developing organs.  
In fact, we have demonstrated an increase in local inflammatory response within 
the brain of the HFD fetus.  Specifically, we demonstrated disturbances in the 
serotonergic system, which led to increased anxiety in the female postnatal offspring 
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from HFD mothers while males tend to be more aggressive in response to stress (Sullivan 
et al., 2010). Also, within the melanocortin system, agouti-related peptide (AGRP) 
mRNA expression and protein immunoreactivity were inhibited, while 
proopiomelanocortin (POMC) mRNA expression was upregulated in hypothalamic 
neurons of HFD fetal offspring (Grayson et al., 2010). These neuronal populations play a 
key role in glucose homeostasis by sensing both glucose and insulin (Fioramonti et al., 
2007; Parton et al., 2007; Woods, Lotter, McKay, & Porte, 1979) and integrating this 
signal by regulating hepatic glucose production (HGP) (Benoit et al., 2002; Pocai et al., 
2005; van den Hoek et al., 2004).  Since AGRP neurons mediate the insulin inhibition of 
hepatic glucose production (Konner et al., 2007), the inhibition of this peptide will likely 
lead to increased HGP. 
Accordingly, we demonstrated that fetal offspring from mothers in years 2 
through 4 on the HFD had increased expression of hepatic gluconeogenic genes and 
transcription factors.  In addition, we demonstrated an increase in liver TGs and evidence 
of hepatic oxidative stress early and increased hepatic apoptosis, consistent with the 
development of nonalcoholic fatty liver disease (NAFLD) (Grant, et al., 2011; McCurdy, 
et al., 2009). Notably, the increased hepatic TG levels persisted until post-natal day 180 
(P180), indicating that early HFD exposure through the maternal diet will likely increase 
the risk for early-onset NAFLD. 
Finally, the HFD leads to aortic endothelial dysfunction in animals exposed to the 
diet until 13 months of age (Fan et al., 2012).  Endothelial dysfunction has been 
established as an early marker for atherosclerosis, indicating that the HFD offspring are at 
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increased risk for developing cardiovascular disease (Celermajer, Sorensen, Bull, 
Robinson, & Deanfield, 1994; Ludmer et al., 1986; Reddy, Nair, Sheehan, & Hodgson, 
1994).  Taken together, these results indicate that maternal HFD consumption places 
increased metabolic pressure on the developing offspring.  The increased liver 
gluconeogenesis, elevation of circulating TGs and endothelial dysfunction indicate that 
the HFD offspring may be susceptible to development of pediatric MetS and may 
ultimately progress to T2DM.  The purpose of my research is to determine how HFD 
consumption by the mother and the post-natal offspring affect pancreas development.   It 
is necessary to determine if maternal HFD or obesity during pregnancy will lead to 
effects on the pancreas that will increase their susceptibility to MetS.  Furthermore, since 
early life post-natal nutrition also plays a significant role in the risk for MetS and T2DM, 
it is essential to determine if HFD consumption during the post-natal period will 
contribute to this risk.  It is my aim to establish how the pancreas responds to the 
increased metabolic pressure of maternal HFD consumption previously described in these 
offspring, and how this will affect long-term pancreas function.  
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Specific Aims 
The first aim of this study was to determine if maternal HFD and/or obesity 
consumption during fetal development will affect islet cell morphology or function. I 
hypothesized that HFD during development would similarly suppress islet development 
of fetal offspring regardless of maternal obesity.  Since maternal HFD consumption leads 
to similar effects on fetal liver TG content and upregulation of gluconeogenic genes 
within these livers, it is likely that pancreatic islets will be similarly affected by the diet.  
These islets would need to compensate for the increased glucose production of the liver 
and elevation in FFA supplied by the maternal HFD and would, thus, display similar 
effects regardless of maternal sensitivity to the diet. 
My second aim was to characterize the metabolic profile of juvenile Japanese 
macaques chronically exposed to a HFD. Specifically, I analyzed the physiology of these 
animals up through weaning to determine if chronic HFD exposure affected glucose 
homeostasis. I hypothesized that the effect on islets caused by HFD during gestation 
would lead to disregulation of insulin secretion and increased susceptibility of the HFD 
offspring to insulin resistance.  While fetal exposure to the HFD should prepare the 
animal for continued post-natal HFD exposure, the increased liver TG deposition will 
likely lead to insulin resistance in this organ.  This insulin resistance will likely be 
compensated by an increase in insulin secretion in the HFD offspring. 
My third aim was to determine if the changes in islet mass would persist after the 
weaning period and lead to persistent changes in glucose homeostatic mechanisms. I 
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hypothesized that chronic HFD exposure in the HFD/HFD juvenile would lead to 
hyperinsulinemia, increased insulin resistance, and persistent changes in islet 
morphology.  By returning the HFD animals to a CTR diet after weaning (HFD/CTR) 
these changes would be ameliorated. Finally, it was my hypothesis that post-weaning 
HFD alone (CTR/HFD) would lead to alterations in islet morphology that would have a 
minimal affect on glucose homeostasis in these animals.  I have reported the results of the 
experiments testing these hypotheses in the following pages and have included the 
methodologies that I used.   
  
Comstock, 41 
 
 
 
 
 
 
 
Chapter 2 Figures 
 
  
Comstock, 42 
Figure 2.1: Characterization of CTR and HFD Dams 
 
IAUC after 2 years in the study is significantly increased in HFD-S but not HFD-R dams 
(A). This correlates with body weight in dams after 4 years on HFD (B). Weight (C) and 
body fat percentage (D) of dams after 4 years is significantly increased due to HFD and 
HFD-S display a further increased over the HFD-R group.  
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Figure 2.2: Characterization of Metabolic Syndrome and Diabetes in Females 
 
Females that have MetS have elevated fasting blood glucose (A), elevated fasting insulin 
(B), increased body weight (C) and increased body fat (D) compared to others on the 
same diet. Females that develop T2DM have increased fasting blood glucose, increased 
fasting insulin and elevated body weight when compared to all other groups (A-C).  Body 
fat percentage was not significantly different from HFD female or other groups that 
developed MetS (D) 
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Table 2.1: Post-natal offspring groups 
Group Pre-natal Pre-weaning Post-weaning 
CTR/CTR CTR CTR 
CTR/HFD CTR HFD 
HFD/CTR HFD CTR 
HFD/HFD HFD HFD 
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Chapter 3: Maternal High-fat Diet Consumption During Pregnancy Leads to 
Reduced α Cell Mass in Fetal Offspring 
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Introduction 
The mechanisms that lead to the association between maternal obesity, childhood 
obesity and metabolic syndrome need to be determined in order to treat or prevent this 
effect from perpetuating.  We have previously demonstrated that HFD consumption 
during pregnancy, independent of maternal metabolic phenotype, can lead to a broad 
range of complications in fetal development that may increase these animals’ 
susceptibility to obesity and diabetes later in life. We have demonstrated increased liver 
TGs, a shift in genes involved in hepatic gluconeogenesis, and increased apoptosis, 
suggesting early signs of NAFLD (Grant, et al., 2011; McCurdy, et al., 2009). We also 
observed placental insufficiency and inflammation in pregnant macaques fed a HFD. 
Importantly, the cytokines produced in the placenta are secreted specifically into the 
developing fetus, where we hypothesized that they initiate inflammatory responses in 
several developing organs (Frias, et al., 2011).  Also, because placental insufficiency has 
been demonstrated to lead to reduced islet vascularization, it is important to determine 
how this will effect fetal islet cell development and function (Fahy, 2009; Martin-Gronert 
& Ozanne, 2007).  
The purpose of this study was to determine the effects of maternal obesity and/or 
HFD consumption during pregnancy on the development of fetal pancreatic islets. 
Principally, I chose to examine islet morphology, α cell and β cell mass, and regulation of 
genes involved in glucose metabolism and islet development. Previous animal model 
studies indicate that much of the disregulation of glucose homeostasis in offspring 
associated with in-utero obesity exposure is due to β cell dysfunction or the suppression 
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of β cell proliferation in response to this early life insult (Bertin et al., 2002; Hales et al., 
1991; Van Assche, De Prins, Aerts, & Verjans, 1977; L. Zhang, et al., 2011).  However, 
recent data has demonstrated the complexity of pancreatic islet paracrine regulation of 
both β cells and α cells that are disrupted in the development of T2DM (Ehses, 
Ellingsgaard, Boni-Schnetzler, & Donath, 2009; Ellingsgaard et al., 2011).  It is 
important to understand how α cells may also be affected by maternal HFD consumption.  
I chose to investigate these hypotheses in our well-characterized model that has 
developmental similarities to humans and in which we can control and manipulate their 
environment. My aim was to determine which islet cells may be affected by maternal 
obesity and/or HFD consumption.  I hypothesized that HFD during development would 
similarly suppress islet development of fetal offspring regardless of maternal obesity.  
Since maternal HFD consumption leads to effects on fetal liver triglyceride content and 
upregulation of gluconeogenic genes within these livers, it is likely that pancreatic islets 
will be similarly affected by the diet.  These islets would need to compensate for the 
increased glucose production of the liver and elevation in FFA supplied by the maternal 
HFD and would thus display similar effects regardless of maternal sensitivity to the diet. 
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Materials and Methods 
Animals. All animal procedures were in accordance with the guidelines of the 
Institutional Animal Care and Use Committee of the ONPRC as previously described 
(Frias et al.; Grant et al.; Grayson et al.; McCurdy, et al., 2009; Sullivan et al.).  Briefly, 
age and weight matched adult female Japanese macaques were fed a control (CTR) or 
HFD for up to 4 years. Mothers were fasted overnight and fetal offspring were obtained 
by c-section G130 (early 3
rd
 trimester) and immediately delivered to necropsy for tissue 
collection. HFD fetal offspring used for this study were taken from mothers in their 4
th
 
year on the HFD (Table 3.1).  
Intravenous Glucose Tolerance Tests. In the dams we performed the IVGTTs at 
123 days (± 5 days) gestation. Mothers were fasted overnight prior to a morning IVGTT, 
while offspring were fasted for 5 hours and the IVGTT was performed in the afternoon.  
Animals were sedated with ketamine (10 mg/kg) and administered a glucose bolus (50% 
dextrose solution) at a dose of 0.6 g/kg via the saphenous vein. Baseline blood samples 
were obtained prior to the infusion, and 500-µL blood samples were taken at 1, 3, 5, 10, 
20, 40, and 60 min after infusion via the femoral artery. Glucose was measured 
immediately using a OneTouch Ultra2 Blood Glucose Monitor (LifeScan), and the 
remainder of the blood was kept in heparinized or clot tubes on ice for insulin 
measurement. After the IVGTT, samples were centrifuged, and plasma was stored with 
5% aprotinin at –80°C until assayed. Insulin was assayed in plasma by RIA (Millipore 
catalog no. RI-13K, Billerica, MA).  HOMA-IR was calculated as fasting serum insulin 
(μU/ml) × fasting plasma glucose (mmol/l)/22.5 as previously described (Bonora et al., 
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2000; Matthews et al., 1985). Glucose-stimulated insulin secretion was measured as the 
insulin area under the curve (IAUC) minus basal fasting insulin levels, while total IAUC 
is a measure of insulin secretion from time 0.  Baseline samples were assayed for 
glucagon (Millipore, catalog no. GL-32K, Billerica, MA), c-peptide (Roche Diagnostics, 
catalog no. 03184897190, Indianapolis, IN) and leptin (Millipore catalog no. HL-81K, 
Billerica, MA). 
.RNA Isolation and Quantitative RT-PCR. Total RNA was isolated from 5 
head-to-tail grouped sections of each offspring pancreas (Fig. 3.1) using TRIzol reagent 
(Invitrogen, Carlsbad, CA).  RNA was bioanalyzed with an Agilent Bioanalyzer 
(Scotland, UK) and only high quality RNA was DNase treated and reverse-transcribed.  
mRNA was measured by real-time quantitative RT-PCR using a PE Applied Biosystems 
PRISM 7700 Sequences Detector System. Premade qPCR gene expression assays 
directed against human sequences were purchased from Applied Biosystems. The 
amplification was performed as follows: 2 min at 50°C, 10 min at 95°C, then 45 cycles 
each at 95°C for 15 sec and at 60°C for 60 sec in the ABI/Prism 7700 Sequences Detector 
System. Standard curves on serial dilutions of the cDNA (1:10, 1:50, 1:100 1:500, 1:1000 
and 1:10,000) were done using cDNA from pooled pancreas samples. Standard curves 
were drawn on the basis of the log of the input RNA versus the critical threshold (CT) 
cycle, in which the fluorescence of the sample is greater than the threshold of the baseline 
fluorescence. Although expression of classical housekeeping genes 18S, β-actin, and 
GAPDH are commonly used to normalize gene expression levels in qRT-PCR assays, all 
three genes were significantly differentially expressed in the fetal groups. A novel 
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reference gene, ALG9 (Kidd et al., 2007), was assayed and also shown to be 
differentially expressed between fetal groups. Therefore, all qPCR results are normalized 
to cDNA concentrations. We have also presented data as gene expression normalized to β 
cell area, α cell area, or islet area, depending on the cell types in which the gene of 
interest is expressed. This methodology has been previously described when whole 
pancreas mRNA is used (Gatford, et al., 2008). 
Immunohistochemistry.  Pancreas tissue was collected from 5 head-to-tail areas 
(Fig. 3.1), section number 3 was fixed with 10% zinc formalin, paraffin-embedded, and 
cut into 5μm sections. Sections were deparaffinized in xylene and then 100%, 95%, 85%, 
and 70% graded ethanol washes for 5 minutes each. Standard antigen retrieval with 
microwave-heated citrate buffer was used. Standard immunohistochemical methods were 
used. Briefly, sections were washed in KPBS and then blocked in 2% donkey serum in 
0.4% triton X/KPBS. Antibodies against insulin (#AB9210, 1:2,000, Chemicon, 
Temecula, CA) and glucagon (#4031-01F, 1:1500, Millipore, St. Charles, MO) were 
used.  Primary antibodies were diluted in 2% donkey serum in 0.4% triton X/KPBS and 
applied to tissue sections where they were incubated overnight. Tissues were then washed 
in KPBS and secondary antibodies were applied for 1 hour at room temperature at a 
dilution of 1:200 (Jackson ImmunoResearch Laboratories, Inc, West Grove, PA). 
Quantitative Analysis. Images were acquired with a MarianasTM imaging 
workstation (Intelligent Imaging Innovations, Denver, CO) using a 20X objective and a 
stereology module to montage images covering whole sections. Areas occupied by β and 
α cells were measured based on intensity segmentation of each fluorescence channel 
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using Slidebook 5.0.  The β and α cells fractions were calculated by dividing by the area 
of the whole section. Total islet area, islet mass [(total islet area/pancreas area)x pancreas 
weight], and β and α cell mass [(total cell area/pancreas area)x pancreas weight] were 
calculated as previously reported (Uchida et al., 2005). 
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Results 
Alpha Cell Mass is Decreased in HFD Fetal Offspring. Overall, the 
physiological phenotype in the HFD fetus was minimally affected by the maternal 
phenotype or diet.  HFD fetal weight was slightly reduced (Table 3.1), which is 
consistent with previous published findings from our lab, although it was not significant, 
likely due to the smaller sample size used for this study (McCurdy, et al., 2009). 
Furthermore, maternal HFD consumption did not lead to significant differences in 
pancreas weight, glucose, or insulin in the fetus (Table 3.1). However, C-peptide was 
significantly decreased in HFD fetuses and glucagon was decreased in fetuses from HFD-
sensitive (HFD-S) mothers (Table 3.1).  Analysis of islets demonstrated no significant 
difference in total islet mass between the fetal groups (Fig. 2.2a). However, a closer 
analysis of specific cell types within the islets demonstrated a significant decrease in α 
cell mass in the HFD offspring (Fig. 3.3a). While glucagon mRNA expression was also 
significantly decreased in the HFD animals (Fig. 3.3b), when this expression was 
normalized to α cell mass, the difference was lost (Fig. 3.3c).  On the contrary, there was 
no significant difference in β cell mass (Fig. 3.3d) or plasma insulin between groups 
(Table 3.1).  However, insulin gene expression was significantly decreased in the HFD 
offspring (Fig. 3.3e) and normalizing to β cell area did not change this effect (Fig. 3.3f). 
The effect on islet cell mass caused a significant increase in the β cell to α cell ratio in 
HFD offspring (Fig. 3.4).   
Since maternally derived glucose may exert an effect islet cell development, we 
measured umbilical vein glucose, which is a measure of glucose delivered to the fetus 
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from the placenta (Kiserud, 2005; Konig, Vest, & Stahl, 1978), Umbilical-vein glucose 
significantly correlated with the β cell to α cell ratio in these fetuses (Fig. 3.4b) In 
addition, while circulating fetal insulin was not significantly affected in the fetal HFD 
group, this may be due reduced clearance by the liver since c-peptide measures indicate 
that there is a decrease in insulin secretion. Since we have previously demonstrated an 
increase in gluconeogenic gene expression in the fetal HFD liver (McCurdy, et al., 2009), 
we chose to investigate the relationship between islet cell mass and the expression of 
these genes.   Both β cell mass and the β cell to α cell ratio significantly correlated with 
expression of phosphoenolpyruvate carboxykinase 1 (PCK1) and peroxisome 
proliferator-activated receptor gamma, coactivator 1 alpha (PGC1A) (Fig. 3.4c-f).  
Transcription Factor Expression in Fetal Pancreas. PDX1 mRNA, a critical 
transcriptional regulator of early pancreatic development, islet cell neogenesis, and 
insulin gene transcription, was downregulated in the HFD fetal pancreas (Fig. 3.5a). 
PDX1 has also been shown to have multiple roles in pancreas development including bud 
expansion (Jonsson, Carlsson, Edlund, & Edlund, 1994; Offield et al., 1996) and islet cell 
differentiation (Ahlgren, Jonsson, Jonsson, Simu, & Edlund, 1998). We also examined 
other genes responsible for differentiation of pancreas endocrine cells. Neurogenin 
differentiation factor 1 (NeuroD), also known as choline dehydrogenase β2 (BETA2), is 
responsible for endocrine cell differentiation and transcriptional activation of insulin 
secretion (Sharma et al., 1999), while NK6 homeobox 1 (NKX6.1) is more specific to 
expansion and maintenance of β cells at this stage of development (Johansson & Grapin-
Botton, 2002; Rivas-Carrillo, Okitsu, Tanaka, & Kobayashi, 2007). Consistent with the 
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decrease in PDX1, both NeuroD and NKX6.1 expression was decreased in the HFD fetal 
pancreas (Fig. 3.5b&c).   
Alteration of Genes Involved in Glucose-stimulated Insulin Secretion in the 
Fetal Offspring. Since we were unable to directly test glucose-stimulated insulin 
secretion, we analyzed gene expression of proteins involved in this pathway, in order to 
determine if GSIS may be affected by the β cell to α cell ratio.  The two initial factors in 
the glucose-stimulated insulin secretion cascade are the facilitated glucose transporter 2 
(Glut2) that allows glucose to enter the cell, expressed in β cells in macaques, and 
glucokinase (GK), the rate-limiting enzyme in glycolysis (Iynedjian, 1993; Kramer, 
Moeller, Hachey, Mansfield, & Wachtman, 2009; Matschinsky, 1996; Newgard & 
McGarry, 1995). Glut2 gene expression, when normalized to β cell area, was increased in 
the HFD animals (Fig. 3.6a). Since, GK is expressed in both α cells and β cells 
(Heimberg et al., 1996), we normalized GK expression to islet area. GK was significantly 
up-regulated in the HFD offspring (Fig. 3.6b). The ATP-sensitive potassium channel 
found in both α and β cells is critical for regulating insulin and glucagon secretion. Gene 
expression of both components of this channel, SUR1 and Kir6.2 (Moritz, Leech, Ferrer, 
& Habener, 2001), when normalized to islet area, were not significantly affected by the 
HFD. (Fig 3.6c&d).  Hepatocyte nuclear factor-4 alpha (HNF-4α), a transcriptional 
activator of KCNJ11, is required for maintenance of normal Kir6.2 mRNA levels (Gupta 
et al., 2005). HNF-4α was also not significantly affected, when expression was 
normalized to islet area (Table  3.2). Further analysis of qRT-PCR results demonstrated 
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that mRNA expression patterns from the fetal groups were not depended on maternal 
sensitivity to the HFD.  
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Discussion 
In the past couple of decades, there has been a clear increase in the occurrence of 
metabolic diseases in children (Cook, Weitzman, Auinger, Nguyen, & Dietz, 2003; Weiss 
et al., 2004) and a significant contributor to this increase has been nutritional and health 
issues during pregnancy, commonly referred to the developmental origin of adult diseases 
hypothesis.  However, somewhat confusingly, the increase in early-onset obesity has 
been shown to be associated with conditions of both undernutrition as well as 
overnutrition during pregnancy.  This has led us to search for a common underlying cause 
between these opposing ends of the spectrum.  Placental insufficiency is another 
condition that greatly increases the risk of early-onset obesity and diabetes, subsequent to 
fetal growth restriction and catch-up growth.  Interestingly, our group recently 
demonstrated that chronic consumption of a HFD during pregnancy in the NHP leads to a 
significant reduction in placental blood flow (Frias, et al., 2011), similar to that observed 
in models of placental insufficiency, thus providing a possible common link between 
conditions of maternal undernutrition and placental insufficiency with that of maternal 
obesity and overnutrition.     
Previously, our group has also demonstrated a premature activation of the fetal 
hepatic gluconeogenic pathway caused by chronic consumption of a HFD during 
pregnancy (McCurdy, et al., 2009).  At that time it was uncertain as to what the driving 
factor for this activation was, especially since HFD fetal circulating glucose levels were 
normal.  Importantly, there are numerous reports that placental insufficiency and 
maternal undernutrition is also associated with premature activation of the fetal 
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gluconeogenesis, including an increase in fetal glucagon levels and activation of hepatic 
glucose production (HGP) (Fowden, Mijovic, & Silver, 1993; Limesand, Rozance, Smith, 
& Hay, 2007).  This is thought to be a compensatory response to adapt to the low levels 
of glucose from maternal sources.  This raised the question as to whether the placental 
insufficiency caused by the maternal HFD resulted in an increase in glucagon secretion 
and possibly an increase in α cell mass in the HFD fetal offspring.  Surprisingly, in 
contrast to placental insufficiency and maternal undernutrition, in our current study we 
demonstrated a significant decrease.  The correlation between hepatic gluconeogenic 
gene expression and both the β cell to α cell ratio and β cell mass suggests that islet cells 
may be adapting to normalize liver glucose secretion.  This adjustment may allow the 
fetuses to maintain glucose homeostasis.  However, while the decline in α cell mass may 
protect the fetus, this may be a maladaptive response that will ultimately lead to 
significant physiological consequences that are not measureable at the fetal stage.  
Analysis of the impact of the maternal metabolic phenotype (not shown) established that 
the lower α cell mass occurred in HFD offspring regardless of maternal obesity or insulin 
resistance.  
Interestingly, although the decrease in α cell mass in HFD offspring suggests 
some fundamental issue with islet development, glucagon gene expression, normalized 
for α cell mass, was not significantly affected by the maternal HFD. However, the 
decreased glucagon secretion in the HFD-sensitive fetal offspring indicates that maternal 
obesity may be leading to a further decline in α cell function.   
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A second potential contributing factor to the decreased α cell mass is placental 
glucose levels, since this was significantly correlated to β/α cell ratio (Fig. 3.4b). It is 
possible that the higher levels of glucose coming from the placenta are a signal that 
suppresses the α cell expansion that normally occurs during this time. Thus, while 
maternal HFD may have some common abnormalities in placental function to maternal 
undernutrition and placental insufficiency models, this does not result in a decrease in 
glucose delivery to through the placenta.  In fact, previous reports have demonstrated an 
increase in glucose transporter expression in the placenta of obese mothers or mothers 
who consume a HFD (H. N. Jones et al., 2009; Zhu, Ma, Long, Du, & Ford, 2010).  This 
may result in increased glucose transfer across the placenta of HFD dams, which would 
impact fetal α cell development. 
In addition, while HFD offspring have normal levels of β cell mass, we did 
observe significant decreases in insulin mRNA expression.  Even after normalization to 
the β cell area, insulin mRNA fell to nearly 1/3 of the normal expression, indicating that 
this is truly a decrease in expression on a per cell basis. Analysis of c-peptide from HFD 
offspring indicates that the decreased insulin gene transcription does translate into 
decreased insulin secretion, although total circulating insulin remained unchanged.  In 
order to understand what factors may be leading to the differences in insulin expression 
and α cell mass we analyzed PDX1, NeuroD and NKX6.1. Similar to the decrease in 
insulin mRNA, PDX1 gene transcription was also decreased. PDX1has been shown to 
regulate insulin gene transcription and islet expansion (Brissova et al., 2002; Jonsson, et 
al., 1994). NeuroD and NKX6.1 mRNA expression were also significantly decreased. 
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While the specific targets of these transcription factors in this NHP fetal tissue require 
further investigation, it is likely that the decrease effects both insulin gene transcription 
and α cell expansion.   Previous studies have demonstrated that α cell secretory products 
lead to increased PDX1 activation of insulin gene transcription (Buteau, Roduit, Susini, 
& Prentki, 1999; Perfetti, Zhou, Doyle, & Egan, 2000; Wang et al., 1999).  While further 
studies in isolated islet are necessary to elucidate the mechanisms that lead to this 
disregulation the decrease in both PDX1 and insulin expression may be due to decreased 
paracrine regulation of β cells caused by the decrease in α cell mass.   
In contrast, while there have been several studies demonstrating changes in β cell 
development and function in response to maternal overnutrition, undernutrition and 
obesity in rodent and sheep models, they have either not investigated abnormalities in the 
α cell or have reported not changes in this cell type.  In ewes, maternal obesity results in 
accelerations in β cell, but not α cell, development in the fetus in mid gestation and 
decreases β cell mass in late gestation (S. P. Ford, et al., 2009; L. Zhang, et al., 2011). In 
rodent models, the timing of HFD consumption – beginning, middle, end or all of 
gestation – results in differential islet effects in fetuses of pregnant rats (Cerf, et al., 
2005). Within these studies, it is not possible to determine if these differential effects are 
due to species differences or whether they are a result of different types of diets and/or 
different exposure periods to the diets.  However, the effect on α cell mass in the NHP 
offspring may represent a novel, unexplored avenue that clarifies the islet defects that 
may occur prior to childhood obesity onset.  Furthermore, because of the essential nature 
of islet paracrine regulation for normal endocrine function, the change in β cell to α cell 
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ratio may lead to islet cell dysfunction (Franklin, et al., 2005; Leung, et al., 2006).   In 
fact, analysis of gene expression in these animals demonstrated an increase in Glut2 and 
GK mRNA expression in the HFD fetus, indicating that maternal HFD consumption 
could lead to increased glycolysis.  However, since insulin gene transcription is 
decreased, this will decrease the reserved supply of insulin in β cell, thereby limiting the 
availability of the ready releasable insulin pool and decreasing insulin secretion which we 
demonstrated by a decrease in c-peptide in these animals.  In disassociated islets, β cells 
exhibit a poor insulin secretory response, despite normal glucose metabolism (Holz, 
Kuhtreiber, & Habener, 1993; Huypens, Ling, Pipeleers, & Schuit, 2000), indicating that 
a basal level of glucagon or other α cell secretagogues that are required for efficient 
insulin secretion.  The decreased α cell mass demonstrated in these animals elucidate a 
possible mechanism by which decreased β cells of insulin secretion results in a 
disconnect between increased glucose metabolism by Glut2 and GK and decreased 
insulin secretion. Studies from isolated fetal islets are essential to determine how the 
glucose-stimulated insulin secretion mechanism may be biochemically altered. Although 
the decrease in α cell mass was unexpected due to results from other animal model 
studies, my hypothesis that HFD during development would similarly suppress islet 
development of fetal offspring regardless of maternal obesity is supported by these 
experiments.  
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Figure 3.1: Diagram of Pancreas Sections 
 
 
Pancreas tissue was sectioned into 10 equal head-to-tail areas. Every other section was 
collected for immunohistochemistry (1-5) or RNA extraction (A-B). Results from IHC 
were averaged together to represent the total expression in the pancreas. Fresh tissue was 
homogenized completely to represent the total gene expression in the pancreas. 
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Figure 3.2: Immunohistochemical Analysis of Fetal Islet Mass 
 
Islet mass was not significantly different between diet groups (A) Representative images 
of CTR (B) and HFD (C) IHC.   *P < 0.05 versus CTR (Student’s t-test).  
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Figure 3.3: Islet Characterization in Fetal Offspring 
 
α cell mass was significantly decreased in the HFD fetal pancreas (A). Glucagon 
expression was suppressed in HFD offspring (B). When normalized to α cell area this 
effect was no longer significant (C). β cell mass was not affected in the HFD animals (D). 
Insulin expression was suppressed (E) and remain suppressed when normalized to β cell 
area (F). *P < 0.05 versus CTR (Student’s t-test). IHC: CTR n = 7, HFD n = 8; Real-
time: CTR n = 12, HFD n = 8 
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Figure 3.4: β cell Correlation Analysis 
 
β/α cell ratio was increased in the HFD offspring (A). *P < 0.05 versus CTR (Student’s t-
test). CTR n = 7, HFD n = 8 There was a significant correlation between the β/α cell ratio 
and umbilical vein glucose (B). Expression of PCK1 (C, E) and PGC1A (D, F) within the 
liver also significantly correlated with β cell mass and β/α cell ratio. 
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Figure 3.5: Transcription Factor Expression in Fetal Pancreas 
 
PDX1, NKX6.1 and NeuroD gene expression were significantly suppressed in the HFD 
offspring (A-C). *P < 0.05 versus CTR (Student’s t-test). CTR n = 12, HFD n = 8 
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Figure 3.6: Expression of Genes Involved in Glucose-stimulated Insulin Secretion in 
Fetal Pancreas 
 
Glut2 was increased in the HFD offspring when normalized to β cell area (A). 
Glucokinase was significantly elevated in the HFD offspring when normalized to islet 
area (B). SUR1 (C) and KCNJ11 (D) were not significantly affected by the HFD when 
normalized to islet area.  *P < 0.05 versus CTR (Student’s t-test). CTR n = 12; HFD n = 
8 
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Table 3.1: Comparison of CTR and HFD Fetuses 
 
Gestational Day 130 Control HFD 
n 12 8 
Weight (g) 350.2 ± 8.0 335.4 ± 18.1 
Pancreas weight (mg) 256.0 ± 16.6 213.4 ± 14.3 
Retro WAT Weight (mg) 120.8 ± 23.0 111.3 ± 18.9 
Insulin (μU/mL) 5.56 ± 0.61 5.92 ± 0.06 
C-peptide (ng/mL) 0.60 ± 0.06 0.44 ± 0.04 * 
Glucose (mg/dL) 116.8 ± 12.2 90.3 ± 11.6 
Glucagon (pg/mL) 126.5 ± 16.6 94.6 ± 15.1 
Leptin (ng/mL) 0.52 ± 0.02 0.51 ± 0.01 
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Table 3.2: Real-time RT-PCR Gene Expression in Fetal Pancreas 
 
Real-time PCR CTR HFD 
HFD 
(Normalized) 
n 12 8 8 
Glucagon 1.00 ± 0.12 0.35 ± 0.08 * 0.72 ± 0.08 
Glucokinase 1.00 ± 0.23 1.45 ± 0.25 2.15 ± 0.23 * 
Glut2 1.00 ± 0.15 1.62 ± 0.34 * 2.41 ± 0.30 * 
HNF4α 1.00 ± 0.11 0.56 ± 0.09 * 0.83 ± 0.12 
Insulin 1.00 ± 0.11 0.32 ± 0.07 * 0.34 ± 0.08 * 
KCNJ11/KIR6.2 1.00 ± 0.12 0.49 ± 0.09 * 0.49 ± 0.09  
NeuroD 1.00 ± 0.11 0.62 ± 0.09 * - 
NKX6.1 1.00 ± 0.13 0.45 ± 0.09 * - 
PDX1 1.00 ± 0.20 0.31 ± 0.07 * - 
SUR1 1.00 ± 0.14 0.59 ± 0.12 * 0.88 ± 0.18 
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Table 3.3: Comparison of CTR and HFD Dams 
Maternal Pregnancy Data CTR HFD 
N 12 8 
Weight (Kg) 8.7 ± 0.48 10.2 ± 0.72 
Pregnancy Weight Gain (Kg) 0.30 ± 0.23 0.90 ± 0.29 
Glucose (mg/dL) 43.7 ± 4.0 42.9 ± 2.3 
Insulin (μU/mL) 19.7 ± 3.7 33.1 ± 9.7 
Glucagon (pg/mL) 110 ± 16.5 87.5 ± 10.6 
Leptin (ng/mL) 22.4 ± 4.9 55.5 ± 12.6 * 
HOMA-IR 2.4 ± 0.65 3.6 ± 1.16 
IVGTT - Insulin AUC 4157 ± 599 8183 ± 1772 * 
IVGTT - Glucose AUC 3905 ± 207 4018 ± 253 
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Chapter 4: High-Fat Diet During Perinatal Development Leads to Early Insulin 
Resistance in the Nonhuman Primate Infant 
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Introduction 
Since maternal HFD consumption is a significant contributor to the increased risk 
of MetS in children, it is essential to analyze the effects in our HFD post-natal offspring 
to determine what physiological processes may be leading up to the development of this 
syndrome. The purpose of these studies was to characterize the metabolic profile of 
juvenile Japanese macaques chronically exposed to a HFD. The decrease in α cell mass 
of fetal HFD offspring likely led to decreased paracrine regulation of β cells, which 
resulted in dysfunction of insulin secretion.  Due to this dysfunction, it is essential to 
determine if continued exposure to the HFD will significantly affect glucose homeostasis 
in the HFD offspring.  I determined to analyze the physiology of the HFD animals up 
through weaning to determine if the islet effects measured in the HFD fetuses would 
translate to detrimental effects in infant glucose metabolism. I hypothesized that the 
decreased α cell mass and relative increase in the β/α cell ratio caused by the HFD during 
gestation would lead to perpetuation of the insulin secretory deficiency, but would 
ultimately result in increased insulin secretion and increased susceptibility of the HFD 
offspring to insulin resistance. 
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Materials and Methods 
Animals. All animal procedures were performed in accordance with the 
guidelines of the Institutional Animal Care and Use Committee of the ONPRC as 
previously described (Frias, et al.; Grant, et al.; Grayson, et al.; McCurdy, et al., 2009; 
Sullivan, et al., 2010)  Briefly, age and weight matched adult female Japanese macaques 
were fed a control (CTR) or high-fat diet (HFD) for up to 5 years. Juvenile offspring 
were born naturally from CTR or HFD mothers during years 2 through 5 on the HFD. 
Physiological data collected from animals occurred during the first 210 days of life, prior 
to weaning. 
Intravenous Glucose Tolerance Tests. We performed IVGTTs at P90 and P180 
in the juveniles. In the dams we performed IVGTTs at 123 days (± 5 days) gestation and 
at approximately 130 days (± 6 days) postnatally. Animals were sedated with ketamine 
(10 mg/kg) and administered a glucose bolus (50% dextrose solution) at a dose of 0.6 
g/kg via the saphenous vein. Baseline blood samples were obtained prior to the infusion, 
and blood samples were taken at 1, 3, 5, 10, 20, 40, and 60 min after infusion via the 
femoral artery. Glucose was measured immediately using a OneTouch Ultra2 Blood 
Glucose Monitor (LifeScan), and the remainder of the blood was kept in heparinized 
tubes on ice for insulin measurement. After IVGTT, samples were centrifuged, and 
plasma was stored with 5% aprotinin at –80°C until assayed. Insulin was assayed in 
plasma by RIA (Millipore catalog no. RI-13K, Billerica, MA). HOMA-IR was calculated 
as fasting serum insulin (μU/ml) × fasting plasma glucose (mmol/l)/22.5 as previously 
described (Bonora, et al., 2000; Matthews, et al., 1985). Baseline samples were assayed 
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for glucagon (Millipore, catalog no. GL-32K, Billerica, MA), and leptin (Millipore 
catalog no. HL-81K, Billerica, MA). 
Intravenous Insulin Tolerance Tests. We performed IVITTs at P210 on a subset 
of animals.  Animals were sedated with telazol (5 mg/kg) and a baseline blood sample 
was collected and measured for glucose. The remainder of the blood was kept in a 
heparinized tube on ice for insulin measurement.  Insulin was infused at 0.05U/Kg and 
sequential blood samples were taken at 1, 3, 5, 10, 15, 20, 25 and 30 minutes. After 
IVITT, the initial baseline sample was centrifuged, and plasma was stored with 5% 
aprotinin at –80°C until assayed. Insulin was assayed in plasma by RIA (Milllipore 
catalog no. RI-13K, Billerica, MA). The insulin sensitivity index (ISI) was calculated as 
the change in glycemia from baseline to 15 minutes (estimated using the linear regression 
from baseline to 15 minutes) divided by the initial glycemia (average of both baselines) 
as previously described (Grulet, Durlach, Hecart, Gross, & Leutenegger, 1993). 
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Results 
Physiology of P30 and P90 Offspring.  At postnatal day 30 (P30), body weight 
was not significantly different between diet groups, although the HFD offspring did have 
increased adiposity (Fig. 4.1a& c). Also, males were significantly heavier than females at 
P30 (Fig. 4.1b). Body mass index (BMI) was significantly decreased in the HFD 
offspring at P30 (Fig. 4.1d), indicating that the intra-uterine HFD exposure lead to growth 
restriction in these animals. 
At P90 males were still heavier than females (Fig. 4.2a). However, females tended 
to have increased body fat (Table 4.1). Glucose was not significantly affected by the diet; 
however, at P90 males did secrete approximately 15% more glucose than females (Fig. 
4.2b).  Also, insulin response to an IVGTT was significantly suppressed in the HFD 
offspring (Fig. 4.2c).  The decreased insulin secretion at P90 is likely due to an increase 
in insulin secretion in the HFD mothers during lactation (Fig. 4.2d), as insulin is passed 
into and absorbed from the breast milk (Jovanovic-Peterson, Fuhrmann, Hedden, Walker, 
& Peterson, 1989). Previous publications from this lab have demonstrated an increase in 
the insulin content of the breast milk of HFD mothers (Grant, et al., 2011). 
Physiology of P180 and P210 Offspring. By P180 HFD offspring were 
significantly heavier (Fig. 4.3a) and the sex effect was no longer demonstrable (Table 
4.1).  While still very lean, the HFD animals had elevated body fat (Fig. 4.3b). At P180 
HFD offspring insulin secretion was normalized to control levels (Fig. 4.3c). At P210, 
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just prior to weaning, animals on the HFD had become insulin resistant as indicated by a 
30% decrease in their insulin sensitivity index (Fig. 4.3d).  
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Discussion 
In order to determine if fetal changes in islet composition and gene expression 
might lead to lasting physiological effects in infant macaques from HFD dams, I studied 
the physiology of these animals after birth until weaning. Infant offspring consume only 
maternal milk during the first three months of life. Since previous studies from our lab 
have shown no significant difference in total fatty acid content in milk from dams on the 
CTR versus HFD, it is likely that they will not be exposed to the specific metabolic 
pressure of the HFD until after P90.  In fact, at P90, we demonstrated decreased insulin 
secretion in the HFD offspring which may be reflective of the high insulin content of the 
mother’s milk.  However, since insulin secretion is clearly affected in the HFD fetal 
offspring, this may reflect the decreased paracrine regulation of HFD fetal islets.  By 7 
months of age, the HFD animals were heavier, had increased body fat and were insulin 
resistant.  However, at this time, there was no significant difference in fasting insulin or 
insulin response to an IVGTT.  This indicates that, while HFD exposure during the early 
post-natal period may lead to whole body insulin resistance.  While islet defects were not 
measureablel at this stage if α cell mass remained decreased, it may produce a beneficial 
effect in the HFD post-natal offspring which will lead to decreased glucagon production 
and allow them to adapt to the high lipid content of the diet.  
Although HFD during fetal development may program the fetal pancreas to 
withstand the early postnatal insults of this diet, this adaptation may not continue when 
the juvenile offspring are chronically exposed to the increased metabolic pressure that the 
HFD produces. As we have previously demonstrated, there are significant effects of the 
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HFD on liver function and morphology in the fetuses of HFD mothers (Grant, et al., 
2011; McCurdy, et al., 2009), indicating that insulin resistance in the HFD animal results 
from dysfunction of peripheral tissues first and then hyperinsulinemia will occur as a 
response to this resistance.  While insulin hyper-secretion and insulin resistance occur 
concurrently in the diabetic adult, in this model we have demonstrated that the pathway 
to disease progression starts with insulin resistance.  My hypothesis that decreased α cell 
mass and relative increase in the β/α cell ratio caused by the HFD during gestation leads 
to elevated insulin secretion is not supported by this data.  The decreased insulin 
secretion at P90 may be a result of β cell dysfunction; however, based on the limitations 
of this study, it is not possible to determine how islet composition is affected.  Yet, these 
animals become insulin-resistant, as I hypothesized.  It is essential to follow these 
animals until a point at which there are significant physiologic measures of islet 
dysfunction in order to determine how islets adapt in the juvenile animal to a HFD.  
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Figure 4.1: P30 Physiology 
 
Body weight was not significantly affected by the HFD at P30 (A). However, males were 
significantly heavier than females (B). Body fat was significantly elevated in the HFD 
offspring (C). BMI was significantly decreased in HFD offspring (D). 
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Figure 4.2: P90 Physiology and Maternal IVGTT IAUC 
 
At P90 males were still significantly heavier than females (A). Fasting glucose was also 
elevated in males (B). IVGTT insulin AUC was decreased in HFD offspring (C). 
Maternal IVGTT insulin AUC was elevated during gestation and lactation (D).  
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Figure 4.3: P180 and P210 Physiology 
 
Body weight was significantly increased in the HFD offspring by P180 (A). Body fat 
percentage was significantly elevated in the P180 offspring (B).  There was no significant 
effect of HFD on insulin secretion during a GTT at P180 (C). *P < 0.05 versus CTR 
(Student’s t-test) CTR n=24, HFD n= 35.  By P210 HFD animals are insulin resistant 
(D). *P < 0.05 versus CTR (Student’s t-test; CTR n=16, HFD n= 14) 
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Table 4.1: Physiology of P30 and P90 Offspring 
Sample Size 10 14 16 19 Diet or 
Sex 
Effect 
Sex Female Male Female Male 
Postnatal Day 30 CTR HFD 
Weight (g) 719 ± 19.8 753 ± 22.1 688 ± 27.6 751 ± 20.1 SEX 
Ponderal Index 57.5 ± 2.95 56.7 ± 2.24 55.7 ± 1.94 56.9 ± 2.93 - 
Total Body Fat % 2.81 ± 0.44 2.69 ± 0.35 5.63 ± 1.32 3.42 ± 0.57 DIET 
Postnatal Day 90 CTR HFD   
Weight (g) 1064 ± 40.3 1149 ± 46 1031 ± 36 1165 ± 35 SEX 
Ponderal Index 5.79 ± 0.24 5.9 ± 0.19 5.6 ± 0.2 5.6 ± 0.2 - 
Body Mass Index 1.51 ± 0.04 1.59 ± 0.04 1.48 ± 0.05 1.53 ± 0.05 SEX 
Total Body Fat % 4.85 ± 0.65 4.38 ± 0.60 5.99 ± 0.54 5.3 ± 0.47 - 
Fasting Glucose (mg/dL) 75.2 ± 9.0 89.9 ± 4.9 72.8 ± 3.5 84.8 ± 6.0 SEX 
Fasting Insulin (μU/mL) 13.9 ± 4.7 14.1 ± 4.5 10.4 ± 1.87 10.0 ± 2.48 - 
Glucagon (pg/mL) 103.4 ± 36.6 110.9 ± 13.6 124.85 ± 25.5 110.5 ± 12.0 - 
Leptin (ng/mL) 2.37 ± 0.52 2.20 ± 0.30 2.52 ± 0.34 2.02 ± 0.31 - 
HOMA-IR 4.27 ± 1.31 4.18 ± 1.02 1.97 ± 0.42 2.44 ± 0.89 - 
IVGTT – GSIS 1179 ± 260 958 ± 186 804 ± 158 579 ± 95 DIET 
IVGTT - Glucose AUC 3712 ± 591 3802 ± 412 3416 ± 274 3788 ± 211 - 
IVGTT - Total Insulin AUC 1663 ± 228 1953 ± 278 1318 ± 213 1286 ± 154 DIET 
IVGTT - 1st Phase Insulin 15.7 ± 3.43 19 ± 4.0 22.0 ± 5.5 18.9 ± 3.4 - 
IVGTT - 2nd Phase Insulin 1493 ± 201 1837 ± 262 1211 ± 93 1166 ± 142 - 
 
Physiological measurements of infantile offspring taken at post-natal day 30 and 90. Diet 
or sex effect indicated on table, P < 0.05 (2 way ANOVA, with Bonferroni’s post-hoc 
test). 
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Table 4.2: Physiology of P180 and P210 Offspring 
Postnatal Day 180 CTR HFD   
Weight (g) 1591 ± 54 1685 ± 85 1576 ± 56 1745 ± 63 DIET 
Body Mass Index 1.66 ± 0.09 1.78 ± 0.11 1.72 ± 0.70 1.86 ± 0.79 - 
Total Body Fat % 4.10 ± 0.61 1.53 ± 0.70 4.22 ± 0.46 3.83 ± 0.52 DIET 
Fasting Glucose (mg/dL) 86 ± 6.0 86 ± 6.9 75 ± 4.5 90 ± 5.1 - 
Fasting Insulin (μU/mL) 15.7 ± 4.9 17.4 ± 5.7 18.7 ± 3.7 17.3 ± 4.2 - 
Glucagon (pg/mL) 104 ± 24.2 122 ± 26.8 142 ± 17.6 159.6 ± 19.8 - 
Leptin (ng/mL) 2.60 ± 0.59 2.34 ± 0.68 3.08 ± 0.45 1.99 ± 0.51 - 
HOMA-IR 3.41 ± 1.17 3.74 ± 1.36 3.71 ± 0.89 4.10 ± 1.00 - 
IVGTT – GSIS 729 ± 137 752 ± 158 850 ± 103 712 ± 117 - 
IVGTT - Glucose AUC 3502 ± 468 3729 ± 541 3750 ± 354 3613 ± 400 - 
IVGTT - Total Insulin AUC 1690 ± 230 1730 ± 266 1824 ± 174 1869 ± 196 - 
IVGTT - 1st Phase Insulin 25.8 ± 4.4 15.3 ± 5.1 22.7 ± 3.3 21.4 ± 3.8 - 
IVGTT - 2nd Phase Insulin 1514 ± 220 1592 ± 242 1665 ± 159 1701 ± 179 - 
Postnatal Day 210 CTR HFD   
Sample Size 7 9 9 5   
Weight (g) 1771 ± 64 1794 ± 66 1824 ± 42 1956 ± 112 DIET 
Fasting Glucose (mg/dL) 83 ± 12.4 86 ± 5.7 79 ± 10.4 73 ± 4.4 - 
Fasting Insulin (μU/mL) 23.4 ± 4.5 18.1 ± 4.7 24.2 ± 8.4 9.8 ± 3.3 SEX 
ITT Insulin Sensitivity Index 0.54 ± 0.08 0.62 ± 0.08 0.45 ± 0.06 0.39 ± 0.05 DIET 
 
Physiological measurements of infantile offspring taken at post-natal day 180 and 210. 
Diet or sex effect indicated on table, P < 0.05 (2 way ANOVA, with Bonferroni’s post-
hoc test). 
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Table 4.3: Physiology of Dams of Infant Offspring 
Sample Size 10 14 16 19 Diet or 
Sex 
Effect 
Offspring Sex Female Male Female Male 
Maternal Pregnancy Data CTR HFD 
Weight (Kg) 8.9 ± 1.1 9.7 ± 1.4 11.8 ± 1.7 11.9 ± 2.2 DIET 
Pregnancy Weight Gain (Kg) 0.23 ± 0.4 0.72 ± 0.3 0.28  ±  0.2 1.4 ± 0.7 - 
Glucose (mg/dL) 43 ± 4.2 42 ± 2.8 39 ± 2.8 48 ± 3.6 - 
Insulin (μU/mL) 10.0 ± 2.2 11.5 ± 2.7 40.6 ± 6.4 63.9 ± 7.5 DIET 
HOMA-IR 1.1 ± 0.2 1.3 ± 0.3 4.2 ± 1.1 8.5 ± 2.2 DIET 
IVGTT - Insulin AUC 2725 ± 49 2388 ± 30 6406 ± 67 10493 ± 106 DIET 
IVGTT - Glucose AUC 4791 ± 34 5341 ± 25 4575 ± 39 4320 ± 30 - 
Maternal Lactation Data CTR HFD   
Weight (Kg) 9.3 ± 0.6 9.5 ± 0.5 12.7 ± 0.7 11.9 ± 0.5 DIET 
Glucose (mg/dL) 53 ± 3.7 51 ± 2.1 55 ± 1.7 53 ± 2.0 - 
Insulin (μU/mL) 15.5 ± 5.0 16.0 ± 2.9 56.8 ± 19.7 32.5 ± 8.4 DIET 
HOMA-IR 2.3 ± 0.8 2.0 ± 0.4 7.4 ± 2.4 5.0 ± 1.1 DIET 
IVGTT - Insulin AUC 3242 ± 926 2819 ± 397 6157 ± 754 4195 ± 758 DIET 
IVGTT - Glucose AUC 6199 ± 622 6260 ± 329 6113 ± 338 5539 ± 396 - 
 
Physiological measurements of dams of infant offspring taken during the third trimester 
of pregnancy and during the 3-4
th
 month of lacation, separated by sex of the offspring. 
Diet or sex effect indicated on table, P < 0.05 (2 way ANOVA, with Bonferroni’s post-
hoc test). 
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Chapter 5: Chronic High-Fat Diet Consumption During Pregnancy and the Early 
Postnatal Period Leads to Decreased α Cell Plasticity in the Juvenile Nonhuman 
Primate  
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Introduction 
In the previous chapters, I have shown that maternal obesity and/or HFD 
consumption can impact fetal islet development and lead to insulin resistance in the post-
natal offspring prior to weaning. Specifically, I demonstrated a decrease in α cell mass 
and a down-regulation of transcription factors involved in the differentiation pathway of 
these cells during pregnancy(Comstock, 2012). In contrast, in rodent models, α cell mass 
is increased in response to a HFD (Cerf, et al., 2005). However, in sheep models, there is 
only evidence of β cell abnormalities when exposed to maternal overnutrition during the 
second trimester of gestation (S. P. Ford, et al., 2009; L. Zhang, et al., 2011).  While 
many studies have been performed on post-natal development in the rodent, there are 
significant species differences. Furthermore, in primate species, there is significant islet 
expansion through puberty (Hansen & Bodkin, 1990; Wolfe-Coote, Louw, Woodroof, & 
Du Toit, 1996). Therefore, post-natal nutrition may also significantly impact islet 
development and function.  
The primary purpose of these studies was to determine the relative impact of early 
programming events (maternal diet) versus post-weaning dietary influence on pancreas 
development and potential long-term susceptibility to diabetes. To accomplish this, I 
compared islet development and function in juvenile macaques from four different 
groups: CTR/CTR, CTR/HFD, HFD/CTR and HFD/HFD. Using these four groups, we 
can determine the relative impact of maternal HFD versus the impact of the HFD during 
the post-weaning period on islet structural morphology and function. I hypothesized that 
the decreased α cell mass in the HFD offspring would perpetuate by continued HFD 
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exposure through the post-weaning period and would lead to hyperinsulinemia, increased 
insulin resistance, and persistant changes in islet morphology.  My second hypothesis was 
that a post-weaning dietary intervention to a standard control (CTR) diet could reverse 
the effects of HFD consumption during early development (HFD/CTR). Finally, my third 
hypothesis was that post-weaning HFD alone (CTR/HFD) would lead to alterations in 
islet morphology that would have diminished effects on glucose homeostasis, compared 
to the HFD/HFD offspring. 
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Materials and Methods 
Animals. All animal procedures performed were in accordance with the 
guidelines of the Institutional Animal Care and Use Committee of the Oregon National 
Primate Research Center (ONPRC) as previously described (Frias, et al.; Grant, et al.; 
Grayson, et al.; McCurdy, et al., 2009; Sullivan, et al.).  Briefly, age- and weight-matched 
adult female Japanese macaques were fed a CTR or HFD. Juvenile offspring were born 
naturally from CTR or HFD mothers during years 2 through 5 on the HFD and allowed to 
stay with their mothers until weaning at approximately 8 months of age (249 +/- 4 days).  
At 8 months, the juveniles were weaned and maintained on the same diet or switched to 
the opposing diet, for 5 months (143 +/- 3 days), thus generating four juvenile groups: 
CTR/CTR, CTR/HFD, HFD/CTR & HFD/HFD. These animals were necropsied at 
approximately 13 months of age (393 +/- 4 days). 
Intravenous Glucose Tolerance Tests. As previously described (Grant, et al., 
2011; McCurdy, et al., 2009), we performed an IVGTT 1 week prior to necropsy. Briefly, 
after a 5 hour morning fast, animals are sedated with ketamine and administered a 
glucose bolus at a dose of 0.6 g/kg via the saphenous vein. Baseline blood samples were 
obtained prior to the infusion, and samples were taken at 1, 3, 5, 10, 20, 40, and 60 
minutes after infusion via the femoral artery. Glucose was measured immediately and the 
remainder of the blood was kept on ice for insulin measurement in plasma by RIA 
(catalog no. RI-13K; Linco). HOMA-IR was calculated as fasting serum insulin (μU/ml) 
× fasting plasma glucose (mmol/l)/22.5, as previously described (Bonora, et al., 2000; 
Matthews, et al., 1985). 
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RNA Isolation and Quantitative RT-PCR. Total RNA was isolated from 5 
head-to-tail grouped sections of each offspring pancreas (Chapter 3, Fig. 3.1) using 
TRIzol reagent (Invitrogen, Carlsbad, CA). RNA was DNase-treated and reverse-
transcribed.  mRNA was measured by real-time quantitative RT-PCR using a PE Applied 
Biosystems PRISM 7700 Sequences Detector System (Invitrogen Life Technologies, 
Carlsbad, CA). Premade qPCR gene expression assays directed against human sequences 
were purchased from Applied Biosystems. The amplification was performed as follows: 2 
min at 50°C, 10 min at 95°C, then 45 cycles each at 95°C for 15 sec and at 60°C for 60 
sec in the ABI/Prism 7700 Sequences Detector System. Standard curves on serial 
dilutions of the cDNA (1:10, 1:50, 1:100 1:500, 1:1000 and 1:10,000) were performed 
using cDNA from pooled pancreas samples. Standard curves were drawn on the basis of 
the log of the input RNA versus the critical threshold (CT) cycle, in which the 
fluorescence of the sample is greater than the threshold of the baseline fluorescence. The 
housekeeping gene β-actin was assayed and shown to be consistently expressed between 
juvenile groups, while two other commonly used genes (18S and GAPDH) were 
significantly differentially expressed in the various diet groups. Therefore, all qRT-PCR 
results are normalized to β-actin expression. 
Immunohistochemistry.  Pancreas tissue was collected from 5 head-to-tail areas 
(Chapter 3, Fig. 3.1) and cut into 5 μm paraffin-embedded sections. Sections were 
deparaffinized in xylene and then washed with 100%, 95%, 85%, and 70% graded 
ethanol for 5 minutes each. Microwaving in citrate buffer was used for antigen retrieval. 
Standard immunohistochemical methods were used. Briefly, sections were washed in 
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KPBS and then blocked in 2% donkey serum in 0.4% triton X/KPBS. Antibodies against 
insulin (#20056, 1:2000, Immmunostar, Hudson, WI) and glucagon (#4031-01F, 
1:10,000, Linco, St. Charles, MO) were used, which have been previously described for 
immunohistochemical identification of β cells and α cells, respectively (Elghazi, Cras-
Meneur, Czernichow, & Scharfmann, 2002; Prado, Pugh-Bernard, Elghazi, Sosa-Pineda, 
& Sussel, 2004).  Primary antibodies were diluted in 2% donkey serum in 0.4% triton 
X/KPBS and applied to tissue sections where they were incubated overnight. Tissues 
were then washed in KPBS and secondary antibodies were applied for 1 hour at room 
temperature at a dilution of 1:200 (Jackson ImmunoResearch Laboratories, Inc, West 
Grove, PA). The specificity of the antibodies were determined by omitting the primary 
and using only the secondary. These tests did not produce staining. 
Quantitative Analysis. Images were acquired with a MarianasTM imaging 
workstation (Intelligent Imaging Innovations, Denver, CO), using a 20X objective and 
the stereology module to montage images covering whole sections. Areas occupied by β 
and α cells were measured based on intensity segmentation of each fluorescence channel 
using Slidebook 5.0.  The β and α cells fractions were calculated by dividing by the area 
of the whole section. Total islet area (insulin and glucagon stained area/DAPI stained 
area), islet mass (total islet area x pancreas weight), β and α cell mass [(total insulin or 
glucagon stained area/DAPI stained area) x pancreas weight] and islet density (total islet 
number/DAPI area) were calculated as previously reported (Uchida, et al., 2005). Islets 
were classified based on size: stained cell clusters with an area greater than 1000 μm2 or 
diameter approximately 35 µm were arbitrarily defined as large islets, while any clusters 
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smaller than this were classified as small islets. Individual α and β cell size and number 
were quantified in a manner similar to that previously described (Beringue, et al., 2002; 
Montanya & Tellez, 2009). Briefly, stereologically sampled 20x images from the tail 
region of each pancreas were selected, and 3 to 5 whole islets were quantified from each 
animal.  Individual α and β cell area was measured based on glucagon and insulin 
staining and the number of nuclei were quantified in that area.  
Data Analysis. For all analyses not specifically described above, data were 
compiled and tested for normality with SPSS Statistics 19 software (Armonk, New 
York). Data was tested for maternal or post-weaning diet effect using two-way ANOVA, 
then Bonferroni post-hoc analysis to test difference between individual groups. In order 
to determine a sex effext, a three-way ANOVA was performed on all data for sex, 
maternal diet and post-weaning diet. Significance was reported as p < 0.05. All graphs 
were made with Prism software (GraphPad Software, Inc., La Jolla, CA). 
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Results 
Metabolic Characteristics of Juvenile Offspring Exposed to a HFD. During 
the post-weaning period, both CTR/HFD and HFD/HFD animals gain significantly more 
weight than CTR/CTR animals (data not shown). However, by 13 months, only the 
HFD/HFD animals were significantly heavier than CTR/CTR animals (Fig. 5.1a). 
Maternal diet did not significantly affect final weight; rather, the post-weaning diet was 
the most significant predictive of weight at necropsy. Interestingly, for the HFD/HFD and 
HFD/CTR groups, males had a higher (approximately 10% higher) final weight than 
females; in contrast, for the CTR/CTR and CTR/HFD, the final weights were similar for 
males and females (Fig. 5.2a).  While all animals exposed to HFD diet tended to have 
slightly elevated overall body fat (as determined by DEXA); this was not significantly 
different (Table 5.1). However, retroperitoneal white adipose tissue (RWAT) mass was 
elevated in both post-wean fed HFD groups (Fig. 5.1b; Table 5.1), and subscapular 
caliper measures, an indicator of subcutaneous fat mass, were also significantly greater in 
these groups (not shown). It should be recognized that, as a whole, these animals are very 
lean at 13 months, with less that 3% body fat (Table 5.1).  Consistent, with the sex-
dependent differences in weight, fasting glucose was significantly elevated specifically in 
the males that had been exposed to the maternal diet (HFD/HFD and HFD/CTR), but was 
not significantly different between the female diet groups (Fig. 4.2b). In contrast, fasting 
insulin, insulin area under the curve (IAUC) and HOMA-IR was similarly increased in 
both sexes in response to the post-weaning high-fat diet exposure (Fig. 5.1c&d, Table 
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5.1); however, this was only significant in the HFD/HFD group. There was no significant 
difference in basal glucagon levels between the different groups (Table 5.1). 
Altered Islet Morphology in HFD Juveniles. Stereological analysis of 
pancreatic islets was performed to determine the relative contribution of islet mass, size, 
density and islet composition upon the physiological effects noted in the juveniles.  
Importantly, pancreas weight was lower specifically in the CTR/HFD group (Table 5.1), 
thus all subsequent measures were normalized to pancreas weight.  Islet mass of the both 
CTR/HFD and HFD/HFD animals was increased by 30% when compared to CTR/CTR, 
while the HFD/CTR was not significantly different from CTR/CTR (Fig 5.3a). 
Interestingly, the increase in islet mass in the HFD/HFD group was due to an increase in 
the average islet diameter (Fig. 5.3b). However, the increase in the CTR/HFD was due to 
an increase in islet density (Fig. 5.3c). Further analysis of islets by size demonstrated an 
increase in large islet mass in the HFD/HFD group and an increase in small islet density 
in the CTR/HFD group (Fig. 5.4a&c). In order to determine which cell type contributed 
to the increase in islet mass, we quantified total α and β cell area separately. Surprisingly, 
while the CTR/HFD group displayed a near doubling of both β cell  cell area (Fig. 
5.5a&b), only β cell area was significantly increased in the HFD/HFD (Fig. 5.5a).  This 
leads to a normal β/α cell ratio in the CTR/HFD group but an increase in the β/α cell ratio 
in HFD/HFD animals (Fig. 5.5c). Since an increase in β cell or α cell area could be a 
result of hyperplasia or hypertrophy, we also determined β cell and α cell size and 
number. While β cell size did not change in any of the groups (Fig. 5.6a), β cell number 
was increased in both the CTR/HFD and HFD/HFD groups (Fig. 5.6b); however, the 
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increase in the CTR/HFD was significantly greater than the HFD/HFD group. In contrast, 
α cell size was increased in both the CTR/HFD and HFD/HFD groups (Fig. 5.6c), even 
though only the CTR/HFD group displayed an increase in α cell number (Fig. 5.6d).  This 
indicates that the increase in α cell area in the CTR/HFD and HFD/HFD groups is due to 
hyperplasia, while the increased β cell area in the CTR/HFD group is due to hypertrophy. 
Differential Islet Gene Expression of HFD Offspring. In order to determine 
which factors may be responsible for the increase in insulin secretion observed in HFD 
offspring, we analyzed the mRNA expression in the whole pancreas of various genes 
involved in insulin production and secretion.  It should be noted that we have presented 
data as both gene expression normalized to a house-keeping gene (β-actin (Fig. 5.78f) as 
well as normalized to β cell area, α cell area, or islet area, depending on the cell types in 
which the gene of interest is expressed. This methodology has been previously described 
when whole-pancreas mRNA is used (Gatford, et al., 2008). Absolute insulin mRNA 
expression was significantly elevated only in HFD/HFD pancreas, when compared to the 
CTR/CTR group (Fig. 5.87a).  When insulin mRNA levels were normalized to the β cell 
area (insulin-producing cells), the effect in the HFD/HFD group was lost, but there was a 
significant overall maternal diet effect (Fig. 5.8a). This would indicate that the increase in 
the HFD groups may be partially dependent on the increase in β cell area, but that 
maternal HFD diet causes an increase in cellular expression.  Consistent with the lack of 
differences in circulating glucagon levels, glucagon mRNA was not significantly 
different between the groups (Fig. 5.7e), even after normalizing to the α cell area (Fig. 
5.8e).  The two key genes involved in the initiation of GSIS are the glucose transporter 
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Glut2 that facilitates diffusion of glucose into the cell, and glucokinase (GK), the rate-
limiting enzyme in glycolysis (Iynedjian, 1993; Matschinsky, 1996; Newgard & 
McGarry, 1995).  In preliminarily studies using immunohistochemistry, we demonstrated 
that the primary glucose transporter in Japanese macaque β cells is Glut2 (Fig. 5.9). 
Interestingly, Glut2 expression (Fig. 5.7c) was significantly increased specifically in the 
CTR/HFD, while GK expression was specifically elevated in HFD/HFD group (Fig. 
5.7b).  However, when normalized for β cell area, the differences in Glut2 mRNA were 
completely eliminated, suggesting that the change in Glut2 is dependent on changes in β 
cell area.  In contrast, when GK expression was normalized to islet area, the effect in the 
HFD/HFD group was lost, but a decrease in expression in the CTR/HFD group was 
unmasked.  This indicates that cellular expression of GK in the islet is normal in 
HFD/HFD animals, but lower in the CTR/HFD group.  
Juveniles on the HFD are exposed to 4 times more fatty acids than the CTR 
animals (Grant, et al., 2011), which can augment insulin secretion through activation of 
the G-protein coupled receptor GPR40/FFAR1 (free fatty acid receptor 1) (Briscoe et al., 
2003; Nolan, Madiraju, Delghingaro-Augusto, Peyot, & Prentki, 2006). Offspring on the 
post-weaning HFD had significantly increased FFAR1 gene expression (Fig. 5.7d). Since 
FFAR1 has been confirmed in α cells as well as β cells (Del Guerra et al., 2010; Flodgren 
et al., 2007; Tomita et al., 2006), FFAR1 expression was normalized to islet area. There 
was no significant effect on normalized FFAR1 expression (Fig. 5.8d), indicating that the 
up-regulation was likely secondary to the increase in islet mass, not individual cell gene 
expression.   
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Discussion 
It is clear from these studies that, in young animals, exposure to a HFD during the 
postnatal period can have a similar impact on overall weight gain and glucose 
homeostasis, irrespective of whether the animal was born to a mother on a CTR or HFD.  
However, these studies point to some fundamental differences in the underlying 
mechanisms leading to the impaired endocrine pancreas function between CTR and HFD 
offspring.  First, it should be noted that HFD/HFD and CTR/HFD offspring displayed a 
higher average body weight, which was only significant in the HFD/HFD group, although 
the increase is only approximately 10%.  Furthermore, while these animals have 
increased adiposity, overall the animals are very lean, with less than 3% body fat.  In 
spite of this modest phenotype, the HFD/HFD offspring have significantly increased 
fasting and GSIS.  There is also a modest sex difference in the metabolic effects. Body 
weight in females is not significantly elevated, but CTR/HFD and HFD/HFD are insulin 
resistant at this stage. However, males are heavier and the effect of the HFD is more 
evident in this sex. Glucose levels are significantly elevated in both the HFD/CTR and 
the HFD/HFD males, indicating that the metabolic effect of maternal HFD is more robust 
in these animals. The sex effect that we have demonstrated is consistent with the findings 
in rodent models in which males tend to be more susceptible to fetal HFD induced 
metabolic effects (Dunn & Bale, 2009; Estrany, Proenza, Llado, & Gianotti, 2011; 
Gomez-Perez, Gianotti, Llado, & Proenza, 2011; Medrikova et al., 2011). Importantly, 
these effects were independent of maternal obesity or insulin resistance.  
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Islet mass is similarly increased in both the CTR/HFD and HFD/HFD offspring. 
However, the underlying factors that contribute to this increase are different. Animals 
exposed to the maternal HFD have larger islets, while the post-weaning HFD alone leads 
to an increased number of islets. Both effects result in increased islet mass, although 
morphological differences are likely to have differential long-term outcomes in these 
animals.  By increasing small islet density, CTR/HFD animals may be able to resist the 
effect of the HFD for longer. Since islet maturation in the macaque continues through 
puberty, the smaller islets will be able to continue to expand in response to metabolic 
pressure and allow for increased insulin secretion in response to chronic, long-term HFD 
exposure. In contrast, larger islets indicate that the HFD/HFD islets have already started 
expanding in response to chronic HFD. The HFD/HFD juveniles will likely progress 
through the stages of insulin resistance leading to diabetes more rapidly by reaching the 
threshold of islet expansion sooner than the CTR/HFD juveniles. 
We demonstrated that the CTR/HFD animals have increased α cell and β cell 
mass, while the HFD/HFD offspring only have increased β cell mass. In contrast, the 
HFD/CTR α cell and β cell mass are normalized to control levels, indicating that islet 
cells are highly plastic during the peri-weaning period. We have previously demonstrated 
that fetuses from HFD mothers have decreased α cell mass. Therefore, the lack of α cell 
expansion in the HFD/HFD juveniles indicates that there is likely a programmed 
suppression of α cells that is a result of chronic HFD throughout the peri-natal period. 
This results in nearly a 40% increase in the β/α cell ratio in HFD/HFD offspring. While 
the CTR/HFD juveniles do have larger islets, the ratio of β cells to α cells is maintained 
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at normal levels, thus expectedly maintaining paracrine function of these islets.  Intact 
paracrine regulation of islet cells is essential for long-term glucose homeostasis (Cabrera, 
et al., 2006; Walker, et al., 2011), indicating that the relative contribution of α cell and β 
cells to islet composition will ultimately predict islet efficiency.  It is not known whether 
the increase in β/α cell ratio in HFD/HFD juveniles is adaptive or maladaptive at this 
stage. Therefore, future studies in these offspring should be performed in order to 
determine the long-term effect that the differential ratio will have on glucose 
homeostasis. 
We also established that the increase in β cell mass in both CTR/HFD and 
HFD/HFD offspring is due to β cell hyperplasia. Since there were no measurable 
differences in fetal β cell mass from HFD mothers, this increase is likely due to the post-
natal diet.  This effect is similar to a rodent model in which post-natal HFD exposure 
leads to increased β cell mass (Matveyenko, Singh, Shin, Georgia, & Devaskar, 2010). 
However, the effects of maternal versus post-weaning HFD exposure on α cell 
development are novel when compared to other model species. In rodents and sheep 
models, α cell area tends to be elevated or unaffected by maternal HFD consumption 
(Cerf, et al., 2005; S. P. Ford, et al., 2009). The HFD/HFD juveniles have increased α cell 
size, but display decreased α cell number, suggesting that they are unable to yield more α 
cells in response to chronic HFD pressure. In contrast, the CTR/HFD offspring retain α 
cell plasticity demonstrably by increasing cell density when hypertrophy is not sufficient 
to balance augmented β cell mass.  These differences indicate that maternal HFD 
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exposure limits the ability of α cells to replicate in response chronic post-natal HFD 
pressure. 
Ultimately, both CTR/HFD and HFD/HFD juveniles are hyperinsulinemic, but 
analysis of gene expression in the pancreas provides evidence that the mechanism 
underlying the elevation in insulin is maternally programmed.  However, it should be 
noted that total gene expression of the pancreas may be biased by the islet cell mass or 
density when islets are isolated from whole pancreas tissue.  Accordingly, gene 
expression from isolated islets is biased toward large islets, because isolation protocols 
generally score islets as high-quality if they have a minimum specified diameter above at 
least 100 μM (Matsumoto et al., 2002). Therefore, in order to obtain gene expression that 
is representative of islet content, we normalized gene expression to the area of tissue in 
which the gene is expressed (i.e., α cell area, β cell area, or islet area). After 
normalization, the key differences demonstrated were an up-regulation of insulin 
expression, which is programmed by the maternal HFD and a down-regulation in GK in 
the CTR/HFD juveniles. Previous studies have shown that GK is the rate-limiting step in 
the initial phases of glucose-stimulated insulin secretion (De Vos et al., 1995; Liang, 
Najafi, & Matschinsky, 1990). Decreased GK expression in the CTR/HFD animals will 
likely cause these islets to be less responsive to glucose, while the β cells of HFD/HFD 
juveniles are primed to respond to glucose.  It is unclear what causes the increased 
secretion demonstrated in CTR/HFD offspring. FFAR1 expression analysis indicates that 
expression of this receptor rises with increasing islet area.  Fatty acid potentiation of 
glucose-stimulated insulin secretion is an additional factor that may contribute to the 
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increased insulin secretion measured in both post-weaned HFD juvenile groups. 
However, future in-vivo and gene-expression studies are essential to determine the role 
both glucose and FFAs play in modulation of GSIS in all diet groups. 
Upon review of the effects of HFD in these animals, it is evident that HFD 
consumption during pregnancy leads to decreased α cell plasticity in the juvenile 
Japanese macaque. When animals are returned to a control diet, most factors are 
ameliorated, indicating that this is a dynamic period of islet development.  However, 
maternally programmed metabolic effects are still evident to some extent in these 
animals, since not all factors are normalized to control levels. Post-natal HFD exposure 
appears to exacerbate the effects of early HFD programming. β cells are hyper-responsive 
in the HFD/HFD juveniles (fasting insulin levels are doubled, but β cell mass is only 
increased by 30%).  This hyper-responsiveness is indicative of early insulin resistance 
and the ultimate progression toward diabetes (Ahlgren, et al., 1998; Weir & Bonner-
Weir, 2004; Weir et al., 2009). 
While there is a rise in β cell to α cell ratio in HFD/HFD juveniles, these animals 
are still apparently capable of managing the metabolic insult. In HFD/HFD animals, α 
cells hypersecrete glucagon. It is likely that by suppressing α cell proliferation, glucagon 
levels are maintained at control levels. However, long-term exposure to the HFD could 
increase the susceptibility of HFD/HFD animals to diabetes because they will be unable 
to maintain an appropriate islet paracrine dynamic, which is essential for normal glucose 
homeostasis. It is unclear if this imbalance in the islet cell ratio prepares the animal to 
combat future metabolic pressure, or if they will reach a peak at which islets are no 
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longer able to withstand the metabolic insult. We anticipate that, by following the 
HFD/HFD through the adolescent period, these animals will ultimately reach the plateau 
of adaptation and start to decline into early metabolic syndrome. Eventually the 
CTR/HFD and HFD/HFD are likely to develop similar metabolic complications because 
adaptation to this HFD is unsustainable. However, these studies suggest that the 
mechanisms in which the disease progresses and ultimately the timing of disease 
progression will be accelerated in the HFD/HFD animals. This is similar to the human 
population in which mothers consuming a HFD give rise to children that succumb to 
metabolic pressures earlier in life. 
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Figure 5.1: Juvenile Physiology 
 
HFD/HFD animals were significantly heavier than the CTR/CTR, while CTR/HFD 
displayed a similar trend (A) and RWAT was significantly elevated in the CTR/HFD and 
HFD/HFD juveniles (B). HFD/HFD fasting (C) insulin and insulin area under the curve 
(D) were significantly elevated when compared to CTR/CTR. Weight, RWAT weight, 
fasting insulin and insulin AUC were significantly affected by the post-weaning diet. 
Two-way ANOVA with Bonferroni’s post-hoc analysis. CTR/CTR, n = 22; CTR/HFD, 
n=9; HFD/CTR, n=14; HFD/HFD, n=21.  
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Figure 5.2: Sex Differences in Body Weight and Fasting Glucose 
 
HFD/HFD male offspring have significantly increased body weight, while no significant 
difference was demonstrated in the females (A). HFD/CTR and HFD/HFD have 
increased fasting glucose secretion and female groups are not significantly different (B). 
Two-way ANOVA with Bonferroni’s post-hoc analysis. Males: CTR/CTR, n = 12; 
CTR/HFD, n=5; HFD/CTR, n=7; HFD/HFD, n=11. Females: : CTR/CTR, n = 10; 
CTR/HFD, n=4; HFD/CTR, n=7; HFD/HFD, n=10. 
  
Comstock, 109 
Figure 5.3: Juvenile Islet Mass and Contributing Factors 
 
Pancreas weight was decreased in the CTR/HFD group due to a post-weaning and an 
interacting diet effect (A).  Both CTR/HFD and HFD/HFD juveniles had a 30% increase 
in islet mass as compared to CTR/CTR animals, which is significantly affected by the 
post-weaning diet (B). Mean islet diameter was significantly elevated only in the 
HFD/HFD offspring, due to a maternal diet effect (C) while islet density was only 
significantly elevated in CTR/HFD and displayed a maternal, post-weaning and 
interacting diet effect (D). Two-way ANOVA with Bonferroni’s post-hoc analysis. 
CTR/CTR, n = 7, CTR/HFD, n =6; HFD/CTR, n=7; HFD/HFD, n=7. 
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Figure 5.4: Relative Mass, Diameter and Density of Islets 
 
Large islet mass was significantly increased in the HFD/HFD as compared to CTR/CTR 
(A). Islet diameter was not significantly affected when islets were separated by size (B).  
Small islet density was significantly increased in the CTR/HFD juveniles and large islet 
density was decreased in the HFD/CTR juveniles as compared to CTR/CTR (C).  *p < 
0.05 CTR/CTR, 2-way anova with post-hoc analysis; n = 7, CTR/HFD, n =6; HFD/CTR, 
n=7; HFD/HFD, n=7. 
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Figure 5.5: α cell and β cell Mass 
 
β cell area was increased in both the CTR/HFD the HFD/HFD juveniles, demonstrating a 
post-weaning diet effect (A). Only the CTR/HFD juveniles displayed significantly 
increased α cell area due to a post-weaning and interacting diet effect (B).  HFD/HFD 
offspring displayed nearly a 50% increase in β/α cell ratio due to an interaction between 
the maternal and post-weaning diet. Two-way ANOVA with Bonferroni’s post-hoc 
analysis. CTR/CTR, n = 7, CTR/HFD, n =6; HFD/CTR, n=7; HFD/HFD, n=7.  
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Figure 5.6:  β cell and α cell Quantification 
 
There was no change in size of β cells from all juvenile groups (A) while β cells from 
both HFD groups displayed significant hyperplasia and had a significant post-weaning 
and interacting diet effect (B). α cell hypertrophy was significant in both CTR/HFD and 
HFD/HFD offspring due to a post-weaning and interacting diet effect (C). Finally, while 
CTR/HFD α cells tended to be hyperplasic, HFD/HFD displayed a decreased number 
compared to the CTR/HFD animals. This response is due to a interacting diet effect (D). 
Two-way ANOVA with Bonferroni’s post-hoc analysis. CTR/CTR n = 30, CTR/HFD n 
=35, HFD/CTR n=30, HFD/HFD n=25. 
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Figure 5.7: Gene Expression in Juvenile Pancreas 
 
Insulin (A) and glucokinase (B) mRNA expression were significantly elevated in the 
HFD/HFD group as compared to the CTR/CTR juveniles. These genes were significantly 
affected by the maternal diet.  The facilitated glucose transporter, Glut2 displayed no diet 
effect, but was significantly elevated in the CTR/HFD animals (C). The β cell free fatty 
acid receptor FFAR1 (D) was also elevated in the CTR/HFD group and displayed a post-
weaning diet effect. Glucagon was not significantly different between groups (E). All 
genes were normalized to β-actin (F). Two-way ANOVA with Bonferroni’s post-hoc 
analysis.  CTR/CTR, n = 12; CTR/HFD, n=6; HFD/CTR, n=9; HFD/HFD, n=12. 
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Figure 5.8: Normalized Gene expression in Juvenile Pancreas 
 
Insulin mRNA/β cell area is significantly affected by the maternal diet, but not different 
between juvenile groups (A). Glucokinase mRNA/Islet Area is significantly down-
regulated in the CTR/HFD animals and affected by an interaction between the maternal 
and post-weaning diet (B). Glut2/β cell area is not significantly affected (C). FFAR1 
mRNA/Islet Area is not significantly affected (D). Glucagon mRNA/α cell area is 
affected by the post-weaning diet but not significantly different between groups (E). All 
genes were also normalized to β-actin. Two-way ANOVA with Bonferroni’s post-hoc 
analysis.  CTR/CTR, n = 12; CTR/HFD, n=6; HFD/CTR, n=9; HFD/HFD, n=12. 
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Figure 5.9: Glut2 versus Glut1 Expression  
 
IHC of pancreas sections demonstrate that Glut1 is limited to exocrine tissue (A) while 
Glut2 is present in islets, principally β cells (B). GLUT1 or GLUT2 labeled in blue, 
insulin labeled in red, glucagon in green and co-labeled insulin and GLUT2 is purple. 
Glut2 m RNA expression is more than double the expression of Glut1 mRNA in pancreas 
tissue, Student’s t-test, n=39, *p<0.05 (C). 
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Table 5.1: Juvenile Physiology 
Juvenile Physiology CTR/CTR CTR/HFD HFD/CTR HFD/HFD Effect 
n 22 9 14 21   
Weight (g) 2508 ± 63 
a
 2788 ± 96 
a,b
 2636 ± 59 
a,b
 2820  ± 84 
b
 PW, S 
Pancreas weight (g) 6.43  ± 0.25 
a
 5.23  ± 0.19 
b
 6.33  ± 0.19 
a,b
 6.08 ± 0.26 
a,b
 - 
Pancreas/Body Weight 2.67 ± 0.06 
a
 1.97 ± 0.07 
b
 2.40 ± 0.05 
a
 2.18 ± 0.07 
c
 PW 
Total Body Fat % 1.81 ± 0.22 2.54 ± 0.21 2.16 ± 0.36 2.30 ± 0.31 - 
Insulin (μU/mL) 4.25 ± 0.69 
a
 8.45 ± 1.41 
a,b
 6.00 ± 1.34 
a,b
 9.64 ± 1.93 
b
 PW 
Glucose (mg/dL) 49 ± 2.8 61 ± 3.7 60 ± 2.6 56 ± 1.6 MxPW, MxS 
IVGTT - GSIS 828 ± 89 
a
 1263 ± 182 
a,b
 1010 ± 96 
a,b
 1267 ± 132 
b
 PW 
IVGTT - GAUC 4789 ± 253 5406 ± 344 5196 ± 293 4601 ± 215 - 
IVGTT - Total IAUC 1184 ± 113 
a
 1655 ± 275 
a,b
 1398 ± 134 
a,b
 1690 ± 103 
b
 PW 
1st Phase Insulin 39.2 ± 6.2 50.9 ± 7.3 41.6 ± 8.6 55.6 ± 6.0 - 
2nd Phase Insulin 1055 ± 102 1469 ± 259 1255 ± 113 1496 ± 92 PW 
HOMA-IR 0.49 ± 0.08 
a
 1.28 ± 0.23 
a,b
 0.91 ± 0.23 
a,b
 1.48 ± 0.33 
b
 PW 
Glucagon (pg/mL) 135  ± 12.1 102.7  ± 5.7 131.0  ± 18.7 132.5  ± 13.9 - 
Leptin (ng/mL) 1.12  ± 0.06 1.23 ± 0.21 1.28 ± 0.12 1.07 ± 0.10 - 
 
Physiological measurements of 4 offspring groups. Three-way ANOVA with 
Bonferroni’s post-hoc analysis.    
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Table 5.2: Juvenile Female Physiology 
13 Months Females CTR/CTR CTR/HFD HFD/CTR HFD/HFD Effect 
n 10 4 7 10   
Weight (g) 2483 ± 85 2818 ± 156 2535 ± 77 2657 ± 112 PW 
Pancreas weight (g) 6.41  ± 0.27 5.23  ± 0.35 6.07  ± 0.27 5.69 ± 0.34 PW 
Pancreas/Body Weight 2.60 ± 0.08 
a
 1.85 ± 0.07 
b
 2.39 ± 0.06 
a
 2.16 ± 0.13 
c
 MXPW, PW 
Total Body Fat % 1.63 ± 0.33 2.44 ± 0.44 2.83 ± 0.57 2.39 ± 0.43 - 
RWAT Weight (mg) 434 ± 49 680 ± 64 476 ± 43 610 ± 92 PW 
Insulin (μU/mL) 4.94 ± 1.28 8.80 ± 1.33 4.87 ± 1.40 9.50 ± 3.56 - 
Glucose (mg/dL) 51 ± 4.5 63 ± 6.7 54 ± 4.9 51 ± 3.0 - 
IVGTT - GSIS 789 ± 128 
a
 1612 ± 148 
b
 995 ± 176 
a,b
 1249 ± 137 
a,b
 MXPW, M 
IVGTT - GAUC 4188 ± 381 5581 ± 748 4825 ± 463 4627 ± 299 - 
IVGTT - Total IAUC 1227 ± 91 1785 ± 413 1423 ± 242 1806 ± 150 PW 
1st Phase Insulin 33.3  ± 3.4 55.4 ± 11.6 39.5 ± 14.4 47.8 ± 5.8 - 
2nd Phase Insulin 1103 ± 84 1574 ± 403 1283 ± 203 1625 ± 138 PW 
HOMA-IR 0.62 ± 0.15 1.42 ± 0.33 0.65 ± 0.29 1.29 ± 0.55 PW 
Glucagon (pg/mL) 141.4 ± 18.7 105.2 ± 8.9 139.5 ± 34.7 150.8 ± 24.3 - 
Leptin (ng/mL) 1.20 ± 0.10 0.72 ± 0.22 1.30 ± 0.14 1.71 ±  0.47 PW 
 
Physiological measurements of females from offspring separately analyzed by sex. Two-
way ANOVA with Bonferroni’s post-hoc analysis. 
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Table 5.3: Juvenile Male Physiology 
13 Month Males CTR/CTR CTR/HFD HFD/CTR HFD/HFD Effect 
N 12 5 7 11   
Weight (g) 2529 ± 94 
a
 2764 ± 134
 a,b
 2736 ± 77 
a,b
 2969 ± 110 
b
 PW 
Pancreas weight (g) 6.75 ± 0.49 5.70 ± 0.50 6.59 ± 0.24 6.40 ± 0.38 - 
Pancreas/Body Weight 2.74 ± 0.08 
a
 2.05 ± 0.11 
b
 2.41 ± 0.09 
a
 2.19 ± 0.09 
b
 MXPW, PW 
Total Body Fat % 1.96 ± 0.32 2.64 ± 0.07 1.66 ± 0.22 2.15 ± 0.60 - 
RWAT Weight (mg) 463 ± 54 
a
 615 ± 91 
a,b
 390 ± 45 
a
 672 ± 81 
b
 PW 
Insulin (μU/mL) 3.56 ± 0.64 8.24 ± 2.23 7.23 ± 2.06 10.0 ± 2.42 - 
Glucose (mg/dL) 47 ± 3.4 
a
 59 ± 4.9 
a,b
 65 ± 3.8 
b
 64 ± 3.1 
b
 M 
IVGTT - GSIS 856 ± 127 
a
 1053 ± 238 
a,b
 1025 ± 94 
a,b
 1285 ± 233 
b
 - 
IVGTT - GAUC 5171 ± 291 5301 ± 395 5567 ± 328 4578 ± 328 - 
IVGTT - Total IAUC 1152 ± 190 1551 ± 404 1368 ± 104 1584 ± 139 - 
1st Phase Insulin 43.6 ± 10.7 47.3 ± 10.3 44.1 ± 9.4 50.4 ± 5.4 - 
2nd Phase Insulin 1019 ± 170 1384 ± 375 1222 ± 90 1380 ± 119 - 
HOMA-IR 0.38 ± 0.05 
a
 1.19 ± 0.34 
a,b
 1.14 ± 0.34 
a,b
 1.65 ± 0.40 
b
 PW 
Glucagon (pg/mL) 129.7 ± 16.4 101.2 ± 8.1 124.9 ± 22.6 115.9 ± 14.0 - 
Leptin (ng/mL) 1.05 ± 0.07 
a,b
 1.53 ± 0.21 
b
 1.26 ±  0.21 
a,b
 0.91 ± 0.06 
a
 MXPW 
 
Physiological measurements of males from offspring groups separately analyzed by sex 
Two-way ANOVA with Bonferroni’s post-hoc analysis.   
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Table 5.4: Real-time PCR Values of Juvenile Pancreas 
Real-time QPCR CTR/CTR CTR/HFD HFD/CTR HFD/HFD Effect 
n 7 6 6 6   
ALG9 1.00 ± 0.06 1.01 ± 0.07 1.02 ± 0.10 0.96 ± 0.03 - 
FFAR1 (GPR40) 1.00 ± 0.21 
a
 2.31 ± 0.50 
b,c
 1.11 ± 0.27 
a
 1.56 ± 0.24 
a,c
 PW 
Glucagon (GCG) 1.00 ± 0.10 1.08 ± 0.16 0.85 ± 0.18 0.67 ± 0.07 - 
Glucokinase (GK) 1.00 ± 0.10 
a
 0.98 ± 0.20 
a
 1.22 ± 0.14 
a,b
 1.58 ± 0.13 
b
 M 
Glut1 1.00 ± 0.05 0.98 ± 0.02 1.07 ± 0.11 1.11 ± 0.13 - 
Glut2 1.00 ± 0.36 
a
 2.67 ± 0.74 
b
 1.28 ± 0.28
 a
 1.11 ± 0.18 
a
 - 
Insulin 1.00 ± 0.16 
a
 1.36 ± 032
 a,b
 1.63 ± 0.21 
a,b
 2.18 ± 0.33 
b
 M 
PDX1 1.00 ± 0.11 1.20 ± 0.07 0.99 ± 0.09 0.95 ± 0.07 - 
 
Real-time PCR expression of genes in juvenile pancreas. Two-way ANOVA with 
Bonferroni’s post-hoc analysis. CTR/CTR, n = 7; CTR/HFD, n =6; HFD/CTR, n=6; 
HFD/HFD, n=6. 
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Table 5.5: α cell and β cell Measurements 
Measurements CTR/CTR CTR/HFD HFD/CTR HFD/HFD 
Average α cell size(μm
2
) 90.83 ± 5.61 118.5 ± 7.42 * 95.61 ± 4.65 121.6 ± 7.43 * 
Average α cell number 86.35 ± 6.71 111.7 ± 8.34 * 100.4 ± 6.33 75.25 ± 5.16 † 
Average α cell area (μm
2
) 7237 13098 8834 8240 
Average β cell size (μm
2
) 79.8 ± 4.32 91.4 ± 6.07 96.6 ± 4.94 94.7 ± 5.48 
Average β cell number 137.4 ± 8.10 219.9 ± 13.4* 144.1 ± 6.91 175.4 ± 12.9 * 
Average β  cell area (μm
2
) 10458 18357 13524 16019 
β/α cell Area 1.45 1.4 1.53 1.94 
% Ratio 100.00% 96.99% 105.94% 134.53% 
 
Analysis of α and β cell area, size, number and relative β/α cell ratio of the 4 groups. 
Islets stereologically randomly selected for each animal. CTR/CTR n = 30, CTR/HFD n 
=35, HFD/CTR n=30, HFD/HFD n=25. 
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Chapter 6: Limitations and Future Studies 
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Limitations of the HFD Fed Macaque Model 
While the macaque is an excellent animal model to study early MetS and disease 
progression to T2DM, it does have some limitations.  First, it should be noted that the 
cost of this model compared to rodent and sheep models is high, which causes 
experimental limits on these studies based on funding.  However, since these animals are 
so similar to humans in the development of MetS and T2DM, whenever possible it is 
essential to design experiments that could be specifically tested in this model.  Rodent 
studies make an excellent starting point.  However, much of the development of the 
pancreas and other organs impacted by HFD consumption in the rodent occurs during the 
early post-natal period, whereas the monkey and human have similar fetal development 
(Aguayo-Mazzucato, Sanchez-Soto, Godinez-Puig, Gutierrez-Ospina, & Hiriart, 2006; 
Fowden & Hill, 2001; Remacle, et al., 2007; Scaglia, et al., 1997). The sheep has also 
been extensively used in developmental work; however, although these animals have 
similar development to humans, they have ruminant digestion and do not process fats 
(Oltjen & Beckett, 1996; Sanz Sampelayo, Chilliard, Schmidely, & Boza, 2007).  
Therefore, the effects of maternal obesity induced by increased caloric intake can be 
studied in fetal offspring, but it is not possible to study the effect of HFD in these 
animals.  Furthermore, they have a cotyledonary placenta that is very different from the 
human and macaque placenta 
A second limitation of this model is the time points of animal sacrifice and tissue 
collection that we selected.  In many rodent models, animals are sacrificed sequentially 
throughout HFD exposure at intervals of a few days to a few weeks (Cerf, et al., 2005; 
Scaglia, et al., 1997).  This allows the investigator to understand sequential development 
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of the conditions that lead to the phenotype studied.  We limited collection time points to 
the early third trimester and the postnatal 13-month time point, due to limited animal 
availability, cost of the animals, and ethical considerations – sacrificing as few animals as 
possible to gain the most knowledge.  Therefore, reasonable deductions about islet 
development were made based on the morphology of islets at the two time points and the 
physiological presentation of the animal between those time points.  However, the time 
points that we chose to characterize are critical for islet development. As a point of 
emphasis, it has taken approximately ten years, to produce sufficient offspring to perform 
these studies. This leads to a third limitation of the model, which is small sample size.  
Sample size within these groups is somewhat limited (n = 9 to 21/group), when compared 
to many rodent studies. However, compared to other primate studies (Choi et al., 2011; 
de Koning, Bodkin, Hansen, & Clark, 1993), the sample size is relatively robust and it 
has sufficient power to determine significant differences between groups. In spite of this 
limitation our studies as a whole have identified key insights into the developmental 
abnormalities that may contribute to early childhood obesity.  In turn, we have increased 
the awareness of the complications that may occur in mothers and their offspring who are 
obese or consume a HFD during the pregnancy period.  The experiments performed in 
these animals have already begun to enlighten clinical investigators about the critical 
period of development in fetal life and can help them understand how to intervene when 
necessary.  In addition, by understanding the effects of HFD consumption and obesity on 
fetal development, physicians can now aid their patients in implementing lifestyle 
changes in order to prevent these effects. 
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Future Study Recommendations 
The specific aims of this study were accomplished but also led to many 
unanswered questions.  First, it is evident that maternal HFD or and/or obesity lead to a 
decrease in α cell mass in the fetal animal.  However, it is unclear what the maternal 
trigger is that produces this: is it hyperinsulinemia, elevated TGs or increased glucose 
exposure to the fetus?  The cellular mechanisms that lead to the decreased mass of these 
cells also need to be uncovered.  Likewise, the timing of α cell loss or decreased 
neogenesis or replication is not clear: what time point in pregnancy is critical for islet 
development? First, in order to determine the mechanisms that lead to the adaptations in 
fetal α cells, it will be necessary to establish the standard rate of α cell replication, 
neogenesis and apoptosis in CTR fetal animals. By comparing these measures to the HFD 
offspring, we can measure how cell cyclicity may be altered.  One pilot experiment, in 
CTR and HFD animals, performed in the spring of 2011, was intended to measure cell 
replication in the fetuses. I gave CTR and HFD dams two thymidine analogs during their 
pregnancy. One, 5-iododeoxyuridine (Idu) was administered at the end of the first 
trimester, and the other, 5-chlorodeoxyuridine (Cldu), was administered at the end of the 
second trimester in each of these animals. The fetal animal was then collected at G130. 
These analogs are incorporated into a cell's DNA when the cell is dividing (during the S-
phase of the cell cycle) (Teta, Rankin, Long, Stein, & Kushner, 2007).  They can then be 
detected by double or triple label immunohistochemistry to determine which cells 
underwent replication.  While this experiment is still in process, we can use the pancreata 
from these animals to determine the number of α or β cells that replicated during these 
time periods. 
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In addition, while I have demonstrated a decrease in the α cell mass in the fetal 
offspring, the biochemical changes that occur due to a decrease in α cell mass in the fetal 
animal should also be measured.  By isolating islets we can determine how the relative β 
cell to α cell ratio affects islet function. First, I propose that whole islets be isolated from 
fetal animals and the basal activity of these islets should be assessed by measuring insulin 
and glucagon secretion in basal glucose islet media. This should be followed by 
stimulation of islets with glucose, insulin, glucagon and FFAs to determine their relative 
reactivity.  I would also suggest disassociating islet cells, as previously described (Halban 
et al., 1982), and performing similar experiments with varying ratios of β cells and α cell 
to determine the effect the ratio of these cells has on secretory ability. 
Also, the expression of insulin mRNA was decreased in fetal HFD offspring 
which lead to a decrease in β cell insulin secretion, as measured by c-peptide content.  
However, the changes demonstrated in other key genes do not always translate into 
protein changes.  I recommend following these studies with both western blotting and 
immunohistochemistry to determine the relative levels of protein.  PDX1 mRNA 
expression was decreased in the fetal offspring; however, immunohistochemical anaylsis 
did not reveal any differences in protein.  This indicates that there may be key protein 
signaling aspects that are impacted. 
The second aim, to characterize the metabolic profile of the infant offspring of 
HFD mothers, was accomplished.  However, the signaling mechanism that results in 
insulin resistance followed by hyperinsulinemia should be elucidated.  The changes in 
physiological adaptation to the HFD in the post-natal animal could be clarified by 
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performing clamp techniques. A hyperinsulinemic-euglycemic clamp requires a steady 
infusion of insulin that retains glucose levels at normal fasting concentrations.  This 
clamp is intended to suppress hepatic glucose production but also allows determination of 
insulin sensitivity of peripheral tissue.  The degree of insulin resistance is inversely 
related to glucose uptake during this protocol (McAuley et al., 2001).  A second clamp 
technique, the hyperinsulinemic-hyperglycemic clamp provides a better measure of β cell 
function. Glucose concentration is raised above basal levels by a continuous infusion of 
glucose then insulin is measured at various time points. Because the plasma glucose 
concentration is held constant, the glucose infusion rate is an index of insulin secretion 
and glucose metabolism (Bolli et al., 1984). These could be performed in the infant 
animal as early as 90 days then followed through at various time points throughout the 
first year of life to obtain an accurate indication of insulin sensitivity and β cell function. 
Furthermore, based on the results of my third aim, it is clear that significant islet 
remodeling is occurring during the post-weaning period.  However, the time period of 
these changes and the specific physiological triggers are still unclear.  The thymidine 
labeling protocol would be beneficial to elucidate the time period of islet changes during 
postnatal development.  By administering the two different thymidine analogs at different 
time points before and after weaning, we may be able to target key stages of islet 
development.  β cell replication is likely a significant contributor to the changes observed 
in insulin secretion in juvenile animal.  These studies would allow us to determine what 
changes are occurring during these key developmental periods.  In addition to replication, 
neogenesis and apoptosis are also likely contributors to the islet remodeling evident in the 
juvenile animals.  One marker of islet neogensis, which has been associated with β cell 
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mass expansion is the islet neogenesis associated protein related protein (INGAP) 
(Rosenberg et al., 2004).  Detection of this protein by immunohistochemistry would 
provide some indication of the neogenesis that is occurring during the post-natal period.  
Another protein, Ki67, is detectable in all cell types during active phases of the cell cycle 
(G1, S, G2, and mitosis), but is absent from resting cells (G0) (Scholzen & Gerdes, 
2000).  Immuno-detection of this protein would indicate which cells are proliferating.  
Co-localization of the Ki67 antibody with an INGAP antibody and a islet cell specific 
antibody, would lead to clarification of which cell types are undergoing neogenesis, 
replication or are static.  A TUNEL (Terminal deoxynucleotidyl transferase dUTP nick 
end labeling) stain, which detects DNA fragmentation, would establish the relative level 
of apoptosis during the juvenile period (Gavrieli, Sherman, & Ben-Sasson, 1992). 
Finally, since, it is evident that there are different mechanisms that lead to islet 
expansion in the CTR/HFD versus the HFD/HFD offspring, the means by which the 
differential islet effects occur should be studied in the post-weaned animal.   Islet 
isolation studies would be beneficial in the juvenile animals to determine how the 
changes in islets effect function.  In order to determine the mechanisms that lead to islet 
response in these animals, I suggest stimulating islets with glucose, insulin, glucagon and 
FFAs and determining the relative gene expression differences between the stimulated 
and basally active islets.   Key genes of interest would be those that were already 
measured, including insulin, glucagon, GK, GLUT2, Kir6.2, SUR1, and FFAR1.  
GLUT5, which is the glucose transporter in α cells (Sato et al., 1996), would also be of 
critical importance.  Since many of the gene expression differences in the juvenile 
animals were inconclusive, I recommend following up on these studies by determining 
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the relative level of protein expression of the key genes examined within specific islet 
cells. Triple label immunohistochemistry with anti-insulin, anti-glucagon and a third 
antibody against the protein of interest would be necessary.  Then sterological analysis of 
islet cell specificity would be required. 
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Chapter 7: Summary and Discussion 
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As childhood MetS is becoming an increasing concern, it is essential to establish a 
model that will help us determine the mechanisms that lead to this disease.  Upon review, 
I believe my studies help to establish the juvenile HFD/HFD animals as a model of early 
onset MetS.  I have demonstrated that maternal HFD decreases fetal α cell mass, which 
results in an increase in the β cell to α cell ratio in the macaque that remains increased 
with continued HFD exposure (Fig. 7.1).  This may be a fetal adaptation in favor of 
decreasing glucose production, reducing lipolysis and maintaining insulin in response to 
increased nutrient supply.  However, by the early postnatal period, the HFD offspring 
become insulin resistant, which is followed by increased insulin secretion and a 
corresponding increase in β cell mass.  The increased β cell to α cell ratio in the 
HFD/HFD juvenile indicates that chronic HFD exposure during the fetal and early post-
natal period may lead to programmed dysfunction in the paracrinolgy of juvenile islets.  
By feeding these animals a HFD, they reach a pre-diabetic state before puberty that is 
similar to what has been demonstrated in adult insulin resistant animals (Bodkin, 
Metzger, & Hansen, 1989; de Koning, et al., 1993; Hansen & Bodkin, 1990).  My results, 
in conjunction with the previously described prediatric NAFLD, hepatic apoptosis, and 
disturbances in the melanocortin system that increase HGP in these animals, indicate that 
these animals have an elevated risk for early-onset diabetes.  
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Fetal Effects of the Maternal HFD 
Epidemiological and animal studies demonstrate an association between 
childhood obesity and maternal obesity and/or high-fat/high calorie intake (Boney, et al., 
2005; Srinivasan, et al., 2006; Whitaker, 2004).  However, while the phenotype of the 
HFD macaque dams varies significantly, maternal sensitivity to weight gain had little 
effect on islet morphology or glucoregulatory function in the offspring.  In fact, maternal 
HFD consumption was demonstrated to be the principal contributing factor to islet 
defects in the fetal offspring, indicating that maternal diet choices may program fetal 
susceptibility to islet malfunction.  
The decreased α cell mass is a novel finding in fetal offspring of HFD mothers 
that may be detrimental to long term islet function, because the paracrine interactions 
between α cell and β cells are essential for glucose homeostasis. Glucagon secretion 
decreases when circulating glucose levels rise. However, glucose does not have a direct 
inhibitory effect on α cells, since glucose is an essential fuel source that is used in ATP 
production in α cells. In fact, isolated α cells secrete glucagon in response to glucose 
when they are disassociated from β cells and lack the paracrine interaction of these cells 
(Franklin, et al., 2005). However, it has been demonstrated the α cell contains an 
abundance of insulin receptors and recent findings have shown that insulin inhibits 
glucagon release from these cells. While α cell stimulatory pathways are still largely 
uncharacterized, it is evident that insulin and other β cell secretory products lead to 
increased sensitivity of KATP channels, which results in α cell hyperpolarization and an 
inhibition of glucagon secretion (Leung, et al., 2006). These studies indicate that the 
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paracrine interaction between β cells and α cells is essential to lead to glucose inhibition 
of glucagon secretion (Fig. 7.2). 
In contrast, glucagon has been demonstrated to have an insulin stimulatory effect 
(Kieffer, Heller, Unson, Weir, & Habener, 1996).  Other factors released by α cells, such 
as glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP), have also 
been shown to stimulate insulin release.  However, the majority of GLP1 and GIP are 
secreted from the intestine (Mojsov, Weir, & Habener, 1987). When disassociated from α 
cells, β cells have a poor insulin secretory response, despite normal glucose metabolism 
(Holz, et al., 1993; Pipeleers, Schuit, Van Schravendijk, & Van de Winkel, 1985). This 
indicates that there is a basal level of glucagon or other α cell secretagogues that are 
required for efficient insulin release by β cells. Also, the glucagon receptor is present on 
both β cells and 10% of α cells (Kieffer, et al., 1996).  The insulinotropic action of 
glucagon may be essential for maintaining basal insulin release because low levels of the 
peptide cause a modest, but significant, release of insulin. These results also demonstrate 
a clear role for paracrine regulation of β cells insulin secretion by α cells (Figure 7.3). 
The loss of α cells in the HFD fetal animal results in an elevation in the β/α-ratio 
that perpetuates into the juvenile period. While initially this may be an adaptive, 
beneficial response, long-term elevation in this ratio could lead to disturbances in 
paracrine regulation of islets.  While no studies have yet shown what the β/α cell ratio has 
on islet function, it is clear from the above mentioned islet paracrine interactions that a 
disturbance in this ratio may lead to detrimental effects in the HFD fed offspring.  It is 
foreseeable that the disproportionate elevation in β cells might lead to decreased glucagon 
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potentiation of insulin release and inefficient insulin secretion, which is often develops in 
T2DM.  
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Post-natal Effects of the HFD 
The post-natal HFD further exacerbates the effects I demonstrated in the HFD 
fetus.  However, in order to determine the severity of islet defects in these animals, it is 
necessary to compare these effects to typical T2DM progression.  The progression of this 
disease occurs due to interplay between insulin resistance and defects in insulin secretion 
that ultimately leads to impaired glucose tolerance (Fig. 7.4).  However, during the initial 
stages of the disease process, fasting insulin levels and glucose-stimulated insulin 
secretion are sufficient to maintain normoglycemia.  As the disease progresses, insulin 
resistance occurs, due to contributing environmental factors, such as obesity, HFD 
consumption, genetic susceptibility or early-life programming effects (Erlich et al., 1993; 
Hales & Barker, 1992; Hancock et al., 2008; B. B. Kahn & Flier, 2000; Srinivasan et al., 
2005).  Since MetS is associated with insulin resistance and obesity, MetS often develops 
in subjects as a precursor to T2DM.  At this stage, β cells compensate by secreting more 
insulin and β cell mass usually expands in response to the increased need for insulin 
production and thus normoglycemia is maintained.  However, β cell compensation 
eventually becomes insufficient to match insulin resistance and subjects develop impaired 
glucose tolerance that ultimately results in persistent hyperglycemia (Augstein & 
Salzsieder, 2009; Paulsen et al., 2010).  This hyperglycemia has also been demonstrated 
to correspond to excessive glucagon stimulation of hepatic gluconeogenesis.  Ultimately, 
in some subjects, insulin compensation declines as a result of either defective β cell 
function or a loss of β cells (Jurgens et al., 2011; Maedler & Donath, 2004). 
In comparison, both  the CTR/HFD and HFD/HFD have increased β cell mass 
and elevated insulin secretion that are characteristic of the initial stages of disease 
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progression, indicating that early post-natal HFD diet consumption significantly increases 
MetS risk.  In fact, in other NHP models, insulin resistance and other MetS-like effects 
do not occur until at least three years of age (Choi, et al., 2011; Guardado-Mendoza et al., 
2009; Kaufman, et al., 2005), but the typical onset of this disease is during middle age 
(15 to 20 years of age) (de Koning, et al., 1993).  This suggests that HFD consumption 
accelerates the development of this disease in juvenile macaques.  However, while both 
the CTR/HFD and HFD/HFD juveniles have increased β cell mass and elevated insulin 
levels, maternal HFD programs the juveniles for excessive β cell hypersecretion.  This is 
evidenced by the fact that both the HFD/CTR and the HFD/HFD offspring have elevated 
insulin gene transcription.  In addition, the β cell hyper-responsiveness that is clearly 
evident in only the HFD/HFD offspring indicates that maternal HFD accelerates disease 
progression in these animals.  The effect may be due to length of exposure to the HFD 
since the CTR/HFD offspring have only consumed the diet for 5 months.  However, the 
maintenance of the elevated β cell to α cell ratio only in the HFD/HFD juvenile indicates 
that maternal programming and post-weaning consumption produce a synergistic effect.  
It should be noted that juvenile offspring are still immature and many effects of 
the post-weaning diet may also program these animals for metabolic dysfunction later in 
life.  It will be necessary to follow these animals to adulthood to determine if maternal 
HFD consumption increases the incidence of obesity and T2DM in these offspring.  
Likewise, by placing both the CTR/CTR and the HFD/CTR animals onto a HFD as 
adults, we will be able to measure the relative impact of the maternal programming effect 
on the adult obesity onset which is so common in the world today. 
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In conclusion, my studies, in concert with the in-depth characterization of these 
animals by other researchers my lab, have demonstrated an increased risk for MetS and 
T2DM in the HFD/HFD offspring.  The findings are most representative of the human 
population today because mothers who consume a high-fat or high-calorie diet will 
continue to feed their children a similar diet (Clark, Goyder, Bissell, Blank, & Peters, 
2007; Johannsen, Johannsen, & Specker, 2006; Spruijt-Metz, Lindquist, Birch, Fisher, & 
Goran, 2002).  The evidence that maternal HFD consumption results in islet 
abnormalities that are intensified by post-natal HFD consumption indicates that the early 
nutritional environment is a significant contributor to increase in MetS.  These studies 
provide unique insight into the pathways that may be leading to the increase in pediatric 
MetS today.  
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Chapter 7 Figures 
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Figure 7.1: Islet Development in the CTR versus HFD Offspring 
 
At G130, HFD offspring have an increased β cell to α cell ratio, which is due to 
decreased α cell mass.  As the animals age, α cell mass is normalized to near CTR levels 
but β cell mass increases, thus maintaining the elevated β cell to α cell ratio. 
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Figure 7.2: Islet Paracrine Function – Glucagon Regulation of Insulin Secretion 
 
Glucose is transported into the NHP β cell by GLUT2 and into α cells by GLUT5.  
GLUT5 has a much lower binding affinity than GLUT2 for glucose, therefore more 
glucose is taken up by the β cell. Insulin is released from the β cell in response to high 
glucose.  Insulin signaling via the insulin receptor leads to a sensitization of -ATP 
channels in α cells.  This leads to reduced glucagon secretion, because much more 
glucose is required to produce a sufficiently elevated ATP/ADP ratio that will depolarize 
the α cell membrane and lead to glucagon exocytosis. However, a basal level of glucagon 
is maintained within the intra-islet space as well as within circulation. Insulin also 
desensitizes KATP channels on β cells which augments insulin secretion. (IR = insulin 
receptor).  
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Figure 7.3: Islet Paracrine Function – Insulin Regulation of Glucagon Secretion 
 
 
 Low glucose levels lead to glucagon secretion, because the inhibitory effects from β cells 
are diminished.  Glucose at low levels is taken up by both α cell and β cells.  β cells 
continue to secrete basal levels of insulin.  However, without desensitization by insulin, 
the α cell K-ATP channels sense the intracellular rise in ATP caused by metabolism of 
glycogen stores. This causes depolarization of the cell membrane and glucagon secretion.  
However, high levels of α cell secretory products been demonstrated to have an autocrine 
function leading to a decline in glucagon release (Huypens, et al., 2000; Uehara et al., 
2004).  β cells require signaling from α cell secratory products, possibly glucagon via its 
receptor, to efficiently release insulin. (GR = glucagon receptor). 
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Figure 7.4: Pathological Progression to T2DM 
 
This graph represents the disease progression of MetS and T2DM.  As subjects age and 
gain weight insulin secretion rises to match decreasing insulin sensitivity. β cell mass 
increases to meet insulin secretory demand, while euglycemia is maintained.  Metabolic 
syndrome is characterized by decreased insulin sensitivity, hyperinsulinemia, elevated β 
cell mass and ultimately rising glucose and glucagon levels.  Overt diabetes occurs when 
β cell function declines and insulin secretion drops and hyperglycemia is uncontrolled. In 
some diabetic subjects, the loss of β cell secretory capacity is associated with a loss of β 
cell mass.  Glucagon secretion is elevated in these subjects when compared to insulin 
secretion. 
 
Comstock, 143 
 
 
 
 
 
 
 
Works Cited 
  
Comstock, 144 
Aguayo-Mazzucato, C., Sanchez-Soto, C., Godinez-Puig, V., Gutierrez-Ospina, G., & 
Hiriart, M. (2006). Restructuring of pancreatic islets and insulin secretion in a 
postnatal critical window. PLoS One, 1, e35. doi: 10.1371/journal.pone.0000035 
Ahlgren, U., Jonsson, J., Jonsson, L., Simu, K., & Edlund, H. (1998). beta-cell-specific 
inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype 
and maturity onset diabetes. Genes Dev, 12(12), 1763-1768.  
Alberti, K. G., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., 
et al. (2009). Harmonizing the metabolic syndrome: a joint interim statement of 
the International Diabetes Federation Task Force on Epidemiology and 
Prevention; National Heart, Lung, and Blood Institute; American Heart 
Association; World Heart Federation; International Atherosclerosis Society; and 
International Association for the Study of Obesity. Circulation, 120(16), 1640-
1645. doi: CIRCULATIONAHA.109.192644 [pii] 
10.1161/CIRCULATIONAHA.109.192644 
Augstein, P., & Salzsieder, E. (2009). Morphology of pancreatic islets: a time course of 
pre-diabetes in Zucker fatty rats. Methods Mol Biol, 560, 159-189. doi: 
10.1007/978-1-59745-448-3_12 
Barker, D. J. (1995). The fetal and infant origins of disease. Eur J Clin Invest, 25(7), 457-
463.  
Barker, D. J., Gluckman, P. D., Godfrey, K. M., Harding, J. E., Owens, J. A., & 
Robinson, J. S. (1993). Fetal nutrition and cardiovascular disease in adult life. 
Lancet, 341(8850), 938-941. doi: 0140-6736(93)91224-A [pii] 
Barker, D. J., Winter, P. D., Osmond, C., Margetts, B., & Simmonds, S. J. (1989). 
Weight in infancy and death from ischaemic heart disease. Lancet, 2(8663), 577-
580. doi: S0140-6736(89)90710-1 [pii] 
Bayol, S. A., Simbi, B. H., & Stickland, N. C. (2005). A maternal cafeteria diet during 
gestation and lactation promotes adiposity and impairs skeletal muscle 
development and metabolism in rat offspring at weaning. J Physiol, 567(Pt 3), 
951-961. doi: jphysiol.2005.088989 [pii] 
10.1113/jphysiol.2005.088989 
Benoit, S. C., Air, E. L., Coolen, L. M., Strauss, R., Jackman, A., Clegg, D. J., et al. 
(2002). The catabolic action of insulin in the brain is mediated by melanocortins. 
J Neurosci, 22(20), 9048-9052. doi: 22/20/9048 [pii] 
Beringue, F., Blondeau, B., Castellotti, M. C., Breant, B., Czernichow, P., & Polak, M. 
(2002). Endocrine pancreas development in growth-retarded human fetuses. 
Diabetes, 51(2), 385-391.  
Bertin, E., Gangnerau, M. N., Bellon, G., Bailbe, D., Arbelot De Vacqueur, A., & Portha, 
B. (2002). Development of beta-cell mass in fetuses of rats deprived of protein 
and/or energy in last trimester of pregnancy. Am J Physiol Regul Integr Comp 
Physiol, 283(3), R623-630. doi: 10.1152/ajpregu.00037.2002 
Bodkin, N. L., Metzger, B. L., & Hansen, B. C. (1989). Hepatic glucose production and 
insulin sensitivity preceding diabetes in monkeys. Am J Physiol, 256(5 Pt 1), 
E676-681.  
Bolli, G., De Feo, P., Perriello, G., De Cosmo, S., Compagnucci, P., Santeusanio, F., et 
al. (1984). Mechanisms of glucagon secretion during insulin-induced 
Comstock, 145 
hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia. J Clin 
Invest, 73(4), 917-922. doi: 10.1172/JCI111315 
Boney, C. M., Verma, A., Tucker, R., & Vohr, B. R. (2005). Metabolic syndrome in 
childhood: association with birth weight, maternal obesity, and gestational 
diabetes mellitus. Pediatrics, 115(3), e290-296. doi: 115/3/e290 [pii] 
10.1542/peds.2004-1808 
Bonner-Weir, S. (2001). beta-cell turnover: its assessment and implications. Diabetes, 50 
Suppl 1, S20-24.  
Bonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., et 
al. (2000). Homeostasis model assessment closely mirrors the glucose clamp 
technique in the assessment of insulin sensitivity: studies in subjects with various 
degrees of glucose tolerance and insulin sensitivity. Diabetes Care, 23(1), 57-63.  
Briscoe, C. P., Tadayyon, M., Andrews, J. L., Benson, W. G., Chambers, J. K., Eilert, M. 
M., et al. (2003). The orphan G protein-coupled receptor GPR40 is activated by 
medium and long chain fatty acids. J Biol Chem, 278(13), 11303-11311. doi: 
10.1074/jbc.M211495200 
M211495200 [pii] 
Brissova, M., Fowler, M. J., Nicholson, W. E., Chu, A., Hirshberg, B., Harlan, D. M., et 
al. (2005). Assessment of human pancreatic islet architecture and composition by 
laser scanning confocal microscopy. J Histochem Cytochem, 53(9), 1087-1097. 
doi: jhc.5C6684.2005 [pii] 
10.1369/jhc.5C6684.2005 
Brissova, M., Shiota, M., Nicholson, W. E., Gannon, M., Knobel, S. M., Piston, D. W., et 
al. (2002). Reduction in pancreatic transcription factor PDX-1 impairs glucose-
stimulated insulin secretion. J Biol Chem, 277(13), 11225-11232. doi: 
10.1074/jbc.M111272200 
M111272200 [pii] 
Buckley, A. J., Keseru, B., Briody, J., Thompson, M., Ozanne, S. E., & Thompson, C. H. 
(2005). Altered body composition and metabolism in the male offspring of high 
fat-fed rats. Metabolism, 54(4), 500-507. doi: S0026049504004275 [pii] 
10.1016/j.metabol.2004.11.003 
Burton, B. T., Foster, W. R., Hirsch, J., & Van Itallie, T. B. (1985). Health implications 
of obesity: an NIH Consensus Development Conference. Int J Obes, 9(3), 155-
170.  
Buteau, J., Roduit, R., Susini, S., & Prentki, M. (1999). Glucagon-like peptide-1 
promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases 
transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA 
binding activity in beta (INS-1)-cells. Diabetologia, 42(7), 856-864. doi: 
10.1007/s001250051238 
Butler, A. E., Cao-Minh, L., Galasso, R., Rizza, R. A., Corradin, A., Cobelli, C., et al. 
(2010). Adaptive changes in pancreatic beta cell fractional area and beta cell 
turnover in human pregnancy. Diabetologia, 53(10), 2167-2176. doi: 
10.1007/s00125-010-1809-6 
Comstock, 146 
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003). 
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. 
Diabetes, 52(1), 102-110.  
Cabrera, O., Berman, D. M., Kenyon, N. S., Ricordi, C., Berggren, P. O., & Caicedo, A. 
(2006). The unique cytoarchitecture of human pancreatic islets has implications 
for islet cell function. Proc Natl Acad Sci U S A, 103(7), 2334-2339. doi: 
0510790103 [pii] 
10.1073/pnas.0510790103 
Carriere, F., Barrowman, J. A., Verger, R., & Laugier, R. (1993). Secretion and 
contribution to lipolysis of gastric and pancreatic lipases during a test meal in 
humans. Gastroenterology, 105(3), 876-888. doi: S0016508593002999 [pii] 
Cattaneo, A., Monasta, L., Stamatakis, E., Lioret, S., Castetbon, K., Frenken, F., et al. 
(2010). Overweight and obesity in infants and pre-school children in the European 
Union: a review of existing data. Obes Rev, 11(5), 389-398. doi: OBR639 [pii] 
10.1111/j.1467-789X.2009.00639.x 
Celermajer, D. S., Sorensen, K. E., Bull, C., Robinson, J., & Deanfield, J. E. (1994). 
Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects 
relates to coronary risk factors and their interaction. J Am Coll Cardiol, 24(6), 
1468-1474. doi: 0735-1097(94)90141-4 [pii] 
Cerf, M. E., Muller, C. J., Du Toit, D. F., Louw, J., & Wolfe-Coote, S. A. (2006). 
Hyperglycaemia and reduced glucokinase expression in weanling offspring from 
dams maintained on a high-fat diet. Br J Nutr, 95(2), 391-396. doi: 
S0007114506000523 [pii] 
Cerf, M. E., Williams, K., Nkomo, X. I., Muller, C. J., Du Toit, D. F., Louw, J., et al. 
(2005). Islet cell response in the neonatal rat after exposure to a high-fat diet 
during pregnancy. Am J Physiol Regul Integr Comp Physiol, 288(5), R1122-1128. 
doi: 00335.2004 [pii] 
10.1152/ajpregu.00335.2004 
Chakravarty, K., Cassuto, H., Reshef, L., & Hanson, R. W. (2005). Factors that control 
the tissue-specific transcription of the gene for phosphoenolpyruvate 
carboxykinase-C. Crit Rev Biochem Mol Biol, 40(3), 129-154. doi: 40/3/129 [pii] 
10.1080/10409230590935479 
Chen, H., Simar, D., Lambert, K., Mercier, J., & Morris, M. J. (2008). Maternal and 
postnatal overnutrition differentially impact appetite regulators and fuel 
metabolism. Endocrinology, 149(11), 5348-5356. doi: en.2008-0582 [pii] 
10.1210/en.2008-0582 
Chen, Y. D., Golay, A., Swislocki, A. L., & Reaven, G. M. (1987). Resistance to insulin 
suppression of plasma free fatty acid concentrations and insulin stimulation of 
glucose uptake in noninsulin-dependent diabetes mellitus. J Clin Endocrinol 
Metab, 64(1), 17-21.  
Choi, J., Li, C., McDonald, T. J., Comuzzie, A., Mattern, V., & Nathanielsz, P. W. 
(2011). Emergence of insulin resistance in juvenile baboon offspring of mothers 
exposed to moderate maternal nutrient reduction. Am J Physiol Regul Integr 
Comp Physiol, 301(3), R757-762. doi: ajpregu.00051.2011 [pii] 
10.1152/ajpregu.00051.2011 
Comstock, 147 
Clark, H. R., Goyder, E., Bissell, P., Blank, L., & Peters, J. (2007). How do parents' 
child-feeding behaviours influence child weight? Implications for childhood 
obesity policy. J Public Health (Oxf), 29(2), 132-141. doi: fdm012 [pii] 
10.1093/pubmed/fdm012 
Comstock, S. M. (2012). High fat diet during perinatal development reduces α-cell mass 
and leads to early insulin resistance in the infantile nonhuman primate.  
Consoli, A., Nurjhan, N., Capani, F., & Gerich, J. (1989). Predominant role of 
gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes, 
38(5), 550-557.  
Cook, S., Weitzman, M., Auinger, P., Nguyen, M., & Dietz, W. H. (2003). Prevalence of 
a metabolic syndrome phenotype in adolescents: findings from the third National 
Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med, 
157(8), 821-827. doi: 10.1001/archpedi.157.8.821 
157/8/821 [pii] 
Cushman, S. W., & Wardzala, L. J. (1980). Potential mechanism of insulin action on 
glucose transport in the isolated rat adipose cell. Apparent translocation of 
intracellular transport systems to the plasma membrane. J Biol Chem, 255(10), 
4758-4762.  
Cusi, K., Kashyap, S., Gastaldelli, A., Bajaj, M., & Cersosimo, E. (2007). Effects on 
insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids 
with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes. 
Am J Physiol Endocrinol Metab, 292(6), E1775-1781. doi: 00624.2006 [pii] 
10.1152/ajpendo.00624.2006 
Dahri, S., Snoeck, A., Reusens-Billen, B., Remacle, C., & Hoet, J. J. (1991). Islet 
function in offspring of mothers on low-protein diet during gestation. Diabetes, 
40 Suppl 2, 115-120.  
Darp, R. A., de Boo, H. A., Phua, H. H., Oliver, M. H., Derraik, J. G., Harding, J. E., et 
al. (2010). Differential regulation of igf1 and igf1r mRNA levels in the two 
hepatic lobes following intrauterine growth restriction and its treatment with intra-
amniotic insulin-like growth factor-1 in ovine fetuses. Reprod Fertil Dev, 22(8), 
1188-1197. doi: RD09292 [pii] 
10.1071/RD09292 
de Koning, E. J., Bodkin, N. L., Hansen, B. C., & Clark, A. (1993). Diabetes mellitus in 
Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in 
beta-cell population. Diabetologia, 36(5), 378-384.  
De Vos, A., Heimberg, H., Quartier, E., Huypens, P., Bouwens, L., Pipeleers, D., et al. 
(1995). Human and rat beta cells differ in glucose transporter but not in 
glucokinase gene expression. J Clin Invest, 96(5), 2489-2495.  
Del Guerra, S., Bugliani, M., D'Aleo, V., Del Prato, S., Boggi, U., Mosca, F., et al. 
(2010). G-protein-coupled receptor 40 (GPR40) expression and its regulation in 
human pancreatic islets: the role of type 2 diabetes and fatty acids. Nutr Metab 
Cardiovasc Dis, 20(1), 22-25. doi: S0939-4753(09)00039-8 [pii] 
10.1016/j.numecd.2009.02.008 
Diagnosis and classification of diabetes mellitus. (2011). Diabetes Care, 34 Suppl 1, S62-
69. doi: 34/Supplement_1/S62 [pii] 
Comstock, 148 
10.2337/dc11-S062 
Drury, D. R., Wick, A. N., Bancroft, R. W., & Mac, K. E. (1951). Glucose utilization by 
the extra-hepatic tissues. Am J Physiol, 164(1), 207-212.  
Dumortier, O., Blondeau, B., Duvillie, B., Reusens, B., Breant, B., & Remacle, C. 
(2007). Different mechanisms operating during different critical time-windows 
reduce rat fetal beta cell mass due to a maternal low-protein or low-energy diet. 
Diabetologia, 50(12), 2495-2503. doi: 10.1007/s00125-007-0811-0 
Dunn, G. A., & Bale, T. L. (2009). Maternal high-fat diet promotes body length increases 
and insulin insensitivity in second-generation mice. Endocrinology, 150(11), 
4999-5009. doi: en.2009-0500 [pii] 
10.1210/en.2009-0500 
Dzeja, P. P., & Terzic, A. (2003). Phosphotransfer networks and cellular energetics. J 
Exp Biol, 206(Pt 12), 2039-2047.  
Dzeja, P. P., Zeleznikar, R. J., & Goldberg, N. D. (1998). Adenylate kinase: kinetic 
behavior in intact cells indicates it is integral to multiple cellular processes. Mol 
Cell Biochem, 184(1-2), 169-182.  
Ehses, J. A., Ellingsgaard, H., Boni-Schnetzler, M., & Donath, M. Y. (2009). Pancreatic 
islet inflammation in type 2 diabetes: from alpha and beta cell compensation to 
dysfunction. Arch Physiol Biochem, 115(4), 240-247. doi: 
10.1080/13813450903025879 
Elghazi, L., Cras-Meneur, C., Czernichow, P., & Scharfmann, R. (2002). Role for 
FGFR2IIIb-mediated signals in controlling pancreatic endocrine progenitor cell 
proliferation. Proc Natl Acad Sci U S A, 99(6), 3884-3889. doi: 
10.1073/pnas.062321799 
062321799 [pii] 
Ellingsgaard, H., Hauselmann, I., Schuler, B., Habib, A. M., Baggio, L. L., Meier, D. T., 
et al. (2011). Interleukin-6 enhances insulin secretion by increasing glucagon-like 
peptide-1 secretion from L cells and alpha cells. Nat Med, 17(11), 1481-1489. doi: 
nm.2513 [pii] 
10.1038/nm.2513 
Enriori, P. J., Evans, A. E., Sinnayah, P., Jobst, E. E., Tonelli-Lemos, L., Billes, S. K., et 
al. (2007). Diet-induced obesity causes severe but reversible leptin resistance in 
arcuate melanocortin neurons. Cell Metab, 5(3), 181-194.  
Erlich, H. A., Zeidler, A., Chang, J., Shaw, S., Raffel, L. J., Klitz, W., et al. (1993). HLA 
class II alleles and susceptibility and resistance to insulin dependent diabetes 
mellitus in Mexican-American families. Nat Genet, 3(4), 358-364. doi: 
10.1038/ng0493-358 
Estrany, M. E., Proenza, A. M., Llado, I., & Gianotti, M. (2011). Isocaloric intake of a 
high-fat diet modifies adiposity and lipid handling in a sex dependent manner in 
rats. Lipids Health Dis, 10, 52. doi: 1476-511X-10-52 [pii] 
10.1186/1476-511X-10-52 
Fahy, A. (2009). Vascularization of the pancreas and islets of langerhans in intrauterine 
growth restricted fetuses and lambs. BS Bachelor, University of Arizona, Tucson.    
Comstock, 149 
Fan, L., Lindsley, R., Comstock, S. M., Takahashi, D., Evans, A. E., Thornburg, K. L., et 
al. (2012). Maternal High-Fat Diet Programs Endothelial Dysfunction in the Aorta 
of Juvenile Nonhuman Primates. International Journal of Obesity, In press.  
Farley, D., Tejero, M. E., Comuzzie, A. G., Higgins, P. B., Cox, L., Werner, S. L., et al. 
(2009). Feto-placental adaptations to maternal obesity in the baboon. Placenta, 
30(9), 752-760. doi: S0143-4004(09)00206-9 [pii] 
10.1016/j.placenta.2009.06.007 
Ferezou-Viala, J., Roy, A. F., Serougne, C., Gripois, D., Parquet, M., Bailleux, V., et al. 
(2007). Long-term consequences of maternal high-fat feeding on hypothalamic 
leptin sensitivity and diet-induced obesity in the offspring. Am J Physiol Regul 
Integr Comp Physiol, 293(3), R1056-1062. doi: 00117.2007 [pii] 
10.1152/ajpregu.00117.2007 
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., et 
al. National, regional, and global trends in body-mass index since 1980: 
systematic analysis of health examination surveys and epidemiological studies 
with 960 country-years and 9·1 million participants. The Lancet, 377(9765), 557-
567. doi: 10.1016/s0140-6736(10)62037-5 
Fioramonti, X., Contie, S., Song, Z., Routh, V. H., Lorsignol, A., & Penicaud, L. (2007). 
Characterization of glucosensing neuron subpopulations in the arcuate nucleus: 
integration in neuropeptide Y and pro-opio melanocortin networks? Diabetes, 
56(5), 1219-1227. doi: db06-0567 [pii] 
10.2337/db06-0567 
Flodgren, E., Olde, B., Meidute-Abaraviciene, S., Winzell, M. S., Ahren, B., & Salehi, A. 
(2007). GPR40 is expressed in glucagon producing cells and affects glucagon 
secretion. Biochem Biophys Res Commun, 354(1), 240-245. doi: S0006-
291X(06)02867-1 [pii] 
10.1016/j.bbrc.2006.12.193 
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002). Prevalence of the metabolic syndrome 
among US adults: findings from the third National Health and Nutrition 
Examination Survey. JAMA, 287(3), 356-359. doi: jbr10281 [pii] 
Ford, S. P., Zhang, L., Zhu, M., Miller, M. M., Smith, D. T., Hess, B. W., et al. (2009). 
Maternal obesity accelerates fetal pancreatic beta-cell but not alpha-cell 
development in sheep: prenatal consequences. Am J Physiol Regul Integr Comp 
Physiol, 297(3), R835-843. doi: 00072.2009 [pii] 
10.1152/ajpregu.00072.2009 
Forsen, T., Eriksson, J. G., Tuomilehto, J., Teramo, K., Osmond, C., & Barker, D. J. 
(1997). Mother's weight in pregnancy and coronary heart disease in a cohort of 
Finnish men: follow up study. Bmj, 315(7112), 837-840.  
Fowden, A. L., & Hill, D. J. (2001). Intra-uterine programming of the endocrine 
pancreas. Br Med Bull, 60, 123-142.  
Fowden, A. L., Mijovic, J., & Silver, M. (1993). The effects of cortisol on hepatic and 
renal gluconeogenic enzyme activities in the sheep fetus during late gestation. J 
Endocrinol, 137(2), 213-222.  
Comstock, 150 
Franklin, I., Gromada, J., Gjinovci, A., Theander, S., & Wollheim, C. B. (2005). Beta-
cell secretory products activate alpha-cell ATP-dependent potassium channels to 
inhibit glucagon release. Diabetes, 54(6), 1808-1815. doi: 54/6/1808 [pii] 
Frias, A. E., Morgan, T. K., Evans, A. E., Rasanen, J., Oh, K. Y., Thornburg, K. L., et al. 
Maternal high-fat diet disturbs uteroplacental hemodynamics and increases the 
frequency of stillbirth in a nonhuman primate model of excess nutrition. 
Endocrinology, 152(6), 2456-2464.  
Frias, A. E., Morgan, T. K., Evans, A. E., Rasanen, J., Oh, K. Y., Thornburg, K. L., et al. 
(2011). Maternal high-fat diet disturbs uteroplacental hemodynamics and 
increases the frequency of stillbirth in a nonhuman primate model of excess 
nutrition. Endocrinology, 152(6), 2456-2464. doi: en.2010-1332 [pii] 
10.1210/en.2010-1332 
Ganong, W. F. (2007). Review of Medical Physiology (22nd ed.). Columbus, OH: 
McGraw Hill. 
Garofano, A., Czernichow, P., & Breant, B. (1997). In utero undernutrition impairs rat 
beta-cell development. Diabetologia, 40(10), 1231-1234. doi: 
10.1007/s001250050812 
Garofano, A., Czernichow, P., & Breant, B. (1998). Beta-cell mass and proliferation 
following late fetal and early postnatal malnutrition in the rat. Diabetologia, 
41(9), 1114-1120. doi: 10.1007/s001250051038 
Garofano, A., Czernichow, P., & Breant, B. (1999). Effect of ageing on beta-cell mass 
and function in rats malnourished during the perinatal period. Diabetologia, 
42(6), 711-718. doi: 10.1007/s001250051219 
Gatford, K. L., Mohammad, S. N., Harland, M. L., De Blasio, M. J., Fowden, A. L., 
Robinson, J. S., et al. (2008). Impaired beta-cell function and inadequate 
compensatory increases in beta-cell mass after intrauterine growth restriction in 
sheep. Endocrinology, 149(10), 5118-5127. doi: en.2008-0233 [pii] 
10.1210/en.2008-0233 
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992). Identification of programmed cell 
death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol, 
119(3), 493-501.  
George, L. A., Uthlaut, A. B., Long, N. M., Zhang, L., Ma, Y., Smith, D. T., et al. (2010). 
Different levels of overnutrition and weight gain during pregnancy have 
differential effects on fetal growth and organ development. Reprod Biol 
Endocrinol, 8, 75. doi: 1477-7827-8-75 [pii] 
10.1186/1477-7827-8-75 
Georgia, S., & Bhushan, A. (2004). Beta cell replication is the primary mechanism for 
maintaining postnatal beta cell mass. J Clin Invest, 114(7), 963-968. doi: 
10.1172/JCI22098 
Gerich, J. E. (1976). Alpha cell function in diabetes mellitus. Metabolism, 25(11 Suppl 
1), 1513-1516.  
Glavas, M. M., Kirigiti, M. A., Xiao, X. Q., Enriori, P. J., Fisher, S. K., Evans, A. E., et 
al. (2010). Early overnutrition results in early-onset arcuate leptin resistance and 
increased sensitivity to high-fat diet. Endocrinology, 151(4), 1598-1610. doi: 
en.2009-1295 [pii] 
Comstock, 151 
10.1210/en.2009-1295 
Gomez-Perez, Y., Gianotti, M., Llado, I., & Proenza, A. M. (2011). Sex-dependent 
effects of high-fat-diet feeding on rat pancreas oxidative stress. Pancreas, 40(5), 
682-688. doi: 10.1097/MPA.0b013e31821f2645 
Grant, W. F., Gillingham, M. B., Batra, A. K., Fewkes, N. M., Comstock, S. M., 
Takahashi, D., et al. Maternal high fat diet is associated with decreased plasma n-
3 fatty acids and fetal hepatic apoptosis in nonhuman primates. PLoS One, 6(2), 
e17261.  
Grant, W. F., Gillingham, M. B., Batra, A. K., Fewkes, N. M., Comstock, S. M., 
Takahashi, D., et al. (2011). Maternal high fat diet is associated with decreased 
plasma n-3 fatty acids and fetal hepatic apoptosis in nonhuman primates. PLoS 
One, 6(2), e17261. doi: 10.1371/journal.pone.0017261 
Grayson, B. E., Levasseur, P. R., Williams, S. M., Smith, M. S., Marks, D. L., & Grove, 
K. L. Changes in melanocortin expression and inflammatory pathways in fetal 
offspring of nonhuman primates fed a high-fat diet. Endocrinology, 151(4), 1622-
1632.  
Grayson, B. E., Levasseur, P. R., Williams, S. M., Smith, M. S., Marks, D. L., & Grove, 
K. L. (2010). Changes in melanocortin expression and inflammatory pathways in 
fetal offspring of nonhuman primates fed a high-fat diet. Endocrinology, 151(4), 
1622-1632. doi: en.2009-1019 [pii] 
10.1210/en.2009-1019 
Groop, L. C., Bonadonna, R. C., Simonson, D. C., Petrides, A. S., Shank, M., & 
DeFronzo, R. A. (1992). Effect of insulin on oxidative and nonoxidative pathways 
of free fatty acid metabolism in human obesity. Am J Physiol, 263(1 Pt 1), E79-
84.  
Grulet, H., Durlach, V., Hecart, A. C., Gross, A., & Leutenegger, M. (1993). Study of the 
rate of early glucose disappearance following insulin injection: insulin sensitivity 
index. Diabetes Res Clin Pract, 20(3), 201-207. doi: 0168-8227(93)90079-K [pii] 
Grundy, S. M. (2006). Does a diagnosis of metabolic syndrome have value in clinical 
practice? Am J Clin Nutr, 83(6), 1248-1251. doi: 83/6/1248 [pii] 
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. 
A., et al. (2005). Diagnosis and management of the metabolic syndrome: an 
American Heart Association/National Heart, Lung, and Blood Institute Scientific 
Statement. Circulation, 112(17), 2735-2752. doi: 
CIRCULATIONAHA.105.169404 [pii] 
10.1161/CIRCULATIONAHA.105.169404 
Guardado-Mendoza, R., Davalli, A. M., Chavez, A. O., Hubbard, G. B., Dick, E. J., 
Majluf-Cruz, A., et al. (2009). Pancreatic islet amyloidosis, beta-cell apoptosis, 
and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic 
baboons. Proc Natl Acad Sci U S A, 106(33), 13992-13997. doi: 0906471106 [pii] 
10.1073/pnas.0906471106 
Guiot, Y., Sempoux, C., Moulin, P., & Rahier, J. (2001). No decrease of the beta-cell 
mass in type 2 diabetic patients. Diabetes, 50 Suppl 1, S188.  
Comstock, 152 
Guo, S. S., Wu, W., Chumlea, W. C., & Roche, A. F. (2002). Predicting overweight and 
obesity in adulthood from body mass index values in childhood and adolescence. 
Am J Clin Nutr, 76(3), 653-658.  
Gupta, R. K., Vatamaniuk, M. Z., Lee, C. S., Flaschen, R. C., Fulmer, J. T., Matschinsky, 
F. M., et al. (2005). The MODY1 gene HNF-4alpha regulates selected genes 
involved in insulin secretion. J Clin Invest, 115(4), 1006-1015.  
Haffner, S. M., Valdez, R. A., Hazuda, H. P., Mitchell, B. D., Morales, P. A., & Stern, M. 
P. (1992). Prospective analysis of the insulin-resistance syndrome (syndrome X). 
Diabetes, 41(6), 715-722.  
Halban, P. A., Wollheim, C. B., Blondel, B., Meda, P., Niesor, E. N., & Mintz, D. H. 
(1982). The possible importance of contact between pancreatic islet cells for the 
control of insulin release. Endocrinology, 111(1), 86-94.  
Hales, C. N., & Barker, D. J. (1992). Type 2 (non-insulin-dependent) diabetes mellitus: 
the thrifty phenotype hypothesis. Diabetologia, 35(7), 595-601.  
Hales, C. N., Barker, D. J., Clark, P. M., Cox, L. J., Fall, C., Osmond, C., et al. (1991). 
Fetal and infant growth and impaired glucose tolerance at age 64. BMJ, 
303(6809), 1019-1022.  
Hall, A. C. G. a. J. E. (2000). Textbook of Medical Physiology (10 ed.). Philadelphia, PA: 
WB Saunder Company. 
Hamada, Y. (1999). Adolescent Growth and Development in Japanese Macaques 
(Macacafuscata): Punctuated Adolescent Growth Spurt by Season. Primates, 
40(3), 14.  
Hancock, C. R., Han, D. H., Chen, M., Terada, S., Yasuda, T., Wright, D. C., et al. 
(2008). High-fat diets cause insulin resistance despite an increase in muscle 
mitochondria. Proc Natl Acad Sci U S A, 105(22), 7815-7820. doi: 0802057105 
[pii] 
10.1073/pnas.0802057105 
Hanley, S. C., Austin, E., Assouline-Thomas, B., Kapeluto, J., Blaichman, J., Moosavi, 
M., et al. (2010). {beta}-Cell mass dynamics and islet cell plasticity in human 
type 2 diabetes. Endocrinology, 151(4), 1462-1472. doi: en.2009-1277 [pii] 
10.1210/en.2009-1277 
Hansen, B. C., & Bodkin, N. L. (1986). Heterogeneity of insulin responses: phases 
leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey. 
Diabetologia, 29(10), 713-719.  
Hansen, B. C., & Bodkin, N. L. (1990). Beta-cell hyperresponsiveness: earliest event in 
development of diabetes in monkeys. Am J Physiol, 259(3 Pt 2), R612-617.  
Hayama, S., Nakiri, S., & Konno, F. (2011). Pregnancy rate and conception date in a wild 
population of Japanese monkeys. J Vet Med Sci, 73(6), 809-812. doi: 
JST.JSTAGE/jvms/10-0420 [pii] 
Hegyi, P., Maleth, J., Venglovecz, V., & Rakonczay, Z., Jr. (2011). Pancreatic ductal 
bicarbonate secretion: challenge of the acinar Acid load. Front Physiol, 2, 36. doi: 
10.3389/fphys.2011.00036 
Heimberg, H., De Vos, A., Moens, K., Quartier, E., Bouwens, L., Pipeleers, D., et al. 
(1996). The glucose sensor protein glucokinase is expressed in glucagon-
producing alpha-cells. Proc Natl Acad Sci U S A, 93(14), 7036-7041.  
Comstock, 153 
Hill, D. J. (2005). Development of the endocrine pancreas. Rev Endocr Metab Disord, 
6(3), 229-238. doi: 10.1007/s11154-005-3054-8 
Holz, G. G. t., Kuhtreiber, W. M., & Habener, J. F. (1993). Pancreatic beta-cells are 
rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-
1(7-37). Nature, 361(6410), 362-365. doi: 10.1038/361362a0 
Howie, G. J., Sloboda, D. M., Kamal, T., & Vickers, M. H. (2009). Maternal nutritional 
history predicts obesity in adult offspring independent of postnatal diet. J Physiol, 
587(Pt 4), 905-915. doi: jphysiol.2008.163477 [pii] 
10.1113/jphysiol.2008.163477 
Huypens, P., Ling, Z., Pipeleers, D., & Schuit, F. (2000). Glucagon receptors on human 
islet cells contribute to glucose competence of insulin release. Diabetologia, 
43(8), 1012-1019. doi: 10.1007/s001250051484 
Isa, T., Yamane, I., Hamai, M., & Inagaki, H. (2009). Japanese macaques as laboratory 
animals. Exp Anim, 58(5), 451-457. doi: JST.JSTAGE/expanim/58.451 [pii] 
Iynedjian, P. B. (1993). Mammalian glucokinase and its gene. Biochem J, 293 ( Pt 1), 1-
13.  
Johannsen, D. L., Johannsen, N. M., & Specker, B. L. (2006). Influence of parents' eating 
behaviors and child feeding practices on children's weight status. Obesity (Silver 
Spring), 14(3), 431-439. doi: 14/3/431 [pii] 
10.1038/oby.2006.57 
Johansson, K. A., & Grapin-Botton, A. (2002). Development and diseases of the 
pancreas. Clin Genet, 62(1), 14-23.  
Jones, H. N., Woollett, L. A., Barbour, N., Prasad, P. D., Powell, T. L., & Jansson, T. 
(2009). High-fat diet before and during pregnancy causes marked up-regulation of 
placental nutrient transport and fetal overgrowth in C57/BL6 mice. FASEB J, 
23(1), 271-278. doi: fj.08-116889 [pii] 
10.1096/fj.08-116889 
Jones, L. C., & Clark, A. (2001). beta-cell neogenesis in type 2 diabetes. Diabetes, 50 
Suppl 1, S186-187.  
Jonsson, J., Carlsson, L., Edlund, T., & Edlund, H. (1994). Insulin-promoter-factor 1 is 
required for pancreas development in mice. Nature, 371(6498), 606-609.  
Jovanovic-Peterson, L., Fuhrmann, K., Hedden, K., Walker, L., & Peterson, C. M. 
(1989). Maternal milk and plasma glucose and insulin levels: studies in normal 
and diabetic subjects. J Am Coll Nutr, 8(2), 125-131.  
Jurgens, C. A., Toukatly, M. N., Fligner, C. L., Udayasankar, J., Subramanian, S. L., 
Zraika, S., et al. (2011). beta-cell loss and beta-cell apoptosis in human type 2 
diabetes are related to islet amyloid deposition. Am J Pathol, 178(6), 2632-2640. 
doi: S0002-9440(11)00270-7 [pii] 
10.1016/j.ajpath.2011.02.036 
Kahn, B. B., & Flier, J. S. (2000). Obesity and insulin resistance. J Clin Invest, 106(4), 
473-481. doi: 10.1172/JCI10842 
Kahn, R., Buse, J., Ferrannini, E., & Stern, M. (2005). The metabolic syndrome: time for 
a critical appraisal. Joint statement from the American Diabetes Association and 
the European Association for the Study of Diabetes. Diabetologia, 48(9), 1684-
1699. doi: 10.1007/s00125-005-1876-2 
Comstock, 154 
Kashyap, S., Belfort, R., Gastaldelli, A., Pratipanawatr, T., Berria, R., Pratipanawatr, W., 
et al. (2003). A sustained increase in plasma free fatty acids impairs insulin 
secretion in nondiabetic subjects genetically predisposed to develop type 2 
diabetes. Diabetes, 52(10), 2461-2474.  
Kaufman, D., Smith, E. L., Gohil, B. C., Banerji, M., Coplan, J. D., Kral, J. G., et al. 
(2005). Early appearance of the metabolic syndrome in socially reared bonnet 
macaques. J Clin Endocrinol Metab, 90(1), 404-408. doi: jc.2004-0452 [pii] 
10.1210/jc.2004-0452 
Kerr, G. R., Allen, J. R., Scheffler, G., & Couture, J. (1974). Fetal and postnatal growth 
of rhesus monkeys (M. mulatta). J Med Primatol, 3(4), 221-235.  
Kidd, M., Nadler, B., Mane, S., Eick, G., Malfertheiner, M., Champaneria, M., et al. 
(2007). GeneChip, geNorm, and gastrointestinal tumors: novel reference genes for 
real-time PCR. Physiol Genomics, 30(3), 363-370.  
Kieffer, T. J., Heller, R. S., Unson, C. G., Weir, G. C., & Habener, J. F. (1996). 
Distribution of glucagon receptors on hormone-specific endocrine cells of rat 
pancreatic islets. Endocrinology, 137(11), 5119-5125.  
Kilpatrick, E. D., & Robertson, R. P. (1998). Differentiation between glucose-induced 
desensitization of insulin secretion and beta-cell exhaustion in the HIT-T15 cell 
line. Diabetes, 47(4), 606-611.  
Kim, A., Miller, K., Jo, J., Kilimnik, G., Wojcik, P., & Hara, M. (2009). Islet 
architecture: A comparative study. Islets, 1(2), 129-136. doi: 10.4161/isl.1.2.9480 
Kiserud, T. (2005). Physiology of the fetal circulation. Semin Fetal Neonatal Med, 10(6), 
493-503. doi: S1744-165X(05)00068-5 [pii] 
10.1016/j.siny.2005.08.007 
Konig, S., Vest, M., & Stahl, M. (1978). Interrelation of maternal and foetal glucose and 
free fatty acids. The role of insulin and glucagon. Eur J Pediatr, 128(3), 187-195.  
Konner, A. C., Janoschek, R., Plum, L., Jordan, S. D., Rother, E., Ma, X., et al. (2007). 
Insulin action in AgRP-expressing neurons is required for suppression of hepatic 
glucose production. Cell Metab, 5(6), 438-449. doi: S1550-4131(07)00131-3 [pii] 
10.1016/j.cmet.2007.05.004 
Koukkou, E., Ghosh, P., Lowy, C., & Poston, L. (1998). Offspring of normal and diabetic 
rats fed saturated fat in pregnancy demonstrate vascular dysfunction. Circulation, 
98(25), 2899-2904.  
Koupil, I., & Toivanen, P. (2008). Social and early-life determinants of overweight and 
obesity in 18-year-old Swedish men. Int J Obes (Lond), 32(1), 73-81.  
Kramer, J., Moeller, E. L., Hachey, A., Mansfield, K. G., & Wachtman, L. M. (2009). 
Differential expression of GLUT2 in pancreatic islets and kidneys of New and 
Old World nonhuman primates. Am J Physiol Regul Integr Comp Physiol, 296(3), 
R786-793. doi: 90694.2008 [pii] 
10.1152/ajpregu.90694.2008 
Lang, G., Goldstein, M. S., & Levine, R. (1954). Influence of the liver on uptake of 
glucose by extrahepatic tissues. Am J Physiol, 177(3), 447-450.  
Leung, Y. M., Ahmed, I., Sheu, L., Gao, X., Hara, M., Tsushima, R. G., et al. (2006). 
Insulin regulates islet alpha-cell function by reducing KATP channel sensitivity to 
Comstock, 155 
adenosine 5'-triphosphate inhibition. Endocrinology, 147(5), 2155-2162. doi: 
en.2005-1249 [pii] 
10.1210/en.2005-1249 
Liang, Y., Najafi, H., & Matschinsky, F. M. (1990). Glucose regulates glucokinase 
activity in cultured islets from rat pancreas. J Biol Chem, 265(28), 16863-16866.  
Limesand, S. W., Jensen, J., Hutton, J. C., & Hay, W. W., Jr. (2005). Diminished beta-
cell replication contributes to reduced beta-cell mass in fetal sheep with 
intrauterine growth restriction. Am J Physiol Regul Integr Comp Physiol, 288(5), 
R1297-1305. doi: 00494.2004 [pii] 
10.1152/ajpregu.00494.2004 
Limesand, S. W., Rozance, P. J., Smith, D., & Hay, W. W., Jr. (2007). Increased insulin 
sensitivity and maintenance of glucose utilization rates in fetal sheep with 
placental insufficiency and intrauterine growth restriction. Am J Physiol 
Endocrinol Metab, 293(6), E1716-1725. doi: 00459.2007 [pii] 
10.1152/ajpendo.00459.2007 
Limesand, S. W., Rozance, P. J., Zerbe, G. O., Hutton, J. C., & Hay, W. W., Jr. (2006). 
Attenuated insulin release and storage in fetal sheep pancreatic islets with 
intrauterine growth restriction. Endocrinology, 147(3), 1488-1497. doi: en.2005-
0900 [pii] 
10.1210/en.2005-0900 
Long, N. M., George, L. A., Uthlaut, A. B., Smith, D. T., Nijland, M. J., Nathanielsz, P. 
W., et al. (2010). Maternal obesity and increased nutrient intake before and during 
gestation in the ewe results in altered growth, adiposity, and glucose tolerance in 
adult offspring. J Anim Sci, 88(11), 3546-3553. doi: jas.2010-3083 [pii] 
10.2527/jas.2010-3083 
Ludmer, P. L., Selwyn, A. P., Shook, T. L., Wayne, R. R., Mudge, G. H., Alexander, R. 
W., et al. (1986). Paradoxical vasoconstriction induced by acetylcholine in 
atherosclerotic coronary arteries. N Engl J Med, 315(17), 1046-1051. doi: 
10.1056/NEJM198610233151702 
Lukinius, A., Korsgren, O., Grimelius, L., & Wilander, E. (1996). Expression of islet 
amyloid polypeptide in fetal and adult porcine and human pancreatic islet cells. 
Endocrinology, 137(12), 5319-5325.  
MacDonald, P. E., Joseph, J. W., & Rorsman, P. (2005). Glucose-sensing mechanisms in 
pancreatic beta-cells. Philos Trans R Soc Lond B Biol Sci, 360(1464), 2211-2225.  
Maedler, K., & Donath, M. Y. (2004). Beta-cells in type 2 diabetes: a loss of function and 
mass. Horm Res, 62 Suppl 3, 67-73. doi: 80503 [pii] 
10.1159/000080503 
Magarey, A. M., Daniels, L. A., Boulton, T. J., & Cockington, R. A. (2003). Predicting 
obesity in early adulthood from childhood and parental obesity. Int J Obes Relat 
Metab Disord, 27(4), 505-513.  
Martin-Gronert, M. S., & Ozanne, S. E. (2007). Experimental IUGR and later diabetes. J 
Intern Med, 261(5), 437-452. doi: JIM1800 [pii] 
10.1111/j.1365-2796.2007.01800.x 
Matschinsky, F. M. (1996). Banting Lecture 1995. A lesson in metabolic regulation 
inspired by the glucokinase glucose sensor paradigm. Diabetes, 45(2), 223-241.  
Comstock, 156 
Matsumoto, S., Qualley, S. A., Goel, S., Hagman, D. K., Sweet, I. R., Poitout, V., et al. 
(2002). Effect of the two-layer (University of Wisconsin solution-
perfluorochemical plus O2) method of pancreas preservation on human islet 
isolation, as assessed by the Edmonton Isolation Protocol. Transplantation, 
74(10), 1414-1419. doi: 10.1097/01.TP.0000034206.66890.B0 
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, 
R. C. (1985). Homeostasis model assessment: insulin resistance and beta-cell 
function from fasting plasma glucose and insulin concentrations in man. 
Diabetologia, 28(7), 412-419.  
Matveyenko, A. V., Singh, I., Shin, B. C., Georgia, S., & Devaskar, S. U. (2010). 
Differential effects of prenatal and postnatal nutritional environment on beta-cell 
mass development and turnover in male and female rats. Endocrinology, 151(12), 
5647-5656. doi: en.2010-0978 [pii] 
10.1210/en.2010-0978 
McAuley, K. A., Williams, S. M., Mann, J. I., Walker, R. J., Lewis-Barned, N. J., 
Temple, L. A., et al. (2001). Diagnosing insulin resistance in the general 
population. Diabetes Care, 24(3), 460-464.  
McCurdy, C. E., Bishop, J. M., Williams, S. M., Grayson, B. E., Smith, M. S., Friedman, 
J. E., et al. (2009). Maternal high-fat diet triggers lipotoxicity in the fetal livers of 
nonhuman primates. J Clin Invest, 119(2), 323-335.  
Medrikova, D., Jilkova, Z. M., Bardova, K., Janovska, P., Rossmeisl, M., & Kopecky, J. 
(2011). Sex differences during the course of diet-induced obesity in mice: adipose 
tissue expandability and glycemic control. Int J Obes (Lond). doi: ijo201187 [pii] 
10.1038/ijo.2011.87 
Meyer, K. M., Koch, J. M., Ramadoss, J., Kling, P. J., & Magness, R. R. (2010). Ovine 
surgical model of uterine space restriction: interactive effects of uterine anomalies 
and multifetal gestations on fetal and placental growth. Biol Reprod, 83(5), 799-
806. doi: biolreprod.110.085381 [pii] 
10.1095/biolreprod.110.085381 
Miki, T., Nagashima, K., & Seino, S. (1999). The structure and function of the ATP-
sensitive K+ channel in insulin-secreting pancreatic beta-cells. J Mol Endocrinol, 
22(2), 113-123.  
Mojsov, S., Weir, G. C., & Habener, J. F. (1987). Insulinotropin: glucagon-like peptide I 
(7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in 
the perfused rat pancreas. J Clin Invest, 79(2), 616-619. doi: 10.1172/JCI112855 
Montanya, E., & Tellez, N. (2009). Pancreatic remodeling: beta-cell apoptosis, 
proliferation and neogenesis, and the measurement of beta-cell mass and of 
individual beta-cell size. Methods Mol Biol, 560, 137-158.  
Moran, A., Zhang, H. J., Olson, L. K., Harmon, J. S., Poitout, V., & Robertson, R. P. 
(1997). Differentiation of glucose toxicity from beta cell exhaustion during the 
evolution of defective insulin gene expression in the pancreatic islet cell line, 
HIT-T15. J Clin Invest, 99(3), 534-539. doi: 10.1172/JCI119190 
Moritz, W., Leech, C. A., Ferrer, J., & Habener, J. F. (2001). Regulated expression of 
adenosine triphosphate-sensitive potassium channel subunits in pancreatic beta-
cells. Endocrinology, 142(1), 129-138.  
Comstock, 157 
Morrison, J. L. (2008). Sheep models of intrauterine growth restriction: fetal adaptations 
and consequences. Clin Exp Pharmacol Physiol, 35(7), 730-743. doi: CEP4975 
[pii] 
10.1111/j.1440-1681.2008.04975.x 
Mourmeaux, J. L., Remacle, C., & Henquin, J. C. (1985). Morphological and functional 
characteristics of islets neoformed during tissue culture of fetal rat pancreas. Mol 
Cell Endocrinol, 39(3), 237-246.  
Myers, R. E., Hill, D. E., Holt, A. B., Scott, R. E., Mellits, E. D., & Cheek, D. B. (1971). 
Fetal growth retardation produced by experimental placental insufficiency in the 
rhesus monkey. I. Body weight, organ size. Biol Neonate, 18(5), 379-394.  
Newgard, C. B., & McGarry, J. D. (1995). Metabolic coupling factors in pancreatic beta-
cell signal transduction. Annu Rev Biochem, 64, 689-719.  
Nolan, C. J., Madiraju, M. S., Delghingaro-Augusto, V., Peyot, M. L., & Prentki, M. 
(2006). Fatty acid signaling in the beta-cell and insulin secretion. Diabetes, 55 
Suppl 2, S16-23. doi: 55/Supplement_2/S16 [pii] 
10.2337/diabetes. 
Offield, M. F., Jetton, T. L., Labosky, P. A., Ray, M., Stein, R. W., Magnuson, M. A., et 
al. (1996). PDX-1 is required for pancreatic outgrowth and differentiation of the 
rostral duodenum. Development, 122(3), 983-995.  
Ogden, C. L., Carroll, M. D., Curtin, L. R., Lamb, M. M., & Flegal, K. M. (2010). 
Prevalence of high body mass index in US children and adolescents, 2007-2008. 
JAMA, 303(3), 242-249. doi: 2009.2012 [pii] 
10.1001/jama.2009.2012 
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. 
M. (2006). Prevalence of overweight and obesity in the United States, 1999-2004. 
Jama, 295(13), 1549-1555.  
Olson, L. K., Sharma, A., Peshavaria, M., Wright, C. V., Towle, H. C., Rodertson, R. P., 
et al. (1995). Reduction of insulin gene transcription in HIT-T15 beta cells 
chronically exposed to a supraphysiologic glucose concentration is associated 
with loss of STF-1 transcription factor expression. Proc Natl Acad Sci U S A, 
92(20), 9127-9131.  
Oltjen, J. W., & Beckett, J. L. (1996). Role of ruminant livestock in sustainable 
agricultural systems. J Anim Sci, 74(6), 1406-1409.  
Park, J. H., Stoffers, D. A., Nicholls, R. D., & Simmons, R. A. (2008). Development of 
type 2 diabetes following intrauterine growth retardation in rats is associated with 
progressive epigenetic silencing of Pdx1. J Clin Invest, 118(6), 2316-2324. doi: 
10.1172/JCI33655 
Parton, L. E., Ye, C. P., Coppari, R., Enriori, P. J., Choi, B., Zhang, C. Y., et al. (2007). 
Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired 
in obesity. Nature, 449(7159), 228-232. doi: nature06098 [pii] 
10.1038/nature06098 
Paulsen, S. J., Jelsing, J., Madsen, A. N., Hansen, G., Lykkegaard, K., Larsen, L. K., et 
al. (2010). Characterization of beta-cell mass and insulin resistance in diet-
induced obese and diet-resistant rats. Obesity (Silver Spring), 18(2), 266-273. doi: 
oby2009245 [pii] 
Comstock, 158 
10.1038/oby.2009.245 
Perfetti, R., Zhou, J., Doyle, M. E., & Egan, J. M. (2000). Glucagon-like peptide-1 
induces cell proliferation and pancreatic-duodenum homeobox-1 expression and 
increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. 
Endocrinology, 141(12), 4600-4605.  
Phillips, D. I. (1996). Insulin resistance as a programmed response to fetal undernutrition. 
Diabetologia, 39(9), 1119-1122.  
Pipeleers, D. G., Schuit, F. C., Van Schravendijk, C. F., & Van de Winkel, M. (1985). 
Interplay of nutrients and hormones in the regulation of glucagon release. 
Endocrinology, 117(3), 817-823.  
Piper, K., Brickwood, S., Turnpenny, L. W., Cameron, I. T., Ball, S. G., Wilson, D. I., et 
al. (2004). Beta cell differentiation during early human pancreas development. J 
Endocrinol, 181(1), 11-23.  
Pocai, A., Lam, T. K., Gutierrez-Juarez, R., Obici, S., Schwartz, G. J., Bryan, J., et al. 
(2005). Hypothalamic K(ATP) channels control hepatic glucose production. 
Nature, 434(7036), 1026-1031. doi: nature03439 [pii] 
10.1038/nature03439 
Poitout, V. (2008). Glucolipotoxicity of the pancreatic beta-cell: myth or reality? 
Biochem Soc Trans, 36(Pt 5), 901-904. doi: BST0360901 [pii] 
10.1042/BST0360901 
Postic, C., Shiota, M., & Magnuson, M. A. (2001). Cell-specific roles of glucokinase in 
glucose homeostasis. Recent Prog Horm Res, 56, 195-217.  
Prado, C. L., Pugh-Bernard, A. E., Elghazi, L., Sosa-Pineda, B., & Sussel, L. (2004). 
Ghrelin cells replace insulin-producing beta cells in two mouse models of 
pancreas development. Proc Natl Acad Sci U S A, 101(9), 2924-2929. doi: 
10.1073/pnas.0308604100 
0308604100 [pii] 
Quesada, I., Tuduri, E., Ripoll, C., & Nadal, A. (2008). Physiology of the pancreatic 
alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes. J 
Endocrinol, 199(1), 5-19. doi: JOE-08-0290 [pii] 
10.1677/JOE-08-0290 
Radaelli, T., Lepercq, J., Varastehpour, A., Basu, S., Catalano, P. M., & Hauguel-De 
Mouzon, S. (2009). Differential regulation of genes for fetoplacental lipid 
pathways in pregnancy with gestational and type 1 diabetes mellitus. Am J Obstet 
Gynecol, 201(2), 209 e201-209 e210. doi: S0002-9378(09)00405-0 [pii] 
10.1016/j.ajog.2009.04.019 
Rao, S., Yajnik, C. S., Kanade, A., Fall, C. H., Margetts, B. M., Jackson, A. A., et al. 
(2001). Intake of micronutrient-rich foods in rural Indian mothers is associated 
with the size of their babies at birth: Pune Maternal Nutrition Study. J Nutr, 
131(4), 1217-1224.  
Ravelli, A. C., van der Meulen, J. H., Michels, R. P., Osmond, C., Barker, D. J., Hales, C. 
N., et al. (1998). Glucose tolerance in adults after prenatal exposure to famine. 
Lancet, 351(9097), 173-177. doi: S0140673697072449 [pii] 
Reddy, K. G., Nair, R. N., Sheehan, H. M., & Hodgson, J. M. (1994). Evidence that 
selective endothelial dysfunction may occur in the absence of angiographic or 
Comstock, 159 
ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am 
Coll Cardiol, 23(4), 833-843. doi: 0735-1097(94)90627-0 [pii] 
Reers, C., Erbel, S., Esposito, I., Schmied, B., Buchler, M. W., Nawroth, P. P., et al. 
(2009). Impaired islet turnover in human donor pancreata with aging. Eur J 
Endocrinol, 160(2), 185-191. doi: EJE-08-0596 [pii] 
10.1530/EJE-08-0596 
Remacle, C., Dumortier, O., Bol, V., Goosse, K., Romanus, P., Theys, N., et al. (2007). 
Intrauterine programming of the endocrine pancreas. Diabetes Obes Metab, 9 
Suppl 2, 196-209. doi: DOM790 [pii] 
10.1111/j.1463-1326.2007.00790.x 
Rivas-Carrillo, J. D., Okitsu, T., Tanaka, N., & Kobayashi, N. (2007). Pancreas 
development and beta-cell differentiation of embryonic stem cells. Curr Med 
Chem, 14(14), 1573-1578.  
Roberts, V. H., Rasanen, J. P., Novy, M. J., Frias, A., Louey, S., Morgan, T. K., et al. 
(2012). Restriction of placental vasculature in a non-human primate: A unique 
model to study placental plasticity. Placenta, 33(1), 73-76. doi: S0143-
4004(11)00494-2 [pii] 
10.1016/j.placenta.2011.10.003 
Robertson, R. P. (2004). Chronic oxidative stress as a central mechanism for glucose 
toxicity in pancreatic islet beta cells in diabetes. J Biol Chem, 279(41), 42351-
42354. doi: 10.1074/jbc.R400019200 
R400019200 [pii] 
Roseboom, T., de Rooij, S., & Painter, R. (2006). The Dutch famine and its long-term 
consequences for adult health. Early Hum Dev, 82(8), 485-491. doi: S0378-
3782(06)00184-8 [pii] 
10.1016/j.earlhumdev.2006.07.001 
Roseboom, T. J., van der Meulen, J. H., Osmond, C., Barker, D. J., Ravelli, A. C., 
Schroeder-Tanka, J. M., et al. (2000). Coronary heart disease after prenatal 
exposure to the Dutch famine, 1944-45. Heart, 84(6), 595-598.  
Rosenberg, L., Lipsett, M., Yoon, J. W., Prentki, M., Wang, R., Jun, H. S., et al. (2004). 
A pentadecapeptide fragment of islet neogenesis-associated protein increases 
beta-cell mass and reverses diabetes in C57BL/6J mice. Ann Surg, 240(5), 875-
884. doi: 00000658-200411000-00021 [pii] 
Rozance, P. J., Limesand, S. W., & Hay, W. W., Jr. (2006). Decreased nutrient-
stimulated insulin secretion in chronically hypoglycemic late-gestation fetal sheep 
is due to an intrinsic islet defect. Am J Physiol Endocrinol Metab, 291(2), E404-
411. doi: 00643.2005 [pii] 
10.1152/ajpendo.00643.2005 
Sanz Sampelayo, M. R., Chilliard, Y., Schmidely, P., & Boza, J. (2007). Influence of 
type of diet on the fat constituents of goat and sheep milk. Small Ruminant 
Research, 68(1–2), 42-63. doi: 10.1016/j.smallrumres.2006.09.017 
Sato, Y., Ito, T., Udaka, N., Kanisawa, M., Noguchi, Y., Cushman, S. W., et al. (1996). 
Immunohistochemical localization of facilitated-diffusion glucose transporters in 
rat pancreatic islets. Tissue Cell, 28(6), 637-643.  
Comstock, 160 
Scaglia, L., Cahill, C. J., Finegood, D. T., & Bonner-Weir, S. (1997). Apoptosis 
participates in the remodeling of the endocrine pancreas in the neonatal rat. 
Endocrinology, 138(4), 1736-1741.  
Scholzen, T., & Gerdes, J. (2000). The Ki-67 protein: from the known and the unknown. 
J Cell Physiol, 182(3), 311-322. doi: 10.1002/(SICI)1097-
4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9 [pii] 
10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9 
Sebert, S. P., Dellschaft, N. S., Chan, L. L., Street, H., Henry, M., Francois, C., et al. 
(2011). Maternal nutrient restriction during late gestation and early postnatal 
growth in sheep differentially reset the control of energy metabolism in the gastric 
mucosa. Endocrinology, 152(7), 2816-2826. doi: en.2011-0169 [pii] 
10.1210/en.2011-0169 
Shafrir, E., & Khassis, S. (1982). Maternal-fetal fat transport versus new fat synthesis in 
the pregnant diabetic rat. Diabetologia, 22(2), 111-117.  
Sharma, A., Moore, M., Marcora, E., Lee, J. E., Qiu, Y., Samaras, S., et al. (1999). The 
NeuroD1/BETA2 sequences essential for insulin gene transcription colocalize 
with those necessary for neurogenesis and p300/CREB binding protein binding. 
Mol Cell Biol, 19(1), 704-713.  
Sharma, A., Olson, L. K., Robertson, R. P., & Stein, R. (1995). The reduction of insulin 
gene transcription in HIT-T15 beta cells chronically exposed to high glucose 
concentration is associated with the loss of RIPE3b1 and STF-1 transcription 
factor expression. Mol Endocrinol, 9(9), 1127-1134.  
Slavin, B. G., Ong, J. M., & Kern, P. A. (1994). Hormonal regulation of hormone-
sensitive lipase activity and mRNA levels in isolated rat adipocytes. J Lipid Res, 
35(9), 1535-1541.  
Smith, C. A. (1947a). The effect of wartime starvation in Holland upon pregnancy and its 
product. Am J Obstet Gynecol, 53(4), 599-608.  
Smith, C. A. (1947b). Effects of maternal under nutrition upon the newborn infant in 
Holland (1944-1945). J Pediatr, 30(3), 229-243.  
Speakman, J., Hambly, C., Mitchell, S., & Krol, E. (2007). Animal models of obesity. 
Obes Rev, 8 Suppl 1, 55-61.  
Spruijt-Metz, D., Lindquist, C. H., Birch, L. L., Fisher, J. O., & Goran, M. I. (2002). 
Relation between mothers' child-feeding practices and children's adiposity. Am J 
Clin Nutr, 75(3), 581-586.  
Srinivasan, M., Aalinkeel, R., Song, F., Mitrani, P., Pandya, J. D., Strutt, B., et al. (2005). 
Maternal hyperinsulinemia predisposes rat fetuses for hyperinsulinemia and adult-
-onset obesity and maternal mild food restriction reverses this phenotype. Am J 
Physiol Endocrinol Metab.  
Srinivasan, M., Katewa, S. D., Palaniyappan, A., Pandya, J. D., & Patel, M. S. (2006). 
Maternal high-fat diet consumption results in fetal malprogramming predisposing 
to the onset of metabolic syndrome-like phenotype in adulthood. Am J Physiol 
Endocrinol Metab, 291(4), E792-799. doi: 00078.2006 [pii] 
10.1152/ajpendo.00078.2006 
Staub, A., Sinn, L., & Behrens, O. K. (1955). Purification and crystallization of glucagon. 
J Biol Chem, 214(2), 619-632.  
Comstock, 161 
Sullivan, E. L., Grayson, B., Takahashi, D., Robertson, N., Maier, A., Bethea, C. L., et al. 
Chronic consumption of a high-fat diet during pregnancy causes perturbations in 
the serotonergic system and increased anxiety-like behavior in nonhuman primate 
offspring. J Neurosci, 30(10), 3826-3830.  
Sullivan, E. L., Grayson, B., Takahashi, D., Robertson, N., Maier, A., Bethea, C. L., et al. 
(2010). Chronic consumption of a high-fat diet during pregnancy causes 
perturbations in the serotonergic system and increased anxiety-like behavior in 
nonhuman primate offspring. J Neurosci, 30(10), 3826-3830. doi: 30/10/3826 
[pii] 
10.1523/JNEUROSCI.5560-09.2010 
Taylor, P. D., McConnell, J., Khan, I. Y., Holemans, K., Lawrence, K. M., Asare-Anane, 
H., et al. (2005). Impaired glucose homeostasis and mitochondrial abnormalities 
in offspring of rats fed a fat-rich diet in pregnancy. Am J Physiol Regul Integr 
Comp Physiol, 288(1), R134-139. doi: 10.1152/ajpregu.00355.2004 
00355.2004 [pii] 
Teta, M., Rankin, M. M., Long, S. Y., Stein, G. M., & Kushner, J. A. (2007). Growth and 
regeneration of adult beta cells does not involve specialized progenitors. Dev Cell, 
12(5), 817-826. doi: S1534-5807(07)00158-X [pii] 
10.1016/j.devcel.2007.04.011 
Tomita, T., Masuzaki, H., Iwakura, H., Fujikura, J., Noguchi, M., Tanaka, T., et al. 
(2006). Expression of the gene for a membrane-bound fatty acid receptor in the 
pancreas and islet cell tumours in humans: evidence for GPR40 expression in 
pancreatic beta cells and implications for insulin secretion. Diabetologia, 49(5), 
962-968. doi: 10.1007/s00125-006-0193-8 
Uauy, R., Peirano, P., Hoffman, D., Mena, P., Birch, D., & Birch, E. (1996). Role of 
essential fatty acids in the function of the developing nervous system. Lipids, 31 
Suppl, S167-176.  
Uchida, T., Nakamura, T., Hashimoto, N., Matsuda, T., Kotani, K., Sakaue, H., et al. 
(2005). Deletion of Cdkn1b ameliorates hyperglycemia by maintaining 
compensatory hyperinsulinemia in diabetic mice. Nat Med, 11(2), 175-182.  
Uehara, S., Muroyama, A., Echigo, N., Morimoto, R., Otsuka, M., Yatsushiro, S., et al. 
(2004). Metabotropic glutamate receptor type 4 is involved in autoinhibitory 
cascade for glucagon secretion by alpha-cells of islet of Langerhans. Diabetes, 
53(4), 998-1006.  
Unger, R. H. (1995). Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. 
Genetic and clinical implications. Diabetes, 44(8), 863-870.  
Unger, R. H., & Zhou, Y. T. (2001). Lipotoxicity of beta-cells in obesity and in other 
causes of fatty acid spillover. Diabetes, 50 Suppl 1, S118-121.  
Van Assche, F. A., De Prins, F., Aerts, L., & Verjans, M. (1977). The endocrine pancreas 
in small-for-dates infants. Br J Obstet Gynaecol, 84(10), 751-753.  
van den Hoek, A. M., Voshol, P. J., Karnekamp, B. N., Buijs, R. M., Romijn, J. A., 
Havekes, L. M., et al. (2004). Intracerebroventricular neuropeptide Y infusion 
precludes inhibition of glucose and VLDL production by insulin. Diabetes, 
53(10), 2529-2534. doi: 53/10/2529 [pii] 
Comstock, 162 
Varastehpour, A., Radaelli, T., Minium, J., Ortega, H., Herrera, E., Catalano, P., et al. 
(2006). Activation of phospholipase A2 is associated with generation of placental 
lipid signals and fetal obesity. J Clin Endocrinol Metab, 91(1), 248-255. doi: 
jc.2005-0873 [pii] 
10.1210/jc.2005-0873 
Villar, J., Merialdi, M., Gulmezoglu, A. M., Abalos, E., Carroli, G., Kulier, R., et al. 
(2003). Nutritional interventions during pregnancy for the prevention or treatment 
of maternal morbidity and preterm delivery: an overview of randomized 
controlled trials. J Nutr, 133(5 Suppl 2), 1606S-1625S.  
Wagner, J. D., Cline, J. M., Shadoan, M. K., Bullock, B. C., Rankin, S. E., & Cefalu, W. 
T. (2001). Naturally occurring and experimental diabetes in cynomolgus 
monkeys: a comparison of carbohydrate and lipid metabolism and islet pathology. 
Toxicol Pathol, 29(1), 142-148.  
Walker, J. N., Ramracheya, R., Zhang, Q., Johnson, P. R., Braun, M., & Rorsman, P. 
(2011). Regulation of glucagon secretion by glucose: paracrine, intrinsic or both? 
Diabetes Obes Metab, 13 Suppl 1, 95-105. doi: 10.1111/j.1463-
1326.2011.01450.x 
Wang, X., Cahill, C. M., Pineyro, M. A., Zhou, J., Doyle, M. E., & Egan, J. M. (1999). 
Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in 
insulinoma cells. Endocrinology, 140(10), 4904-4907.  
Weir, G. C., & Bonner-Weir, S. (2004). Five stages of evolving beta-cell dysfunction 
during progression to diabetes. Diabetes, 53 Suppl 3, S16-21.  
Weir, G. C., Marselli, L., Marchetti, P., Katsuta, H., Jung, M. H., & Bonner-Weir, S. 
(2009). Towards better understanding of the contributions of overwork and 
glucotoxicity to the beta-cell inadequacy of type 2 diabetes. Diabetes Obes 
Metab, 11 Suppl 4, 82-90.  
Weiss, R., Dziura, J., Burgert, T. S., Tamborlane, W. V., Taksali, S. E., Yeckel, C. W., et 
al. (2004). Obesity and the metabolic syndrome in children and adolescents. N 
Engl J Med, 350(23), 2362-2374. doi: 10.1056/NEJMoa031049 
350/23/2362 [pii] 
Whitaker, R. C. (2004). Predicting preschooler obesity at birth: the role of maternal 
obesity in early pregnancy. Pediatrics, 114(1), e29-36.  
Williams, J. A., & Lee, M. (1976). Microtubules and pancreatic amylase release by 
mouse pancreas in vitro. J Cell Biol, 71(3), 795-806.  
Wolfe-Coote, S., Louw, J., Woodroof, C., & Du Toit, D. F. (1996). The non-human 
primate endocrine pancreas: development, regeneration potential and metaplasia. 
Cell Biol Int, 20(2), 95-101. doi: S1065-6995(96)90013-X [pii] 
10.1006/cbir.1996.0013 
Woods, S. C., Lotter, E. C., McKay, L. D., & Porte, D., Jr. (1979). Chronic 
intracerebroventricular infusion of insulin reduces food intake and body weight of 
baboons. Nature, 282(5738), 503-505.  
Xiao, X. Q., Williams, S. M., Grayson, B. E., Glavas, M. M., Cowley, M. A., Smith, M. 
S., et al. (2007). Excess weight gain during the early postnatal period is associated 
with permanent reprogramming of brown adipose tissue adaptive thermogenesis. 
Endocrinology, 148(9), 4150-4159.  
Comstock, 163 
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., et al. (2001). Control 
of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature, 
413(6852), 131-138. doi: 10.1038/35093050 
35093050 [pii] 
Zhang, L., Long, N. M., Hein, S. M., Ma, Y., Nathanielsz, P. W., & Ford, S. P. (2011). 
Maternal obesity in ewes results in reduced fetal pancreatic beta-cell numbers in 
late gestation and decreased circulating insulin concentration at term. Domest 
Anim Endocrinol, 40(1), 30-39. doi: S0739-7240(10)00097-4 [pii] 
10.1016/j.domaniend.2010.08.004 
Zhang, X., Zhang, R., Raab, S., Zheng, W., Wang, J., Liu, N., et al. (2011). Rhesus 
macaques develop metabolic syndrome with reversible vascular dysfunction 
responsive to pioglitazone. Circulation, 124(1), 77-86. doi: 
CIRCULATIONAHA.110.990333 [pii] 
10.1161/CIRCULATIONAHA.110.990333 
Zhu, M. J., Han, B., Tong, J., Ma, C., Kimzey, J. M., Underwood, K. R., et al. (2008). 
AMP-activated protein kinase signalling pathways are down regulated and 
skeletal muscle development impaired in fetuses of obese, over-nourished sheep. 
J Physiol, 586(10), 2651-2664. doi: jphysiol.2007.149633 [pii] 
10.1113/jphysiol.2007.149633 
Zhu, M. J., Ma, Y., Long, N. M., Du, M., & Ford, S. P. (2010). Maternal obesity 
markedly increases placental fatty acid transporter expression and fetal blood 
triglycerides at midgestation in the ewe. Am J Physiol Regul Integr Comp Physiol, 
299(5), R1224-1231. doi: ajpregu.00309.2010 [pii] 
10.1152/ajpregu.00309.2010 
Zimmet, P. Z. (1992). Kelly West Lecture 1991. Challenges in diabetes epidemiology--
from West to the rest. Diabetes Care, 15(2), 232-252.  
 
 
 
